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Epithelial tissues renew rapidly and continuously by reactivating a pool of quiescent 
cells. How the quiescent cells are established, maintained, and reactivated is poorly defined. 
Recent studies suggest that the insulin-like growth factor (IGF)-PI3 kinase-AKT-mTOR 
signaling pathway plays a key role in regulating epithelial cell quiescence-proliferation decision 
but the underlying mechanism remains unclear. In my thesis work, I use a zebrafish model to 
investigate the IGF action in a group of Ca2+-transporting epithelial cells, known as Na+-K+-
ATPase-rich (NaR) cells. When zebrafish are kept in normal and physiological [Ca2+] embryo 
rearing media, NaR cells are quiescent, characterized by a very slow division rate and 
undetectable Akt and Tor activity. When subjected to low [Ca2+] stress, the NaR cells exit the 
quiescent state and proliferate due to elevated IGF1 receptor-mediated Akt and Tor activity. To 
understand how the IGF signaling is activated exclusively in NaR cells under low [Ca2+] stress, I 
first investigated the role of Igfbp5a, a secreted protein belonging to the IGF binding protein 
(IGFBP) family. Zebrafish igfbp5a is specifically expressed in NaR cells and genetic deletion of 
igfbp5a blunted the low Ca2+ stress-induce IGF-Akt-Tor activity and NaR cell reactivation. 
Similarly, knockdown of IGFBP5 in human colon carcinoma cells resulted in reduced IGF-
stimulated cell proliferation. Re-expression of zebrafish or human Igfbp5a/IGFBP5 in NaR cells 
restores NaR cell proliferation. Mechanistically, Igfbp5a acts by binding to IGFs using its ligand-
binding domain and promoting IGF signaling in NaR cells. These results reveal a conserved 
mechanism by which a locally expressed Igfbp activates IGF signaling and promoting cell 
Abstract 
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quiescence-proliferation transition under Ca2+-deficient states. NaR cells are functionally 
equivalent to human intestinal epithelial cells, and they contain all major molecular components 
of the transcellular Ca2+ transport machinery, including the epithelial calcium channel Trpv6. 
Ca2+ is a central intracellular second messenger controlling many aspects of cell biology. I next 
investigated the role of Trpv6 and intracellular [Ca2+]. I discovered that NaR cells are maintained 
in the quiescent state by Trpv6-mediated constitutive Ca2+ influx. Genetic deletion and 
pharmacological inhibition of Trpv6 promote NaR cell quiescence-proliferation transition. In 
zebrafish NaR cells and human colon carcinoma cells, Trpv6/TRPV6 elevated intracellular 
Ca2+ levels and activated PP2A, a group of conserved protein phosphatases, which down-
regulates IGF signaling and promotes the quiescent state. Finally, chemical biology screens and 
genetic experiments identified CaMKK as a link between low Ca2+ stress and IGF signaling 
activation in NaR cells. Depletion of the ER Ca2+ store abolished NaR cell reactivation and IGF 
signaling. These results suggest that ER Ca2+ release in response to the low [Ca2+] stress activates 
CaMKK, which in turn increases IGF signaling and NaR cell reactivation. Taken together, the 
results of my thesis research provide new insights into the epithelial cell proliferation-quiescence 
regulation and have deepened our understanding of cellular quiescence regulation. These new 




The vast majority of cells in multicellular organisms are non-dividing cells, such as 
postmitotic neurons and skeletal muscle cells. Some of these cells are senescent, or terminally 
differentiated cells that can no longer re-enter the cell cycle to proliferate. In contrast, a subset of 
non-dividing cells are ‘re-activatable’. They can re-enter the active cell cycle in response to 
physiological growth signals, thereby these cells are called quiescent cells (Cheung and Rando, 
2013). Cell quiescence protects long-lived cells by delaying cell aging through reducing DNA 
replication, metabolic activity, gene transcription, and mRNA translation. As all of these 
activities are accompanied by molecular damage. Maintaining a pool of quiescent cells that can 
be rapidly reactivated to expand cell population upon stimulation is critical for tissue 
homeostasis and repair (Cheung and Rando, 2013). The homeostatic balance between 
quiescence, proliferation, and differentiation is tightly controlled by integrating intrinsic and 
extrinsic mechanisms. Dysregulation of quiescence is linked to a wide range of hypo- and hyper-
proliferative diseases like osteoporosis, cancer, autoimmune diseases and fibrosis (Fiore et al., 
2018; Kitaori et al., 2009).  
Historically, quiescence had been simply regarded as a passive and dormant cellular state 
lacking proliferative activities. Recent studies have revealed that cellular quiescence is actively 
maintained in the cell and it corresponds to a collection of heterogeneous states (Sun and 
Buttitta, 2017; Yao, 2014). Cell cycle inhibitors such as p21 and p57 (Kippin et al., 2005; 
Matsumoto et al., 2011), as well as, tumor suppressor genes such as Retinoblastoma (Rb) and 
Chapter 1 Introduction 
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p53 have been identified as important regulators for quiescence maintenance (Flamini et al., 
2018; Kim et al., 2017; Liu et al., 2009).  
Recent studies in genetically tractable organisms have suggested that the evolutionarily 
ancient insulin/insulin-like growth factor (IGF)-PI3 kinase-AKT-TOR signaling pathway plays a 
key role in regulating cellular quiescence (Figure 1.1).  Quiescent cells often exhibit reduced PI3 
kinase and TOR activity (Valcourt et al., 2012). Re-activation of the IGF/PI3K/AKT/TOR 
signaling cascade is an evolutionally conserved mechanism that mediates quiescence exit in in 
various cell types across a wide range of species (Figure 1.1). Activation of the imprinted IGF2 
gene also results in reactivation of HSCs from quiescence (Venkatraman et al., 2013b). Mouse 
genetic studies revealed that IGF2 plays a key role in reactivation adult neural stem cell and 
intestinal stem cells (Ferron et al., 2015; Venkatraman et al., 2013a; Ziegler et al., 2019; Ziegler 
et al., 2015). Genetic studies in the mouse model showed that activation of mTOR signaling by 
deletion of the Tsc gene in adult hematopoietic stem cells (HSCs) promotes these cells to exit 
quiescence and begin to proliferate (Chen et al., 2008). Conversely, inhibition of mTOR acivity 
by rapamycin has been shown to preserve the long-term self-renewal and hematopoietic capacity 
of HSCs (Chen et al., 2009). This mechanism is conserved in Drosophila as the long-term self-
renewal capacitity of hematopoietic progenitors is also regulated by insulin-PI3K-TOR signaling 
(Shim et al., 2012). Drosophila neural stem cells are reactivated in response to dietary amino 
acids and this has been attributed to insulin peptide produced by neighboring glia cells (Britton 
and Edgar, 1998; Chell and Brand, 2010; Huang and Wang, 2018; Sousa-Nunes et al., 2011).  
The regulatory role of the IGF/PI3K/AKT/TOR signal pathway in quiescence exit is not 
limited to adult stem cells (Chell and Brand, 2010; Gil-Ranedo et al., 2019; Hemmati et al., 
2019; Sousa-Nunes et al., 2011). Naive T cells, for example, circulate in the body as non-
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dividing and quiescent cells with characteristically low TOR activity. When presented with an 
antigen, TORC1 signaling is increased and these cells exit from the quiescent state and rapidly 
divide (Yang et al., 2013).  
Recent studies from our lab suggested that the IGF/PI3K/AKT/TOR signaling is also 
crucial in regulating the proliferation-quiescence decision in a population of epithelial cells in 
zebrafish larval epidermis (Dai et al., 2014a; Liu et al., 2017a). These mitochondria-rich cells 
known as ionocytes or NaR cells take up Ca2+ from the surrounding aquatic habitat to maintain 
body Ca2+ homeostasis (Hwang, 2009a; Yan and Hwang, 2019a). When zebrafish are kept in 
media containing normal and physiological concentration of Ca2+, NaR cells are most quiescent: 
characterized by a very slow division rate and undetectable Akt and Tor activity. When subjected 
to low [Ca2+] stress, the NaR cells exit the quiescent state and rapidly proliferate due to elevated 
Akt and Tor activity (Dai et al., 2014b; Liu et al., 2017a).  
The similarities among mammalian and fly adult stem cells, T cells, and fish ionocytes 
imply evolutionarily conserved and general mechanisms at work (Figure 1.1). However, how 
activity of this pathway is regulated by environmental or microenvironmental stimuli is poorly 
understood. A recent study in Drosophila intestinal stem cells indicates cytosolic Ca2+ can be a 
signal integration node in the stem cell proliferation-quiescence decision. Another recent study 
discovered that simply growing mouse HSCs in low Ca2+ culture media helps to preserve HSCs’ 
stemness (Luchsinger et al., 2019). Ca2+ is also proposed as a novel guardian for mouse 
embryonic stem cells (mESCs) pluripotency (MacDougall et al., 2019). Reactivation of 
mesenchymal stem cell can be achieved through manipulation of extracellular Ca2+ in mice (Lee 
et al., 2018). Although a possible link between Ca2+ signaling and PI3 kinase-AKT-TOR activity 
(Almasi et al., 2019; Chen et al., 2010; Danciu et al., 2003; Divolis et al., 2016; Lee et al., 2017; 
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Vassiliadis et al., 2011; Zhang et al., 2017) has been postulated, the underlying molecular 
mechanisms are poorly understood. 
In this thesis, I use zebrafish Ca2+-transporting epithelial cells (NaR cells) as an 
experimental model to study how IGF/PI3K/AKT/TOR signaling is regulated by Ca2+ signaling. 
In the following sections, I will introduce more details about IGF signaling pathway, epithelial 
Ca2+ uptake, intracellular Ca2+ signaling, and the zebrafish NaR cell biology.  
1.2 IGF/PI3K/AKT/TOR signaling cascade 
1.2.1 IGF ligands and receptors 
The IGF signaling axis plays fundamental roles in regulating growth, development, 
metabolism, and aging. The IGF system consists of two types of ligands, IGF1 and IGF2 
(Laviola et al., 2007). IGF1 and IGF2 belong to the insulin family of peptide hormones that share 
primary and three-dimensional structures. Mature IGF1 contains 70 amino acids and IGF2 
contains 67 amino acids (Denley et al., 2005). IGF ligands and insulin regulate physiology at 
both the whole organism level and the cellular level (Pollak, 2008a). At the cellular level, IGF 
signaling regulates cell proliferation, differentiation, survival, and migration (Hakuno and 
Takahashi, 2018). 
The action of IGF1 and IGF2 is mediated by several types of receptors.  The IGF1 
receptor (IGF1R) binds to IGF1 with the highest affinity but also binds to IGF2 and insulin with 
approximately 6- and 100-fold lower affinity, respectively. IGF1R belongs to the tyrosine 
receptor kinase (RTK) family and functions as tetramers with two α subunits and two β subunits 
covalently linked. IGF1R gene encodes a single chain amino acid precursor which later gets 
glycosylated, dimerized and cleaved to generate α and β subunits (Ullrich et al., 1986). The α 
subunit contains ligand binding site while the β subunit contains the transmembrane domain and 
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intracellular tyrosine kinase domain (Steele-Perkins et al., 1988). The IGF1R is structurally 
related to insulin receptor (IR). IR exists in two isoforms (IR-A and IR-B) due to alternative 
splicing. While IR-B preferentially binds to insulin, IR-A binds to both insulin and IGF2 (Frasca 
et al., 1999). Binding of IGF ligands to IGF1R or IR-A results in activation of the receptor and 
downstream signaling. The IR exhibits a high degree of homology with the IGF1R, especially in 
their tyrosine kinase domains and can mediates similar intracellular signaling pathways. The IR 
and IGF1R can also form heterodimers (Pandini et al., 2002). The IGF2 receptor (IGF2R), which 
is structurally distinct, preferentially binds to IGF2 (Hakuno and Takahashi, 2018). The IGF2R 
lacks tyrosine kinase activity and has been proposed to target IGF2 to lysosome for degradation 
(O'Gorman et al., 2002). 
The conventional view of insulin signaling and IGF signaling is that insulin signaling 
mediates mainly a metabolic response, whereas IGF signaling mediates growth promoting effects 
(Siddle et al., 2001). This is supported by the results from the IR and IGF1R knock-out mice. 
Mice lacking the IGF1R display pronounced growth retardation (Baker et al., 1993), whereas the 
IR knockout mice had only slight growth retardation. The IR knockout mice die during the first 
week of life from severe hyperglycemia and diabetic ketoacidosis (Accili et al., 1996; Joshi et 
al., 1996). Therefore, the ability of the two receptors to compensate for each other is limited and 
they are not interchangeable. In addition, phenotypes of the insulin knock-out mice and IGF1 
knock-out mice are similar to those of IR knockout and IGF1R knockout, respectively (Duvillie 
et al., 1997; Powell-Braxton et al., 1993). 
1.2.2. Signal transduction downstream of the IGF1R.  
Upon ligand binding, the intracellular tyrosine kinase domain of IGF1R auto-
phosphorylates specific tyrosine residues, which creates docking sites for adaptor proteins such 
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as insulin receptor substrates (IRSs) and Src homology collagen (Shc). They are subsequently 
activated by IGF1R through phosphorylation and then will recruit other substrates, leading to 
activation of different signaling cascades, including the Ras/Raf/MEK/extracellular signal-
regulated kinases (ERK) pathway and the PI3K/AKT/TOR pathway, that stimulate cell 
proliferation and survival (Le Roith, 2003).  
Growth factor receptor-bound 2 (GRB2) consists of a Src homology 2 (SH2) domain that 
binds to phosphorylated tyrosine in IGF1R substrate proteins (IRS1, IRS2, and Shc). The 
interaction between GRB2 and IGF1R substrates leads to the activation of GRB2-associated 
Sone of Sevenless (SOS) guanine nucleotide exchange activity, resulting in the activation of Ras 
small GTPase. Activated Ras interacts with and activates Raf, which in turn phosphorylates and 
activates MEK, then activates ERK. Activated ERK is shown to be required for the IGF-induced 
DNA synthesis and cell survival in various cell types (McCubrey et al., 2007).  
The other major intracellular signaling pathway downstream of IGF1R activation is the 
PI3K/AKT/TOR pathway. Class I phosphoinositide 3-kinases (PI3Ks) comprise one catalytic 
subunits (p110) and a regulatory subunit of variable sizes (Jean and Kiger, 2014; Thorpe et al., 
2015). RTKs primarily activate one subset within this group, Class 1A PI3K, which are 
comprised of a heterodimer of one p110α, β, or γ catalytic subunit and one p85α (or its splice 
variants p50α and p55α), p85β or other regulatory subunits. Class 1B PI3Ks consist of the p110γ 
catalytic subunit and the p101 and p87 regulatory subunits and they are mainly activated by G-
protein coupled receptor (GPCR) signaling instead (Vadas et al., 2013). For Class IA PI3Ks, the 
interaction of regulatory and catalytic subunits is constitutive in the absence of signals and 
suppresses the activity of catalytic subunits (Miled et al., 2007; Vadas et al., 2011). Binding of 
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the regulatory subunit to specific motifs harboring phosphorylated tyrosine residues via its SH2 
domains relieves the inhibition of p110 subunits.  
Activated PI3K leads to increased level of phosphatidylinositol 3,4,5-trisphosphate 
(PI(3,4,5)P3) and PI(3,4)P2 in the membrane, which recruits the critical downstream kinase AKT 
to the plasma membrane through the binding of its pleckstrin homology (PH) domain to PIP3. 
AKT is a serine/threonine-specific protein kinase playing a fundamental role in numerous 
cellular processes (Manning and Toker, 2017). AKT is activated through phosphorylation at its 
Thr308 and Ser473 residues by phosphoinositide dependent protein kinase 1 (PDK1) and TOR 
complex 2 (TORC2), respectively (Moore et al., 2011). Normally, phosphorylation of Ser473 
promotes phosphorylation of Thr308, stabilizing the activated form of AKT. However, AKT 
lacking Ser 473 phosphorylation can still be active, but with greatly lowered capacity (Alessi et 
al., 1996). A third, constitutively phosphorylated site at Thr450 in the turn motif of AKT is 
essential for its folding and stability (Facchinetti et al., 2008). Fully-activated AKT can be 
observed within seconds to minutes after growth factor stimulation. The down-regulation of 
AKT phosphorylation is achieved through phosphatase and tensin homolog (PTEN), which 
dephosphorylates PIP3 to PIP2, limiting AKT binding to the membrane, therefore decreasing its 
activity. Additionally, protein phosphatase 2A (PP2A) and the PH domain leucine-rich repeat 
protein phosphatases (PHLPP1 and PHLPP2) can dephosphorylate AKT at Thr308 and Ser473 
sites, respectively (Andjelkovic et al., 1996; Gao et al., 2005).  
A recent study suggested that the PH domain within the SIN1 component of TORC2 
binds to PIP3, relieving the autoinhibition of TOR kinase activity (Liu et al., 2015). PIP3 binding 
therefore has dual functions of re-localizing TORC2 to membranes (where AKT is also 
recruited) and relieving conformational constraints on the TOR kinase, allowing AKT 
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phosphorylation. Another study using intracellular compartment-specific reporters, however,  
concluded that PI3K activation is dispensable for TORC2 activity (Ebner et al., 2017b).  
The conventional model for AKT signaling suggests that activated AKT dissociates from 
the membrane and freely diffuses through the cytosol in a “locked” active state, phosphorylating 
substrates in other subcellular compartments. This model has been challenged by recent 
publications which have demonstrated active AKT is primarily associated with cellular 
membranes (Ebner et al., 2017a). Binding of AKT to PIP3 results in a conformational change in 
AKT that relieves the steric block against substrate binding. This is followed by phosphorylation 
of its hydrophobic motif, resulting in high-affinity substrate binding and activation (Lucic et al., 
2018). Although earlier studies suggested that PIP3 is exclusively localized to the plasma 
membrane, more recent reports have provided evidence for endomembrane pools of PIP3 and 
PI(3,4)P2 that directly contribute to AKT activation (Jethwa et al., 2015; Liu et al., 2018b; Siess 
and Leonard, 2019). Activated AKT can phosphorylate up to 200 substrates. Restriction of AKT 
activity to subcellular membrane compartments helps define the specificity of AKT signaling by 
targeting the kinase to a particular set of substrates. Knockdown of the endosomal protein Appl1 
in zebrafish resulted in decreased phosphorylation of the Akt substrate glycogen synthase kinase 
(Gsk) 3β, but not tuberous sclerosis complex 2 (Tsc2) (Schenck et al., 2008), demonstrating that 
Akt localization to early endosomes restricts Akt substrate specificity to Gsk3β. Phosphorylation 
of another AKT substrate TSC2 appears to be restricted to lysosomes (Demetriades et al., 2014; 
Menon et al., 2014), although whether lysosomal localization of AKT is sufficient for TSC2 
phosphorylation is currently unknown.  
AKT phosphorylation of TSC2 releases TSC’s inhibition of the Ras homolog enriched in 
brain (RHEB). GTP-binding RHEB directly activates the mechanistic target of rapamycin 
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Complex 1 (mTORC1 or TORC1). TORC1 has three core components: TOR kinase, the 
regulatory-associated protein of TOR (Raptor), and mammalian lethal with SEC13 protein8 
(mLST8) (Kim et al., 2002). Additionally, AKT can phosphorylate PRAS40, a non-core 
component of TOC1. PRAS40 functions as a negative regulator of TORC1 and its 
phosphorylation mediated by AKT results in its disassociation from TORC1 and relieve its 
inhibition (Sancak et al., 2007; Vander Haar et al., 2007). TORC1 is a highly conserved regulator 
of cell growth and is one of the most highly integrated signaling nodes present in all cells 
(Beauchamp and Platanias, 2013; Dibble and Manning, 2013; Laplante and Sabatini, 2012). It 
plays a central role in regulating the production of proteins, lipids, and nucleotides for cell 
division while also suppressing catabolic pathways such as autophagy and therefore controls the 
balance between anabolism and catabolism in response to environmental conditions (Howell et 
al., 2013; Saxton and Sabatini, 2017).  
1.2.3 IGFBP5 
The bioavailability and biological activity of IGFs also is further regulated by a family of 
secreted IGF binding proteins (IGFBPs) of which there are six distinct types in most vertebrates 
(Allard and Duan 2018). These IGFBPs share significant sequence homology and they are 
capable of binding IGFs with equal or greater affinity than the IGF1R. They regulate IGF 
signaling both globally and locally. Because IGFBPs do not bind to insulin, these proteins can 
prevent potential cross-binding of IGFs to the IR (Clemmons, 1993). 
The precursor forms of all six IGFBPs contain a signal peptide ranging from 20 to 39 
amino acids. The mature proteins are found in the extracellular space. They share a highly 
conserved structure that consists of three domains: an N-terminal highly cysteine rich region (N-
domain), a C-terminal cysteine rich region (C-domain), and a linker region (L-domain). The N-
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terminal and C-terminal regions contribute to IGF binding and are highly conserved among the 
IGFBPs and across species. The L-domain is variable and contain sites of post-translational 
modification such as glycosylation, serine/threonine phosphorylation and proteolysis (Jones and 
Clemmons, 1995). 
IGFBP5 is the most highly conserved members of the IGFBP family (Baxter and Twigg, 
2009; Duan and Xu, 2005). Similar to other IGFBPs, human IGFBP-5 has a secretory signal 
peptide of 20 amino acids and the mature protein contains 252 amino acids (Wetterau et al., 
1999). The primary IGF binding site is located in the N-domain (Kalus et al., 1998). Mutations 
of five residues (K68N/P69Q/L70Q/L73Q/ L74Q) in the N-domain caused a 1,000-fold 
reduction in its affinity for IGF1 (Imai et al., 2000). The N-domain also contains several acidic 
residues and prolines that are critical for transcriptional activation activity (Zhao et al., 2006b). 
The C-domain of IGFBP5 has a stretch of basic amino acids (R201-R218) that are involved in 
nuclear localization (Xu et al., 2004), acid-labile subunit (ALS) binding (Firth et al., 2001), and 
extracellular matrix (ECM) binding (Zheng et al., 1998b). In the blood, IGFBP5 forms a 
complex with IGF and ALS (Baxter et al., 1989; Twigg and Baxter, 1998), which can prolong 
the half-life of IGFs and prevent the potential hypoglycemic effect of IGFs (Binoux and 
Hossenlopp, 1988; Daughaday and Kapadia, 1989; Lewitt et al., 1994; Ueki et al., 2000). Studies 
with cultured human fetal fibroblasts suggest that binding to ECM can protect IGFBP5 from 
degradation and potentiate the biological actions of IGF1 (Jones et al., 1993). 
1.2.4 IGF signaling in human diseases 
IGF1 and IGF2 are both strong mitogens in a wide variety of cancer cell lines. High 
circulating levels of IGF1 have been associated with increased risks for breast, prostate, and 
colon cancers (Pollak, 2008b). IGF2 is maternally imprinted, and loss of this imprinting results 
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in increased IGF2 production. This process was first described in Wilms tumor, a childhood 
nephroblastoma, and has been subsequently identified in adult tumors. Increased IGF2 
production is also commonly associated with an increased risk of colon cancer (Cui et al., 2003). 
It has been shown that IGF2 is the single most overexpressed gene in colorectal neoplasia 
relative to normal colorectal mucosa (Zhang et al., 1997). IGF1R is ubiquitously expressed in 
normal tissues and plays an important role in growth and various physiological functions. 
Increases in IGF1R have been shown in different types of cancers, such as melanomas, and 
carcinomas. The IGF signaling has been implicated with the transformation of normal cells to 
malignant cells, and also with cancer cell proliferation, growth, survival, and metastasis.  
Therefore,  it has been an attractive therapeutic target (Denduluri et al., 2015; Laviola et al., 
2007; Siddle, 2012; Weroha and Haluska, 2012). 
 There are three major classes of IGF/IGF1R inhibitors developed and clinically tested 
(Chen and Sharon, 2013): 1) IGF1R targeting monoclonal antibodies, 2) IGF1 and IGF2 
neutralizing monoclonal antibodies, and 3) small molecule tyrosine kinase inhibitors. Early trials 
of these IGF1R inhibitors have clearly shown therapeutic benefit by slowing disease progression. 
However, these results were not replicable in larger phase III randomized trials. Another 
potential drawback of such approaches is the negative side effects or toxicities due to the 
interference with the insulin signaling pathway. Instead, IGFBPs could potentially serve as better 
therapeutic targets as these proteins do not bind insulin and thus do not interfere with insulin-
insulin receptor interactions (Brahmkhatri et al., 2015). 
The action of IGFBP5 on IGF signaling has been intensively studied in mammalian cells. 
In vitro studies suggested that IGFBP5 can both potentiate and/or inhibit IGF signaling (Conover 
and Kiefer, 1993; Dai et al., 2010; Ding et al., 2016; Kiefer et al., 1992; Schneider et al., 2001). 
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IGFBP5 has been associated with metastasis and poor prognosis in breast cancer cells (Mita et 
al., 2007; Wang et al., 2008). However, forced-overexpression of IGFBP5 in breast cancer cell 
lines has been shown to inhibit cell growth (Butt et al., 2003). Further studies suggested that the 
subcellular localization of IGFBP5 influences its biological effect. Cytoplasmic IGFBP5 
promoted cell proliferation and motility while nuclear IGFBP5 did not (Akkiprik et al., 2009). 
IGF-independent activity for IGFBP5 is thought to involve the AKT pathway with effects on 
ovarian cancer angiogenesis (Tripathi et al., 2009).  
1.3 Epithelial Ca2+-transporting cells 
1.3.1 NaR cells are conserved from fish to human 
NaR cells belong to a large family of specialized epithelial cells known as ionocytes that 
are responsible for ion homeostasis regulation in different species. Ionocytes, formerly known as 
chloride cells,  were originally described in the gills of seawater acclimated European eel 
(Anguilla anguilla) (Keys and Willmer, 1932). They were so named because they secret excess 
sodium and chloride. The secretory mechanism in these teleost ionocytes is functionally 
comparable to that in the intercalated cells in mammalian kidney collecting duct (Haas and 
Forbush, 2000). Recently, this term has also been adopted to describe a new lung cell type that 
express high levels of cystic fibrosis transmembrane conductance regulator (CFTR) (Montoro et 
al., 2018; Plasschaert et al., 2018). Mutation of CFTR disrupts airway fluid and mucus 
physiology, resulting in cystic fibrosis (De Boeck and Amaral, 2016).  
In addition to the renal and airway epithelium, ionocytes are also known to exist in the 
human epididymis (Palacios et al., 1991), ciliary epithelium, retinal pigment epithelium of the 
eye, and liver epithelium (Marshall, 2011). These cells contain elaborate basolateral infoldings 
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that produce an extensive intracellular tubular system associated with the ion-transporting 
enzyme Na+, K+-ATPase (Karnaky et al., 1976) and numerous mitochondria. 
Ionocyte cell specification and development are most extensively studied in zebrafish 
(Figure 1.3). All types of ionocytes originate from a population of epidermal stem cells that 
express ΔNp63 (an isoform of transcription factor p63, a member of p53) (Lee and Kimelman, 
2002). p63 induces the specification of epidermal ectoderm and inhibits the neural ectoderm 
formation during early gastrulation (Aberdam et al., 2007; Bakkers et al., 2002). After 
gastrulation, p63-positive epidermal stem cells differentiate into Forkhead‐box I transcription 
factor 3a (Foxi3a) -activated ionocyte progenitors and Foxi3a-inactive Keratinocyte progenitors 
by a Notch signaling-mediated lateral inhibition mechanism (Hsiao et al., 2007). Kruppel-like 
factor 4 (Klf4) has recently been shown to play a crucial role in maintaining the ionocyte 
progenitor cell pool by stimulating epidermal cell stem proliferation (Chen et al., 2019).  
The ionocyte progenitors then give rise to different types of ionocytes, expressing 
respective unique sets of transporters and enzymes, through complicated transcriptional networks 
mediated by Foxi3a/b, Foxi1, and Glial cell missing 2 (Gcm2) (Chang et al., 2009; Esaki et al., 
2009). The detailed regulatory mechanisms controlling the specification of ionocyte subtypes are 
not fully understood and need to be further elucidated. Five subtypes of ionocytes have been 
identified to date: Na+‐K+‐ATPase rich (NaR) cells, H+‐ATPase‐rich (HR) cells, Na+‐
Cl− cotransporter (NCC) expressing cells, K+‐secreting (KS) cells and solute carrier 26-
expressing (SLC26) cells (Abbas et al., 2011; Bayaa et al., 2009; Lin et al., 2006; Wang et al., 
2009). These different ionocytes are required to deal with diverse ionic changes in varied 
hypotonic milieus (Hwang and Chou, 2013).  
 14 
Among the five types of ionocytes, NaR cells are specialized for Ca2+ uptake. Zebrafish 
are freshwater fish and must be able to maintain normal blood Ca2+ levels. Active uptake of Ca2+ 
is therefore a requisite for them to live and grow. As early as 1981, physiological studies in 
freshwater teleosts have speculated that ionocytes are responsible for calcium uptake (Payan et 
al., 1981). The need of Ca2+ uptake is not unique to aquatic habitants. Terrestrial animals like 
humans also uptake Ca2+ transportation in the intestine and kidney . On a daily basis, around 
80% Ca2+ filtered at the glomerulus will be reabsorbed and 20% is via an active transcellular 
Ca2+ transport route in the distal part of the nephron. During pregnancy and lactation, Ca2+ 
transport from mother to the fetus and Ca2+ secretion to the milk both require active Ca2+ 
transportation against the chemical gradient (Lee et al., 2009). Therefore, Ca2+ -transporting 
epithelial cells exist in epithelium in the human gastrointestinal tract, bone, kidney, and placenta 
(Hoenderop et al., 2005).   
In early developmental stages of zebrafish, before the gills are fully developed and 
functional, NaR cells are located in the epithelia covering the yolk. These extra-branchial NaR 
cells are considered to be the major site of ionic regulation in embryonic and larval zebrafish 
(Hwang and Chou, 2013). The transparency of zebrafish embryos and larvae as well as their ex 
utero development allows for noninvasive real-time imaging to monitor biological events in vivo 
(Lawson and Weinstein, 2002). Epithelia of zebrafish embryos or larvae are therefore an 
excellent model to study the functions of vertebrate Ca2+-transporting epithelia. 
Early studies in rainbow trout (Oncorhynchus mykiss) and Nile tilapia (Oreochromis 
niloticus) demonstrated that low Ca2+ adaptation increases the density of NaR cell-like Ca2+-
transporting cells in parallel with Ca2+ transport capacity (McCormick et al., 1992). Studies 
about the hormonal regulation in low Ca2+ adaptation in zebrafish revealed that a set of 
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hormones (e.g., parathyroid hormones, stanniocalcin, cortisol, isotocin) are responsible for 
regulating NaR cell number through controlling NaR cell differentiation from epidermal stem 
cells (Lin and Hwang, 2016). Studies from our group demonstrated that the increased NaR cells 
in zebrafish larvae under low Ca2+ adaptation are mainly due to the elevated proliferation of pre-
existing NaR cells (Dai et al., 2014a; Liu et al., 2017a). Similarly, dietary Ca2+ levels have been 
inversely associated with colon cancer risk for a long time (Han et al., 2015; Lamprecht and 
Lipkin, 2003; Peterlik and Cross, 2005). Presumably, epithelial cells in the colon epithelium can 
undergo an aberrant reactivation and contribute to the hyperactivity of cell proliferation in colon 
cancer initiation and progression. Mitochondrion-rich phenotype is also strongly associated with 
poor prognosis of ERG negative prostate cancers (Grupp et al., 2013). After acute kidney injury, 
resident differentiated tubule cells are known to be self-renew and produce differentiated 
offsprings This proliferation capacity is required for the tissue repair (Feng et al., 2015; 
Vogetseder et al., 2007; Vogetseder et al., 2008). Intercalated cells in the mammalian kidney 
epithelium were also thought to be terminally differentiated and unable to further proliferate. 
However, proliferation of these intercalated cells has been shown during acidosis in mouse and 
rat kidney (Duong Van Huyen et al., 2008; Welsh-Bacic et al., 2011). This elevated proliferation 
of intercalated cells may contribute to the adaptive re-modelling of the collecting duct. In 
addition, unrestrained intercalated cell proliferation was linked to chromophobe renal cell 
carcinomas and oncocytomas of the kidney (Storkel et al., 1989). IGF/PI3K/AKT/TOR pathway 
seems to play a decisive role in chromophobe renal cell carcinoma in preclinical models (Shuch 
et al., 2012). Therefore, studying the activation mechanism of IGF/PI3K/AKT/TOR signaling 
cascade in fish NaR cells can contribute to the general understanding of the quiescence to 
proliferation state switch of ionocytes. In addition to the potential indication in cancer therapy, 
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IGFPB5 might also be a conserved regulator for fish osmoregulation. Recently, transcriptome 
analysis of different ecotypes of stickleback identified igfbp5 as a potential regulator for salinity 
adaptation as it is differentially expressed in marine and freshwater sticklebacks (Kusakabe et al., 
2017). Igfbp5 is also found to be highly expressed in another anadromous fish, the Atlantic 
salmon (Breves et al., 2017). Therefore, elucidating role of igfbp5 in the adaptive proliferation of 
NaR cells under low Ca2+ stress can shed light on our limited knowledge of Igfbp5 in the fish 
homeostasis regulation as well. 
1.3.2 Epithelial Ca2+ channel TRPV6 
The transcellular Ca2+ transportation pathway in epithelial cells is a multistep process, 
consisting of Ca2+ entry through the apical membrane of epithelial cells, Ca2+ transportation from 
the entry point to the basolateral membrane, and Ca2+ extrusion into the circulatory system 
(Hoenderop et al., 2005). The molecular identity of the apical Ca2+ influx protein in intestinal 
epithelia was unraveled by functional expression cloning of RNA isolated from the duodenum of 
rats fed with a Ca2+ -deficient diet. The epithelial Ca2+ channel (ECaC, later known as Trpv6) 
transcript expression was enriched in rat small intestine and colon (Peng et al., 1999). In mice, 
significant Trpv6 expression was shown in duodenum, cecum, and distal colon (Rievaj et al., 
2013). Immunohistochemistry has shown TRPV6 localizes in the apical membrane of villous 
cells in human intestine (Zhuang et al., 2002).  
TRPV6 belongs to transient receptor potential (TRP) channel superfamily. The trp gene 
was initially discovered in Drosophila as a phototransduction channel in late 1960s (Cosens and 
Manning, 1969). Since then, more then 100 TRP genes have been identified based on a common 
structure feature. They act as cellular sensors and can be activated by a plethora of extracellular 
and intracellular stimuli including temperature changes, chemicals, mechanical force, and light 
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(Nilius and Flockerzi, 2014). Most TRP channels are permeable to Ca2+, but only two, TRPV5 
(synonyms ECaC1, CaT2) and TRPV6 (synonyms ECaC2, CaT1, CaT-like) are highly Ca2+-
selective with PCa/PNa ratios > 100 (Vennekens et al., 2000). Compared to TRPV6, TRPV5 is 
mainly expressed in the kidney epithelium. TRPV5 and TRPV6 are juxtaposed on the human 
chromosome 7 with a distance of only 22kb, suggesting an evolutionary gene duplication event. 
In the zebrafish genome, only one orthologue of TRPV5/6 is present (Vanoevelen et al., 2011). 
Zebrafish Trpv6 was cloned in 2005 (Pan et al., 2005). 
Functional analysis indicates TRPV6 constitutes the rate-limiting step in the tricellular 
Ca2+ transport pathway in intestinal epithelia (Hoenderop et al., 2005). Two Trpv6-deficient 
mice mutants generated independently both exhibited decreased intestinal Ca2+ absorption under 
Ca2+-restricted diets (Bianco et al., 2007; Lieben et al., 2010; Weissgerber et al., 2011), 
demonstrating a critical role of TRPV6 in Ca2+ absorption, especially under conditions of limited 
Ca2+ supplies. This function is conserved in zebrafish. Zebrafish trpv6 expression in NaR cells is 
elevated in response to low environmental Ca2+ levels (Liao et al., 2007). Zebrafish trpv6 
mutants display a severe Ca2+ deficiency in calcified structures from early larval stage and are 
lethal around 7-9 dpf (Vanoevelen et al., 2011).  
In addition to the intestine and kidney, maternal-fetal transport of Ca2+ also requires an 
transcellular transport mechanism, as the serum Ca2+ is higher in fetuses than in mothers 
(Schauberger and Pitkin, 1979). Recent studies have reported that patients with TRPV6 mutations 
have transient neonatal hyperparathyroidism (TNHP) and severe skeletal under-mineralization, 
most likely due to a defect in the maternal-fetal calcium transport through the placenta (Burren et 




Ca2+-dependent feedback regulation of TRPV6 has been demonstrated by whole cell 
patch clamp experiments in HEK293 cells as well as structural analysis using cryo-electron 
microscopy (Bate et al., 2018; Singh et al., 2018a). Calmodulin have been shown to directly 
interact with TRPV6 (Kovalevskaya et al., 2012; Lambers et al., 2004) and TRPV6 channel 
inactivation was proposed to occur via a CaM-dependent manner (Lambers et al., 2004). 
Mutation of TRPV6 CaM-binding sites significantly increased the intracellular Ca2+ 
concentration in HEK293 cells (Cao et al., 2013).  
It is possible TRPV6 has functions beyond as a Ca2+ channel. TRPV6 channel 
permeability is estimated to be about 100 times more selective for Ca2+ than for Na+, and a single 
aspartate residue (D542 in human, D541 in mice and D539 in zebrafish) in the pore-forming 
region between the 5th and the 6th transmembrane domain of TRPV6 determines such selectivity 
(Voets et al., 2004). Under physiological conditions, TRPV6 mainly conducts Ca2+ ions.  
However, in the absence of divalent cations, the channel conducts monovalent ions such as Na+. 
An increase in Ca2+ concentration leads to an increase of Ca2+ current but a reduction of Na+ 
current or whole cell current. As Ca2+ continues to increase, the Ca2+ current becomes dominant 
again and the channel is highly Ca2+-selective. When HEK293 cells overexpressing TRPV6 were 
exposed to divalent-free (DVF) solutions, currents induced by voltage ramps/steps increased 
markedly compared to that in 10 mM Ca2+ containing solution (Yue et al., 2001).  
This conversion to non-selectivity in the absence of Ca2+ is referred as anomalous mole 
fraction effect (AMFE) and has also been observed in TRPV5 and L-type voltage-gated Ca2+ 
channels. AMFE is generally accepted as evidence for a channel pore containing multiple 
binding sites occupied by permeant ions moving in single file through the channel (Hille, 1978). 
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Crystal structures of TRPV6 were resolved recently through Cryo-EM and further support the 
kinetic model proposed for ion permeation through TRPV6 pore region (McGoldrick et al., 
2018; Saotome et al., 2016). Consistent with the physiological studies, non-equilibrium 
simulations based on the crystal structure suggest a “knock-off” Ca2+ permission mechanism: the 
high affinity of D541 side chain to Ca2+ makes the absence of a bound Ca2+ energetically 
unfavorable. Removal of Ca2+ from D541 aspartate ring requires an immediate replacement of 
another Ca2+ ion and therefore a substantially high local Ca2+ would be necessary for the Ca2+ 
permission to proceed (Sakipov et al., 2018). On the other side, Na+ permeation through TRPV6 
is completely different. Many Na+ ions can occupy the selectivity filter and the permission of 
Na+ is completely independent of the approaching Na+ from the above. TRPV6 has been known 
to be subjected to Ca2+-dependent feedback inhibition through interaction with calmodulin in the 
intracellular domain (Bate et al., 2018; Cao et al., 2013; Lambers et al., 2004; Singh et al., 
2018a). In contrast, Na+ current do not inactivate TRPV6 channel (Nilius et al., 2002; Vennekens 
et al., 2000). Naturally, inactivated Na+ influx might result in a change of the membrane 
potential and thus contribute to the cell status change. 
1.3.3 Implication of TRPV6 in cell cycle regulation 
TRPV6 has been implicated in malignancies and its oncogenic potential has been 
suggested by in vitro studies (Lehen'kyi et al., 2012; Santoni et al., 2011). Clinically, TRPV6 
expression correlates with Gleason scores in prostate cancer and with poor prognosis in breast 
cancer (Peng et al., 2000; Peters et al., 2012). Elevated expression of TRPV6 mRNA was 
detected in human prostate cancer cell lines (LNCaP and PC-3) in comparison to normal and 
benign cells (PrEC, BPH1) (Peng et al., 2001). Immunohistochemistry has shown substantial 
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increase of TRPV6 proteins in carcinomas of prostate, colon, breast, thyroid cancers compared to 
normal tissue (Zhuang et al., 2002).  
Different results have been reported for TRPV6 action.  Silencing TRPV6 expression 
attenuated cell proliferation and increased apoptosis in prostate, colon, breast, and pancreatic 
cancer cell lines (Lehen'Kyi et al., 2007; Peleg et al., 2010; Peters et al., 2012; Skrzypski et al., 
2016b), presumably because of diminished activity of the Ca2+/NFAT-dependent pathway. 
Soricidin-derived TRPV6-antagonistic peptides (SOR-C13 and SOR-C27) was found to 
effectively inhibit tumor growth in mice bearing xenografted ovarian tumors (Xue et al., 2018). 
In a recent Phase I clinical trial, two of four patients showed stable decease of tumor size after 
two cycles of treatment of SOR-C13 (Fu et al., 2017). On the contrary, other studies suggested 
that TRPV6 may act as a tumor suppressor. Curcumin, a ligand of 1,25-vitamine-D3 receptor, 
exerts chemoprevention effects in colon cancer cells through promoting Ca2+ uptake by up-
regulation of TRPV6 expression (Bartik et al., 2010). Capsaicin, which is normally considered to 
be a TRPV1 agonist, induce cell apoptosis in gastric cancer cells and small cell lung cancers and 
such effects were dependent on TRPV6 activity (Allard and Duan, 2018; Chow et al., 2007; Lau 
et al., 2014). Dietary calcium intake has been associated negatively with colon cancer risk for a 
long time (Han et al., 2015; Meng et al., 2018b; Peterlik et al., 2009). High calcium diet 
abrogated hyperplasia in a citrobacter rodentium-induced transmissible murine colonic 
hyperplasia (TMCH) model (Peleg et al., 2010).   
These discrepancies can partially be explained by the different stages or type of cancer 
cells/tumor tissues used in different studies. However, as all the studies by far were carried out in 
cancer cell lines or tumor tissues which are already advanced in cancer progression. it remains 
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unclear whether TRPV6-mediated Ca2+ influx or ion-independent function of TRPV6 is involved 
in cell proliferation and whether it has an oncogenic potential in vivo. 
1.3.4 Other Ca2+ signaling machinery in NaR cells  
In epithelial cells responsible for active Ca2+ uptake, Ca2+ buffer proteins are crucial 
(Feher and Wasserman, 1979). In the mammalian kidney epithelium, calbindin-D9k and -D28k 
are known to play important roles in facilitating cytosolic Ca2+ diffusion between the apical and 
basolateral surfaces of the cell to achieve transcellular Ca2+ transport (Feher et al., 1992). 
Calbindin-D28k knockout mice exhibited a two times higher urinary Ca2+ excretion compared 
with their wild-type littermates, but no significant differences in serum Ca2+, PTH, or in serum 
and urinary Mg2+ and  phosphate were observed (Sooy et al., 2000). Calbindin-D9k are also 
known to be expressed and localized in the bovine uterus and placenta during pregnancy together 
with TRPV6 (Sprekeler et al., 2012).  Additionally, it is proposed that Ca2+-enriched vesicles and 
lysosome can be used in those Ca2+-transporting cells to sequester Ca2+ and facilitate its 
movement to the basolateral membrane (Larsson and Nemere, 2002). 
S100A10, which belong to the S100 EF-hand Ca2+ binding protein family, has been 
shown to be associated with TRPV5 and TRPV6 and regulate their activity (van de Graaf et al., 
2003). However, S100A10 is the only S100 member that does not bind Ca2+. Both Ca2+-binding 
sites in S100A10 are missing and the function of S100A10 is suggested to be Ca2+-independent 
(Zimmer et al., 2003). Interestingly, zebrafish s100a11 exhibits a salt-and-pepper expression 
pattern in zebrafish embryonic skin (Kraemer et al., 2008). S100A11 expression is increased in 
various tumors, and is associated with tumor metastasis as well as poor prognosis in pancreatic, 
lung and colon cancers (Cross et al., 2005; Melle et al., 2006).  
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In zebrafish, six plasma membrane Ca2+ -ATPases (PMCA) and seven isoforms of Na+/ 
Ca2+ exchanger (NCX1) have been identified, of which only PMCA2 and NCX1b were found in 
NaR cells, as determined by triple in situ hybridization and immunocytochemistry (Liao et al., 
2007). While all trpv6-expressing cells co-expressed ncx1b, only half of the trpv6-expressing 
cells co-expressed pmca2, indicating the possible existence of sub-populations within NaR cells. 
The NCX has low Ca2+ affinity but high capacity for Ca2+ transport, whereas the PMCA has a 
high Ca2+ affinity but low transport capacity. Thus, traditionally, the PMCA pump has been 
attributed a housekeeping role in maintaining cytosolic Ca2+, and the NCX the dynamic role of 
counteracting large cytosolic Ca2+ variations (Brini and Carafoli, 2011). NCX, like other 
secondary active transporters, utilizes the electrochemical gradient of Na+ across the membrane, 
which is generated by the primary active transporter, the Na+-K+-ATPase. Na+-K+-ATPase, a 
heterodimeric integral membrane protein composed of a catalytic subunit and a smaller 
glycosylated subunit, enables ion transport directly through movement of ions across epithelial 
membranes. Moreover, of the six NKAα1 subunit genes, only atp1a1a.1 was expressed in NaR 
cells (Liao et al., 2009). 
In mammals, PMCA2 was found to be expressed in the hair cell hair bundle in the inner 
ear, suggesting that it may be responsible for endolymph Ca2+ homeostasis (Shull, 2000). 
Mammalian PMCA1 was found to be a major Ca2+ extrusion transporter for Ca2+ absorption in 
intestine and kidney (Armbrecht et al., 1999). However, the opposite is true in zebrafish as 
zebrafish pmca2 is expressed in a housekeeping. Zebrafish pmca1a on the other hand, showed an 
expression pattern in hair cells during embryonic stages (Liao et al., 2007).  
In zebrafish, the NCX1b isoform is required for Ca2+ extrusion in gill/skin ionocytes, 
while its paralogue NCX1a is expressed specifically in the heart where mutant forms cause 
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cardiac fibrillations (Langenbacher et al., 2005). Conversely, a single NCX1 performs the roles 
of both NCX1a and NCX1b in mammals (Cho et al., 2003). 
1.3.5 Intracellular Ca2+ signaling 
Ca2+ signaling is crucial for many cell behaviors, including muscle contraction, secretion, 
fertilization of oocytes, embryonic pattern formation, cell proliferation, differentiation, and cell 
death. Starting from 1970s, evidence began to emerge suggesting that cytosolic Ca2+ levels are 
involved in the regulation of cell proliferation (Balk, 1971; Durham and Walton, 1982). It was 
observed that while tumor cells can proliferate in Ca2+-depleted medium, normal cells cannot, 
suggesting normal cells probably have higher intracellular Ca2+ storage (Boynton and Whitfield, 
1976). Indeed, tumor cells are reported to have several folds higher intracellular Ca2+ 
concentration ([Ca2+]i) level compared to normal cells (Mignen et al., 2017).  
The level of free Ca2+  in the extracellular fluids ([Ca2+]e ≈ 1 mM) is approximately 
10,000 times higher than the level of resting  Ca2+ in the cytosol ([Ca2+]i ≈ 100 nM). Correlation 
of Ca2+ signals and T cell proliferation revealed that an average rise of [Ca2+]i from 40 nM to 220 
nM is sufficient to induce maximal proliferation (Schwarz et al., 2007). However, increased 
global or local Ca2+  level is not always pro-proliferative. Pharmacological activation of TRPV4 
channels reduces proliferation of tumor endothelial cells (Thoppil et al., 2015), suggesting the 
role of [Ca2+]i in cell cycle regulation is context dependent. 
Unlike many other intracellular signals, Ca2+ cannot be created from an enzymatic 
reaction or converted into an inactive metabolite. Source of Ca2+ signals is either from the 
external medium or the from internal Ca2+ stores. External Ca2+ entry is mediated by the opening 
of plasma membrane Ca2+ -permeable ion channels such as voltage-gated (classified through 
electrophysiological properties into L-type, T-type, P/Q-type, R-type and N-type), or members of 
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the transient receptor potential (TRP) family (Deliot and Constantin, 2015). [Ca2+]i levels can 
also be increased through Ca2+ release from internal Ca2+ stores, such as inositol 1,4,5-
triphosphate (IP3), which activates the IP3 receptors (IP3Rs) in the endoplasmic reticulum (ER). 
IP3 can be generated through the stimulation of GPCRs or RTKs, through activation of 
phospholipase C (PLC) (Nixon et al., 1994; Taylor and Machaca, 2018). Ca2+ release from ER 
can also mediated by ryanodine receptors (RyRs). RyRs are the largest known ion channels and 
bind to the plant alkaloid ryanodine (Lanner et al., 2010; Otsu et al., 1990). Several TRP 
channels, in addition to their roles in the plasma membrane, may also mediate release of Ca2+  
from intracellular stores (Gees et al., 2010). ER-localized TRPV channels have been recently 
demonstrated to be responsible for ER Ca2+ release and are required for glucose starvation-
induced AMPK activation (Li et al., 2019). The depletion of the ER Ca2+ store can be detected 
by the ER Ca2+ sensor stromal interaction molecule 1 (STIM1). STIM1 proteins are redistributed 
upon Ca2+ store depletion and subsequently interact with plasma membrane ORAI1 proteins and 
lead to store-operated Ca2+ entry (SOCE) (Hogan and Rao, 2015).  
Due to the spatial distribution and temporal kinetics of different Ca2+ permeable 
molecules, the actual elevation of intracellular Ca2+ can vary widely between different cell types 
and sub-cellular compartments, and local concentrations have been estimated to reach levels as 
high as 10-100 μM during an induced Ca2+ influx from the plasma membrane or Ca2+ release 
from ER Ca2+ store (Berridge, 2006; Matthews et al., 2013).  
Once [Ca2+]i or local Ca2+ concentration increases, Ca2+-sensitive proteins propagate the 
signal and many of these signal transduction events are mediated by members of the EF-hand 
family of calcium binding proteins via interaction with target proteins in a Ca2+-dependent 
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manner. The EF-hand calcium-binding protein family can further be classified as sensor or buffer 
proteins based on their function (Ikura, 1996).  
Another mechanism to tightly control cytosolic Ca2+ level is through Ca2+ uptake into the 
intracellular ER Ca2+ store mediated by sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), 
which is widely distributed in the endoplasmic reticulum of most cells. ER is the major 
intracellular Ca2+ reservoir and it is also responsible for protein synthesis and post-translational 
modifications (Humeau et al., 2018). The maintenance of high intraluminal Ca2+ is essential for 
these processes. Therefore, alterations in Ca2+ concentration within the endoplasmic reticulum 
([Ca2+]ER) may destabilize the physiological balance of the endoplasmic reticulum lumen, and 
hence inhibit cell growth (Humeau et al., 2018).  
It has been well described that exposing cells to SERCA blocker thapsigargin results in 
depletion of Ca2+ pools and inhibition of cell proliferation, suggesting a potential role of SERCA 
proteins in regulating cell growth (Short et al., 1993). However, current data concerning the role 
of ER Ca2+ level and SERCA activity in cell growth are rather contradictory. In some model 
systems inhibition of ER Ca2+ uptake through SERCA by thapsigargin induces cell cycle arrest 
(Furuya and Isaacs, 1994), whereas in other systems, it stimulates cell proliferation 
(Charlesworth and Rozengurt, 1994; Legrand et al., 2001).  
Lately, thapsigargin-induced depletion of the ER Ca2+ store has been more and more 
recognized as a signal to trigger store-operated Ca2+ entry (SOCE). The molecular basis for this 
pervasive signaling pathway was not resolved until large scale genomic screens revealed the two 
fundamental players: STIM proteins that sense Ca2+ levels in the endoplasmic reticulum, and 
Orai proteins that constitute the basic pore-forming subunits of the store-operated channels 
(Feske et al., 2006; Liou et al., 2005). Depletion of ER Ca2+ stores results in loss of Ca2+ from EF 
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hand domain of STIM and eventually causes oligomerization of STIM into large puncta that are 
readily visible by light microscopy (Liou et al., 2007). These puncta are stabilized in a subplasma 
membrane ER that localizes within 10-20 nm of the cell membrane, where they physically 
recruit Orai1 into coincident puncta at the cell membrane, leading to Orai1 opening and Ca2+ 
influx (Yeromin et al., 2006).  
Mammalian genomes contain two STIM homologues, STIM1 and STIM2. STIM1 has 
been shown to be essential for SOCE, whereas STIM2 appears to be primarily involved in 
maintaining Ca2+ homeostasis (Cahalan, 2009). Expression of the STIM1 cytoplasmic domain 
alone produces constitutively active SOCE (Huang et al., 2006). The Orai family has three 
homologs, Orai1, 2, and 3 wherein Orai3 is exclusively present in mammals (Cai, 2007).  
Zebrafish has three Orai genes (orai1a, orai1b and orai2) and four STIM1 paralogues (stim1a, 
stim1b, stim2a, stim2b) (Wasilewska et al., 2019). Knockdown of Orai1b by morpholino has 
been shown to lead to heart failure and skeletal myopathy in zebrafish (Volkers et al., 2012). 
Zebrafish STIM1a morphants have substantially reduced number of the pigmented black‐colored 
melanophores (Motiani et al., 2018). 
A critical role for STIM and Orai proteins in promoting tumorigenesis has emerged with 
increasing studies supporting the idea that STIM and Orai proteins could be therapeutically 
targeted for better management of cancers. SOCE-mediated Ca2+ influx is essential for breast 
cancer cell migration (Yang et al., 2009). In colorectal cancers, higher STIM1 expression 
correlated with increased tumor size, tumor invasion, and metastasis (Wang et al., 2015a). 
Increase in SOCE was suggested to be associated with increased proliferation, invasion, and cell 
survival of colorectal carcinoma cells (Sobradillo et al., 2014).  
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The role of  TRP channels in SOCE was controversial as they were later found to behave 
in a non-store-operated manner (Acharya et al., 1997). However, with studies of TRP 
homologues in mammals, increasing evidence has suggested a role for TRP channels in the 
conduction of SOCE, especially the transient receptor potential canonical (TRPC) subfamily 
members, which can be activated in response to stimuli, and result in PIP2 hydrolysis 
(Venkatachalam and Montell, 2007). Inhibition of TRPC1 and TRPC3 channels in HEK cells 
reduced Ca2+  influx after the depletion of Ca2+ stores and the knockdown of other TRPC 
channels such as TRPC4 inhibited SOCE in human corneal epithelial cells (Cheng et al., 2013). 
TRPV6 has been found to function as a component of store-operated Ca2+ entry (SOCE) in 
prostate cancer cells and facilitates Ca2+ entry (Raphael et al., 2014). SOCE inhibitor 2-
aminoethoxydiphenyl borate (2-APB) has been shown to inhibit Ca2+ influx mediated by TRPV6 
(Kovacs et al., 2012; Singh et al., 2018b). 
The third way to remove excessive cytosolic Ca2+ is mediated by passive Ca2+ uptake 
through mitochondria Ca2+ uniporter (MCU) into mitochondria matrix. One major feature of 
ionocytes is that they possess many mitochondria, occupying approximately 28% of the 
cytoplasmic volume, and are therefore also named mitochondria-rich (MR) cells (Becerra and 
Anadon, 1993). Mitochondria are dynamic organelles involved in numerous physiological 
functions. They can localize at specific positions throughout the cell and shape the cellular Ca2+ 
responses and play a key role in the buffering of cytosolic Ca2+ (Wacquier et al., 2019). As 
mitochondria are the central metabolic and energetic hub in cells controlling ATP production, 
redox balancing and cellular metabolism, Ca2+ transported into the matrix also regulates 
mitochondrial function. Therefore, mitochondria function both as regulators and decoders of 
Ca2+ input (Giorgi et al., 2018).  
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MCU activity is heavily depending on the surrounding cytosolic Ca2+ concentration 
(Moreau et al., 2006). The affinity of MCU for Ca2+ is relatively low (Kd ≈ 10 μM), so the basal 
Ca2+ concentration in the cytosol is not sufficient to allow for an efficient mitochondrial uptake. 
However, mitochondria located near plasma membrane or ER Ca2+ channels can be exposed to 
large concentrations of Ca2+  (or Ca2+  microdomains) and take up considerable amounts of Ca2+  
(Nunez et al., 2006; Villalobos et al., 2001). It is now well-established that one of the main 
functions of mitochondria-ER contact sites is to generate highly localized and concentrated Ca2+  
microdomains facilitating Ca2+  transport into mitochondria (Giacomello and Pellegrini, 2016). It 
has also been proposed that mitochondria re-localize to the plasma membrane to directly buffer 
Ca2+  entry and inhibit the Ca2+-dependent inactivation of the Orai1 channels during store-
operated Ca2+ entry (Schwindling et al., 2010). The ability of surrounding mitochondria to 
remove or dampen Ca2+ microdomains determines the extent and duration of SOCE (Malli and 
Graier, 2017).  
Studies have shown that mitochondrial Ca2+  uptake is dependent on the steep 
mitochondrial membrane potential (Δψ ≈ -180mV) and was inhibited by the drug Ruthenium 
Red or its analog Ruthenium 360 (Pathak and Trebak, 2018). In and Jurkat T lymphocytes and 
HT29 human colon carcinoma cells, studies have demonstrated that disruption of mitochondria 
Ca2+ uptake through mitochondrial depolarization by mitochondrial un-couplers prevent 
mitochondrial Ca2+ uptake, and therefore hinder SOCE and cell proliferation in a dose-dependent 
manner (Nunez et al., 2006; Valero et al., 2008). Induction of mitochondrial stress by depletion 
of mitochondrial DNA results in rise in cytosolic Ca2+ that in turn stimulates pro-survival and 
invasive pathways in human pulmonary carcinoma cells (A549) (Berra-Romani et al., 2008). 
 29 
Prolonged increase in [Ca2+]mito leads to the opening of the mitochondrial permeability transition 
pore (mPTP), a critical event driving to cell death by apoptosis (Giorgi et al., 2008).  
AKT and its activator TORC2 have been known to localize to mitochondria-ER contact 
sites, phosphorylating IP3R and blocking the IP3R-mediated Ca2+ flow from ER to mitochondria 
(Betz et al., 2013; Marchi et al., 2012; Marchi et al., 2008). Additionally, AKT has been recently 
shown to be responsible for phosphorylating the MCU regulatory subunit MICU1 and impairing 
MICU1 stability, resulting in aberrant mitochondrial Ca2+ levels and tumor progression (Marchi 
et al., 2019).  
However, compared to our increasing knowledge about the PI3K/AKT/TOR pathway in 
the regulation Ca2+ transfer in intracellular organelles (Rimessi et al., 2019), little is known for 
how intracellular Ca2+ signaling can regulate PI3K/AKT/TOR activity. The mitochondrial 
GTPase mitofusin-2 (MFN2), which is essential for mitochondria fission and tethering ER-
mitochondria membranes, has been identified to negatively regulate cancer cell proliferation 
through inhibiting TORC2-AKT activity (Xu et al., 2017). MFN2 silencing drives quiescence 
exit of embryonic stem cells and promotes neural differentiation via regulating AKT signaling 
(Yi et al., 2019). Moreover, studies in human CD8+ T cells have shown TORC2-AKT activity is 
regulated by Ca2+ flow from ER to mitochondria but the underlying mechanism remains unclear 
(Bantug et al., 2018). 
1.5 Project summary 
Both IGF signaling and Ca2+ signaling have been implicated in the quiescence-
proliferation decision in several cell types across species. However, how these two signaling 
pathways crosstalk is still poorly understood. Zebrafish NaR cells offer an excellent in vivo 
model to address this question because 1) NaR cells are directly in contact with external 
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environment and readily accessible for experimental manipulations and observations, 2) there is 
only one copy of epithelial Ca2+ channel in zebrafish and therefore ruling out functionally 
redundancy and compensation existing in mammalians, and 3) Akt phosphorylation is strongly 
and exclusively elevated in NaR cells while not in the surrounding epithelial cells under low 
Ca2+ stress, providing an easy readout of IGF signaling activity. 
In chapter 2, I tested the hypothesis that local IGF binding proteins are important in the 
cell specific activation of IGF signaling. I report that loss of Igfbp5a impairs Akt and Tor 
signaling activation and diminishes the quiescence-proliferation transition in NaR cells under 
low Ca2+stress. Mechanistically,Igfbp5 functions through its ability to bind IGF ligands. In 
chapter 3, I report a crucial role of Trpv6 in suppressing IGF signaling and in promoting NaR 
cell quiescent state. Through constructing a NaR cell-specific Ca2+ reporter fish, I found Trpv6 
constitutively transports Ca2+ into NaR cells and maintains the intracellular Ca2+ concentration 
([Ca2+]i). Pharmacological blockage or genetic knockout of Trpv6 resulted in reduced [Ca2+]i, 
elevated IGF signaling, and increased NaR cell quiescence exit.  Chemical biology screen 
reveals protein phosphatase 2A (PP2A) as a possible Ca2+ -sensing molecule mediating the 
Tprv6-mediated Ca2+ influx to the suppression of IGF signaling. In chapter 4, I provide 
preliminary results indicating that the Ca2+/calmodulin-dependent kinase kinase (CaMKK) is 
required for low [Ca2+]i-triggered NaR cell reactivation. I propose local Ca2+ microdomains 
mediated by Ca2+ release from the ER Ca2+ store can is underlying the regulation of CaMKK 
activity. In agreement with this proposed mechanism, depletion of ER Ca2+ store blocks Akt 





Figure 1.1 Role IGF/PI3K/AKT/TOR pathway in regulating quiescence exit 
Cell cycle consists of G1 phase, S phase, G2 phase and M phase. Cells that pass the restriction 
point in the G1 phase will progress through the cell cycle and divide. By contrast, non-dividing 
cells can enter the G0 phase and become quiescent. Insulin/insulin-like growth factor (IGF)-PI3 
kinase-AKT-TOR signaling pathway activation is an evolutionary conserved mechanism for 
quiescence exit in yeast, adult stem cells, naïve T cells. Recently, it is shown that 
IGF/PI3K/AKT/TOR pathway is exclusively activated in zebrafish Ca2+-transporting epithelial 







Figure 1.2 The IGF/PI3K/AKT/TOR signaling cascade 
Insulin-like growth factors (IGFs) bind to the IGF1 receptor and induce autophosphorylation of 
the receptor via its tyrosine kinase domain, providing docking sites for adaptors. Activated 
adaptors phosphorylates phosphatidylinositol 3-kinases (PI3Ks), which subsequently turns 
phosphatidylinositol 4,5-trisphosphate (PIP2) to phosphatidylinositol 3,4,5-trisphosphate (PIP3). 
PIP3 recruits AKT to the membrane through interaction with its pleckstrin homology (PH) 
domain. AKT is then phosphorylated by phosphoinositol-dependent kinase 1 (PDK1) at Thr 308 
site and TOR complex 2 (TORC2) at Ser 473 site. Activated AKT phosphorylates a wide range 
of substrates and activates TOR complex 1 (TORC1). IGF binding proteins (IGFBPs) are a 
group of secreted protein known to bind IGF ligands with high affinity. IGFBPs serve as critical 





Figure 1.3 Developmental origin and Ca2+-transporting machinery of NaR cells 
Ionocytes are originated from epidermal stem cells. Various types of ionocytes are responsible 
for transport of different ions using distinct set of ion transporters. In NaR cells, Ca2+ entry in the 
apical membrane is mediated by epithelial Ca2+ channel Trpv6. Intracellular Ca2+ transportation 
is proposed to be mediated by Ca2+-binding proteins. At the basolateral membrane, Ca2+ 
extrusion to the circulation system is mediated by plasma membrane Ca2+-ATPase 2 (PMCA2) 




The phenotype gap is a major challenge to genetic dissection of the highly redundant 
endocrine signaling network. A notable example is the insulin-like growth factor binding protein 
(IGFBP) family, of which six distinct types exist. Gain-of-function studies have demonstrated 
that IGFBPs can inhibit, potentiate IGF actions or have IGF-independent actions. However, 
mutant mice lacking IGFBP-encoding genes do not exhibit major phenotypes. Here we report 
that although deletion of zebrafish igfbp5a did not result in notable phenotypes when raised in 
Ca2+ rich solutions, mutant fish died prematurely in low Ca2+ conditions. The igfbp5a gene is 
expressed in a group of epithelial cells, which take up Ca2+ to maintain constant body Ca2+ 
levels. When the environmental Ca2+ levels are low, these cells undergo proliferation due to an 
activation of IGF1R-PI3K-Akt-Tor signaling. Deletion of igfbp5a blunted the low Ca2+ stress-
induced IGF signaling and impaired the adaptive proliferation. Reintroducing zebrafish Igfbp5a, 
but not its ligand binding deficient mutant, restored the adaptive cell proliferation. Likewise, 
constitutive activation of Akt was sufficient to restore NaR cell proliferation. Expression of 
human IGFBP5, but not two cancer-associated IGFBP5 mutants, had similar effect. Knockdown 
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of IGFBP5 in human colon carcinoma cells resulted in a similar reduction in IGF-stimulated cell 
proliferation. These results reveal a conserved mechanism by which a locally expressed Igfbp 
regulates organismal Ca2+ homeostasis and survival by activating IGF signaling in epithelial cells 
and promoting their proliferation under Ca2+ deficient states. These findings underscore the 
importance of physiological context when analyzing loss-of-function phenotypes of endocrine 
factors.  
2.2 Introduction 
Zebrafish live in hypo-osmotic environments and continuously lose Ca2+ and other ions 
into the surrounding water. They constantly take up Ca2+ from the aquatic habitat to maintain 
body Ca2+ homeostasis. This vital task is accomplished by a group of epithelial cells called Na+-
K+-ATPase-rich (NaR) cells in zebrafish (Hwang, 2009b). NaR cells are functionally equivalent 
to human intestinal epithelial cells and they contain all major molecular components of the 
transcellular Ca2+ transport machinery, including the epithelial Ca2+ channel Trpv5/6 (Flik et al., 
1995; Hwang, 2009b). Although distributed in the adult intestine and gills (a major 
osmoregulatory organ in fish), NaR cells are located on the yolk sac skin during the embryonic 
and larval stages, making them easily accessible for experimental manipulation and observation 
(Flik et al., 1995; Hwang, 2009b). When faced with low [Ca2+] challenge, preexisting NaR cells 
re-enter the cell cycle to yield more cells (Dai et al., 2014a; Liu et al., 2017a). This is considered 
to be an adaptive response that allows fish to acquire adequate Ca2+ to maintain their body Ca2+ 
constant to survive under low [Ca2+] environments (Dai et al., 2014a; Liu et al., 2017a). Ca2+ 
deficiency also stimulates mammalian and human intestinal epithelial cell proliferation (Beaty et 
al., 1993; Lamprecht and Lipkin, 2003; Mokady et al., 2000; Tu et al., 2004), suggesting an 
evolutionarily conserved mechanism at work. We have shown that low [Ca2+] stress activates 
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insulin-like growth factor (IGF) receptor (IGF1R)-mediated PI3 kinase-Akt-Tor signaling in 
NaR cells exclusively and the increased IGF signaling promotes NaR cells to re-enter the cell 
cycle and proliferate (Dai et al., 2014a; Liu et al., 2017a). How the IGF signaling is activated 
specifically in NaR cells under low [Ca2+] stress is not clearly understood.  
IGFs are evolutionarily ancient polypeptides structurally related to insulin. IGF binds to 
and activates the IGF1R, a receptor tyrosine kinase structurally related to the insulin receptor. 
Unlike insulin, however, IGFs are bound to one of six types of IGF binding proteins (IGFBPs) in 
extracellular fluids. Binding to an IGFBP increases IGF half-life in the circulation and prevents 
the potential interaction of IGFs to the insulin receptor (Baxter, 2014; Clemmons, 2016). In 
addition to these endocrine roles, gain-of-function studies have suggested that IGFBPs can also 
act locally, both negatively and positively modulating IGF action in target tissues and some 
IGFBPs have IGF-independent biological activities (Baxter, 2014; Baxter and Twigg, 2009; 
Clemmons, 2016; Duan and Xu, 2005). Some IGFBPs have been shown to be present in the 
nucleus and possess nuclear activity (Baxter and Twigg, 2009; Duan and Xu, 2005). 
Unexpectedly, mice lacking IGFBP-encoding genes do not exhibit major phenotypes. IGFBP2 
knockout mice are phenotypically normal with the exception of minor gender specific changes in 
bone structure and minor changes in the spleen and liver in adult males (DeMambro et al., 2008; 
Wood et al., 2000). IGFBP3 knockout mice are normal in size (Zhao et al., 2006a). Deletion of 
the IGFBP4 gene in mice results in a mild 10-15% reduction in prenatal growth, which is 
somewhat paradoxical given that overexpression of IGFBP4 also reduces growth (Zhao et al., 
2006a). IGFBP5 knockout mice are phenotypically normal (Zhao et al., 2006a). The IGFBP3, 4, 
and 5 triple knockout mice are viable and only show a 25% reduction in body growth (Zhao et 
 37 
al., 2006a). Although it was postulated that genetic redundancy and possible changes in other 
IGFBPs may be responsible for the lack of phenotypes, the underlying mechanism(s) is not clear.  
We have previously reported that one of the zebrafish igfbp genes, igfbp5a, is specifically 
expressed in NaR cells (Dai et al., 2014a). Knockdown of Igfbp5a using antisense 
morpholinos decreases the low [Ca2+] stress-induced Akt signaling, suggesting that locally 
expressed Igfbp5a may be important (Dai et al., 2014a). Because morpholinos only knock 
down target genes transiently, this approach could not be used to investigate the possible role 
of Igfbp5a in adaptive NaR cell proliferation nor the long-term biological consequence. More 
importantly, we now understand that morpholinos have many limitations, including high 
toxicity and "off-target" effects (El-Brolosy and Stainier, 2017). In this study, we sought to 
investigate the functional role of Igfbp5a in NaR cells and its long-term functional significance 
by deletion Igfbp5a using TALEN and CRISPR-Cas9 technology. The igfbp5a-/- mutant fish 
appeared indistinguishable from their wild type siblings when raised in Ca2+ rich embryo 
solutions. When raised in regular water or low Ca2+ solutions, however, they died prematurely. 
Further analyses showed that deletion of Igfbp5a impaired the low [Ca2+] stress-induced NaR 
cell proliferation and diminished IGF signaling. The diminished IGF signaling and NaR cell 
proliferation were restored by reintroducing Igfbp5a or human IGFBP5. Further mechanistic 
analyses suggested that Igfbp5a acts by binding to IGF ligand and activating Akt-Tor signaling 
in epithelial cells under Ca2+ deficient states and this action is conserved in human colon 




2.3.1 Deletion of Igfbp5a leads to premature death 
Two independent F1 lines were obtained using a TALEN-based approach (Figure 2.1 and 
Figure 2.2A). Both are predicted to be null alleles. The igfbp5aΔ4 line harbors a 4 bp deletion 
allele that introduces a 23-amino acid sequence shortly after the signal peptide. The igfbp5aΔ11 
line contains an 11 bp deletion allele, which truncates Igfbp5a after the signal peptide. F2 
progeny from these lines were raised in the standard embryo solution (containing 0.33 mM 
[Ca2+] and referred as E3 solution hereafter) to 5 days post fertilization (dpf), and transferred to 
the standard fish system water. Genotyping of adults showed a complete lack of homozygous 
adult fish in both lines. To determine whether the mutant fish died prematurely, we intercrossed 
each of the two F1 lines and randomly genotyped their F2 progeny at the larval and adult stages. 
While 27% of larvae (5 dpf) in the igfbp5aΔ4 group were homozygous, adult progeny were 
either heterozygous or wild type (Figure 2.2B). Likewise, none of homozygous igfbp5aΔ11 fish 
(20% detected in 3 dpf) survived to 3 months (Figure 2.2B). Among the survived igfbp5aΔ11 
adult fish, 43% were heterozygous (Figure 2.2B). This lower percentage may be related to the 
fact that the heterozygous fish had a lightly higher mortality rate (See Figure 2.6A).  
2.3.2 igfbp5a-/- mutant fish develop and grow normally in Ca2+-rich solutions 
Because igfbp5a mRNA is specifically expressed in NaR cells, which are crucial for Ca2+ 
uptake, we speculated that the mutant fish died due to the deficiency of this essential ion. If this 
were correct, then raising the progeny in embryo solutions containing high [Ca2+] should rescue 
the mutant fish because Ca2+ can enter through paracellular transport in Ca2+ rich solutions. 
Indeed, when progeny of igfbp5aΔ4 intercrosses and igfbp5aΔ11 intercrosses were raised in the 
5PPT solution (containing 1.6 mM [Ca2+] and referred as high [Ca2+] solution hereafter), many 
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mutant fish grew to adulthood (Figure 2.2C). The adult mutant fish in both lines were fertile and 
morphologically indistinguishable from their siblings. There was no notable difference in the 
growth rate or speed of development (Figure 2.3A-D). The igfbp5aΔ11 line, referred as igfbp5a-/- 
mutant fish hereafter, were used in subsequent studies unless otherwise stated.  
2.3.3 Deletion of Igfbp5a increases mortality and impairs adaptive NaR cell proliferation 
To investigate whether Igfbp5a plays a local role in NaR cell development, we randomly 
sampled progeny from an igfbp5a+/- intercross at various stages. NaR cells were visualized, 
quantified, and then each fish genotyped individually. There was no difference in the NaR cell 
number between the igfbp5a-/- mutants and their siblings at all stages examined (Figure 2.3E). 
The expression of igfbp5aΔ11 mRNA was confirmed (Figure 2.4A). Because of genetic 
redundancy, genetic compensation and/or transcriptional adaptation can mask what would 
otherwise be more obvious phenotypes (El-Brolosy and Stainier, 2017), we measured the 
expression of igfbp5a, but found no differences between igfbp5a-/- mutant fish and their siblings 
(Figure 2.4B). No difference was detected in the expression pattern or levels of the paralogous 
igfbp5b between wild-type and igfbp5a-/- mutant fish, either (Figure 2.5A and B). 
To confirm that igfbp5a-/- fish were prone to premature death, we performed a blind, low 
[Ca2+] challenge test with 5 dpf larvae obtained from an igfbp5a+/- intercross. igfbp5a-/- mutant 
fish died earlier and at a significantly greater rate (Figure 2.6A). On 2 and 3 days post low [Ca2+] 
challenge, igfbp5a-/- mutants comprised 66% and 38% of the dead larvae. These values were 
much greater than the expected 25% according to Mendelian ratio. Similarly, igfbp5aΔ4 mutant 
fish died at a significantly greater rate under the low [Ca2+] challenge (Figure 2.7). We 
hypothesized that the premature death of igfbp5a-/- fish was due to Ca2+ deficiency in the body. 
Indeed, Alizarin red staining showed that calcified bone mass in the mutant fish raised in a 
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solution containing 0.2 mM [Ca2+] (referred as regular [Ca2+] solution because its [Ca2+] is 
similar to fish system water) was comparable to that of those wild-type fish raised in a solution 
with 10 folds lower Ca2+ levels (Figure 2.6B). Calcified bone mass in igfbp5a-/- fish was further 
reduced by exposure to the lower [Ca2+] solution (Figure 2.6B-C). Increased trpv5/6 expression 
is an indication of a Ca2+ deficient state in the body (Hwang, 2009b; Liu et al., 2017a). The 
igfbp5a-/- group showed increased trpv5/6 expression in NaR cells under regular [Ca2+] solution 
(Figure 2.6D). Low [Ca2+] challenge treatment increased trpv5/6 mRNA levels in both wild type 
and igfbp5a-/-, but the magnitude of increase was significantly greater in the igfbp5a-/- group. 
These results suggest that deletion of Igfbp5a leads to body Ca2+ deficiency and low [Ca2+] 
treatment further exacerbates the Ca2+ deficiency.  
When acclimated to low [Ca2+] environments, NaR cells undergo proliferation to yield 
more NaR cells in order to take up sufficient Ca2+ for survival (Dai et al., 2014a; Liu et al., 
2017a). We tested whether deletion of Igfbp5a impaired this adaptive proliferation response. 
Visualization of NaR cells by in situ hybridization using a trpv5/6 probe showed that 48 h low 
[Ca2+] treatment significantly increased the NaR cell number in the wild type and heterozygous 
larvae. This increase was blunted in the igfbp5a-/- larvae (Figure 2.6E). We next crossed igfbp5a-
/- fish with Tg(igfbp5a:GFP) fish, a transgenic line in which NaR cells are labeled by GFP 
expression, allowing real-time visualization and quantification of NaR cell division (Liu et al., 
2017a). Low [Ca2+] treatment resulted in significant increases in NaR cells in Tg(igfbp5a:GFP) 
larvae at 96, 104, and 120 hpf (Figure 2.6F). This increase was significantly reduced in igfbp5a-
/-;Tg(igfbp5a:GFP) larvae (Figure 2.6F). Next, we performed transient knockout experiments in 
Tg(igfbp5a:GFP) fish using a CRISPR/Cas9-based approach (Figure 2.8A). Transient deletion of 
Igfbp5a using two different sgRNAs significantly decreased NaR cell proliferation under low 
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[Ca2+], but had no effect under normal [Ca2+] (Figure 2.8B). Therefore, either permanent or 
transient deletion of Igfbp5a impairs the adaptive proliferation response of NaR cells.  
RNA expression analysis showed that among members of the IGF and insulin gene 
family, igf2b is most abundantly expressed in NaR cells followed by igf2a (Figure 2.9A). The 
expression of igf1, insulin a and insulin b was minimal (Figure 2.9A). The strong expression of 
igf2b mRNA in NaR cells was confirmed by double label staining (Figure 2.9B). The two igf1r 
genes and two insr genes were all expressed in NaR cells with igf1ra being the most abundant 
one (Figure 2.9A). Low [Ca2+] treatment did not alter the expression of any of the above genes 
(Figure 2.9A and B).  
2.3.4 Deletion of Igfbp5a but not its paralog Igfbp5b impairs low-[Ca2+] stress-induced Akt-
Tor signaling in NaR cells 
Our previous studies using double label staining have shown that low [Ca2+] treatment 
induces phosphorylated Akt signaling in NaR cells exclusively (Dai et al., 2014a; Liu et al., 
2017a). In agreement with these previous reports, immunostaining analysis revealed that there 
were few phosphorylated Akt-positive NaR cells on the yolk sac in wild-type larvae under 
regular [Ca2+] conditions. Low [Ca2+] treatment resulted in a robust increase in NaR cells 
positive for phosphorylated Akt (Figure 2.10A and B). In comparison, low [Ca2+] treatment 
resulted in a significantly lower number of NaR cells positive for phosphorylated Akt in igfbp5a-
/- larvae (Figure 2.10A and B), indicating that deletion of Igfbp5a impairs Akt signaling. Similar 
results were observed with the phosphorylated S6, an indicator of Tor signaling, although the 
basal phosphorylated S6 levels were higher (Figure 2.10C and D). In contrast, phosphorylated 
Erk levels were similar between wild-type and igfbp5a-/- larvae under both regular and low 
[Ca2+] conditions (Figure 2.10E and Figure 2.11). The phosphorylated Erk signal was authentic 
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because it was abolished by MEK inhibitor treatment (Figure 2.10E and Figure 2.11). As another 
control, we knocked out the paralogous igfbp5b gene using CRISPR-Cas9. Deletion of Igfbp5b 
did not change the induction of phosphorylated Akt in NaR cells by low [Ca2+] treatment (Figure 
2.10F).  
2.3.5 Reintroduction of Igfbp5a or constitutively active Akt in NaR cells restores adaptive 
proliferation 
To test whether expression of Igfbp5a was sufficient to activate IGF signaling in NaR 
cells, zebrafish Igfbp5a, its ligand binding domain (LBD), or nuclear localization signal (NLS) 
mutants was randomly expressed in NaR cells in igfbp5a-/-;Tg(igfbp5a:GFP) larvae using a Tol2 
transposon BAC-mediated genetic mosaic assay (Figure 2.12A and B). NaR cells expressed 
Igfbp5a were able to proliferate under low [Ca2+] stress and stained positive for phosphorylated 
Akt (Figure 2.12C and D). NaR cell proliferation in igfbp5a-/-;Tg(igfbp5a:GFP) larvae under low 
[Ca2+] stress was also restored by the expression of the Igfbp5a NLS mutant, but not by that of 
the LBD mutant (Figure 2.12C), suggesting that Igfbp5a acts in an IGF-binding dependent 
manner. If Igfbp5a indeed stimulates NaR cell proliferation by binding to IGFs and activating 
Akt signaling, then expression of a constitutively active Akt should rescue the defective NaR cell 
proliferation in igfbp5a-/- larvae. Indeed, expression of myr-Akt restored NaR cell proliferation in 
response to low [Ca2+] stress (Figure 2.12E). Because the Tol2 transposon BAC-mediated 
genetic mosaic assay only targets the expression of Igfbp5a in a small number of NaR cells 
randomly, this approach cannot be used to rescue the lethality phenotype. 
To test whether IGFBP5 acts in a similar manner in human epithelial cells, human colon 
carcinoma (LoVo) cells were transfected with a validated siRNA plasmid (pSuperBP5) targeting 
human IGFBP5 L-domain (Yin et al., 2004). The effect of IGFBP5 knockdown on IGF2-induced 
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cell proliferation was analyzed by FACS analysis as reported (Dai et al., 2014a). In cells 
transfected with the empty pSuper plasmid, IGF2 treatment resulted in a significant increase in 
the percentage of S-phase cells. This increase was abolished in the pSuperBP5 transfected cells 
(Figure 2.13A), suggesting the endogenous IGFBP5 is required in the proliferative response of 
these human cells to IGF2 stimulation. To demonstrate the specificity of the siRNA knockdown 
effect and the sufficiency of IGFBP5, we co-transfected LoVo cells with pSuperBP5 and 
IGFBP545. The latter contains IGFBP5 N- and C-domain but the L-domain from IGFBP4 and 
therefore resistant to pSuperBP5 (Yin et al., 2004). The results showed expression of IGFBP545 
restored the proliferation response to IGF2 stimulation (Figure 2.13A). To further investigate the 
function of human IGFBP5 and its mechanism of action in an in vivo setting, we expressed 
human IGFBP5 and two mutants (G223R and W242*) in NaR cells in igfbp5a-
/-;Tg(igfbp5a:GFP) embryos using the genetic mosaic assay (Figure 2.13B). G223R and W242* 
are two cancer-associated mutations that were speculated to have lost IGF binding ability (Ding 
et al., 2016). Ectopic expression of wild-type human IGFBP5, but not these mutants, 
significantly increased NaR cell proliferation under low [Ca2+] stress (Figure 2.12D). These 
results suggest that human IGFBP5 acts by binding to the IGF ligand and promoting IGF action 
in human LoVo cells.  
2.4 Discussion 
IGFBP5 is the most conserved member of the IGFBP family (Baxter and Twigg, 2009; 
Duan and Xu, 2005). There is a host of in vitro and overexpression studies in the literature 
indicating its action in inhibiting, potentiating IGF actions, or acting as a growth factor by itself 
in mammalian cells (Baxter, 2014; Baxter and Twigg, 2009; Clemmons, 2016; Duan and Xu, 
2005). In spite of these findings, IGFBP5 deficient mice do not have overt phenotypes (Ning et 
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al., 2007). In this study, we showed that genetic deletion of zebrafish Igfbp5a causes body Ca2+ 
deficiency and premature death under regular laboratory conditions. The igfbp5a-/- mutant larvae 
exhibited clear and specific defects in NaR cell adaptive proliferation under Ca2+ deficient 
conditions. These results reveal a critical role of Igfbp5a in regulating organismal survival and 
Ca2+ balance by promoting NaR cell proliferation under low Ca2+ states. 
It was postulated that the lack of phenotype in IGFBP5 null or other IGFBP null mice 
might be due to the greater genetic redundancy in the mouse model (Duan and Xu, 2005). We 
now realize that the phenotype gap is widely present among a wide range of organisms, 
including zebrafish. Recent advances in CRISPR-Cas9 and TALEN make deleting and editing 
genes increasingly easy and versatile. While great progress has been made, many cases have 
been reported in which permanent deletion of gene(s)-encoding various hormones and growth 
factors, including many that were previously thought to be critical or even essential, show no 
notable phenotypic changes (Allard and Duan, 2018; El-Brolosy and Stainier, 2017; Ewen-
Campen et al., 2017; Liu et al., 2017b; Tang et al., 2015). Genetic studies in zebrafish have also 
found major discrepancies in phenotypes between permanent genetic knockout and transient 
knockdowns (Anderson et al., 2017; Kok et al., 2015; Rossi et al., 2015; Zhang et al., 2016). 
Several additional mechanisms, including genetic compensation, transcriptional adaptation, and 
altered mRNA processing, have been proposed to account for the lack of phenotypes in 
permanent genetic mutants (Anderson et al., 2017; El-Brolosy and Stainier, 2017). These 
mechanisms cannot fully explain the findings of this study. The zebrafish genome contains 9 
igfbp genes due to a teleost-specific genome wide duplication event (Daza et al., 2011). One 
could argue that zebrafish may have a greater genetic redundancy than mice. For example, there 
are two igfbp5 genes, igfbp5a and igfbp5b in zebrafish compared to a single IGFBP5 gene in 
 45 
mice and humans (Dai et al., 2010). Nevertheless, our genetic data showed that permanent 
deletion of Igfbp5a compromised the adaptive NaR cell proliferation response and led to low 
body Ca2+ contents and premature death. We did not detect any sign of non-sense-mediated 
mRNA decay of igfbp5a mRNA nor observe compensatory increases in the paralogous igfbp5b 
expression in the igfbp5a-/- mutant fish. We showed that transient deletion of Igfbp5a resulted in 
similar defects in NaR cells. A key and interesting finding made in this study is that the 
phenotypes of the igfbp5a-/- mutant fish were context-dependent. When raised in [Ca2+] rich 
solutions, however, igfbp5a-/- mutant fish grew to the adult stage and appeared indistinguishable 
from their siblings. When raised in low [Ca2+] solutions, they showed specific defects in adaptive 
NaR cell proliferation and died prematurely. These context-dependent phenotypes were specific 
because no such changes were found in the igfbp5b-/- mutant fish. Our findings underscore the 
importance of physiological context in genetic dissection of the highly redundant endocrine 
signaling network. 
The role of IGF signaling in regulating global growth and development is well 
established (Baker et al., 1993; Liu et al., 1993). IGF signaling also exerts many cell type-
specific and context-dependent actions (Clemmons, 2016). How the IGF signaling system exerts 
these cell-type specific and context-dependent actions is not well understood. In this study, we 
showed that genetic deletion of Igfbp5a, but not the closely related Igfbp5b, reduced IGF1R-
mediated Akt and Tor signaling in NaR cells specifically and in a Ca2+ concentration-dependent 
manner. Re-introducing Igfbp5a was sufficient to activate Akt signaling in the mutant NaR cells 
and restore their proliferation. Importantly, knockdown of IGFBP5 abolished the human LoVo 
cell proliferation response to IGF2 stimulation. Re-expression of a siRNA resistant form of 
IGFBP5 restored the mitotic response to IGF2 stimulation. These results reveal a conserved 
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mechanism by which a locally expressed IGFBP activates the IGF signaling in a cell-type 
specific and context-dependent manner.  
Mammalian cell culture studies suggest that IGFBP5 has several modes of actions. When 
added to cultured human or rodent cells together with IGF1 or IGF2, IGFBP5 inhibits IGF-
induced cell proliferation and/or differentiation (Conover and Kiefer, 1993; Dai et al., 2010; 
Ding et al., 2016; Kiefer et al., 1992; Schneider et al., 2001). IGFBP5 can also potentiate IGF-
induced cell proliferation and/or survival (Andress and Birnbaum, 1991; Bautista et al., 1991; 
Duan and Clemmons, 1998; Mohan et al., 1995; Ren et al., 2008). IGFBP5 has also been shown 
to possess IGF-independent activities (Baxter, 2014; Baxter and Twigg, 2009; Clemmons, 2016; 
Duan and Xu, 2005). Mammalian IGFBP5 is detected in the nucleus and has nuclear activity (Xu 
et al., 2004; Zhao et al., 2006b). The nuclear localization and action is also observed in zebrafish 
(Dai et al., 2010). How IGFBP5 acts in vivo under a physiological context has not been reported. 
In this study, we elucidated the mechanism of Igfbp5a action using genetic mosaic assays. The 
results showed that Igfbp5a acts by binding to IGF ligand and activating Akt-Tor signaling in 
NaR cells because the LBD mutant lacked the activity to stimulate NaR cell proliferation. 
Mutation of the NLS of Igfbp5a had no effect on its ability, suggesting the nuclear presence is 
not important for this action of Igfbp5a. The conclusion that Igfbp5a acts through binding to 
IGFs in NaR cells is further supported by the gene expression analysis results. In the zebrafish 
genome, there are four IGF ligand genes (igf1, igf2a, igf2b, and igf3 (also known as igf1b) and 
two igf1r genes due to a teleost linage-specific genome duplication (Maures et al., 2002; 
Schlueter et al., 2006; Zou et al., 2009). Both igf1r genes were detected in NaR cells with igf1ra 
more abundant. Future studies will be needed to determine whether Igfbp5 acts by binding to 
Igf2b to activate Igf1ra and/or Igf1rb in NaR cells. Mammalian cell culture and biochemical 
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studies suggest that IGFBP5 can potentiate IGF action by bringing IGF ligand to the IGF1R 
through the proteolysis of IGFBP5 or association with the cellular membrane or extracellular 
matrix proteins (Conover and Oxvig, 2017; Mohan et al., 1995; Schmid et al., 1996). Whether 
these mechanisms are involved in Igfbp5a action in NaR cells need to be elucidated in the future. 
Aberrant regulation or mutations of key components in the IGF-PI3 kinase-AKT-TOR 
signaling pathway have been linked to major human diseases including cancers (Manning and 
Toker, 2017). In colon cancers, for example, several genes belonging to this pathway are mutated 
(Massoner et al., 2010). These mutations result in increased IGF2 gene expression, increased 
PIK3CA and PIK3R1 activity, reduced PTEN expression or activity (Sood et al., 2012). Ding et 
al. (Ding et al., 2016) has identified over 20 non-synonymous mutations for IGFBP5 in cancer, 
including several frame-shift and non-sense mutations. While some of these mutations were 
evaluate in culture human cells, none was tested in an in vivo setting. Because the IGF-PI3K-
Akt-Tor pathway is highly conserved and activation of this pathway is both required and 
sufficient for NaR cell proliferation, the zebrafish larvae-NaR cell system provides an excellent 
in vivo platform for functional analysis of these cancer-associated mutations. As a proof-of 
principle experiment, we compared the activities of two cancer-associated IGFBP5 mutations 
G223R and W242* with wild-type IGFBP5. While IGFBP5 was able to stimulate NaR cell 
proliferation in vivo, both mutants lost this biological activity. These results provided in vivo 
evidence supporting the idea that IGFBP5 G223R and W242* have lost IGF binding ability 
(Ding et al., 2016). 
In summary, the findings in this study reveal a conserved mechanism by which a locally 
expressed Igfbp regulates organismal Ca2+ homeostasis and survival by activating IGF signaling 
in epithelial cells and promoting their proliferation under Ca2+ deficient states. This type of 
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regulatory mechanism may not be limited to zebrafish or IGFBP5. Although IGFBP5 knockout 
mice exhibit normal mammary gland development under standard lab conditions, these animals 
show delayed mammary gland involution and enhanced alveolar bud formation after 
ovariectomy followed by estrogen treatment (Ning et al., 2007). In breast cancer cells, 
doxorubicin-induced senescence increases IGFBP3 expression and cleavage of IGFBP3 prevents 
cell senescence (Baxter, 2014). In human vascular endothelial cells, hypoxia induced the 
expression of IGFBP6. The elevated IGFBP6 in turn suppresses angiogenesis as a negative 
feedback during tumor growth (Zhang et al., 2012). Future studies are needed to identify 
additional stressful or disease conditions that different IGFBPs respond to and to determine 
whether regulation of IGF signaling locally by IGFBPs is a widespread mechanism. 
2.5 Materials and methods 
 
Ethics statement 
All experiments were conducted in accordance with the guidelines approved by the 
Institutional Committee on the Use and Care of Animals, University of Michigan. 
 
Zebrafish husbandry and embryo rearing media with different Ca2+ concentrations 
All zebrafish lines were raised and crossed according to zebrafish husbandry guidelines 
(61). Embryos were obtained by natural cross and staged following Kimmel et al. (Kimmel et al., 
1995a). Several embryo rearing media were used. A standard solution containing 0.33 mM 
[Ca2+], referred as E3 solution, was prepared as described in Zebrafish Book (Westerfield, 
2000b). A solution containing high centration of Ca2+ (1.6 mM [Ca2+]), referred as 5PPT high 
[Ca2+] solution, was prepared by dissolving 5 g Instant Ocean® salt in 1000 ml distilled water. 
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Two embryo rearing solutions containing either 0.2 mM [Ca2+] (referred to as regular [Ca2+] 
solution) or 0.001 mM [Ca2+] (referred to as low [Ca2+] solution) were prepared as previously 
reported (Dai et al., 2014a). To inhibit pigmentation, 0.003% (w/v) N-phenylthiourea (PTU) was 
added to these solutions.  
 
Chemicals and reagents  
Reagents were purchased from Fisher Scientific (Pittsburgh, PA, USA) unless stated 
otherwise. The MEK inhibitors (U0126 and PD98059), Phospho-Akt, Phospho-S6, and Phospho-
Erk antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). 
Restriction enzymes were bought from New England BioLabs (Ipswich, MA, USA). Primers, 
cell culture media and supplements, the TRIzol reagent, M-MLV reverse transcriptase, and 
Alexa Fluor 488 Tyramide SuperBoost Kit were bought from Invitrogen (Carlsbad, CA, USA). 
Cas9 protein was purchased from ToolGen (Seoul, South Korea). Calcein and Alizarin Red S 
was purchased from Sigma (St. Louis, MO, USA). Anti-Digoxigenin-POD and Anti-
Digoxigenin-AP were purchased from Roche (Basel, Switzerland). 
 
Generation of igfbp5a mutant line using TALEN  
TALEN target sites were designed following published criteria (Bedell et al., 2012) and 
shown in Supplemental Fig. 1A. TALEN constructs were assembled using a Golden Gate 
cloning strategy following a published protocol (Cermak et al., 2011). The assembled plasmids 
were determined by StuI and AflII digestion and confirmed by DNA sequencing.  
TALEN capped mRNA was synthesized by in vitro transcription using T3 polymerase 
(Ambion mMessage mMachine kit, Austin, TX) and injected into embryos at the 1-cell stage. 
 50 
After confirming indels using T7E1 assays in a subset of pooled F0 embryos, the remaining F0 
embryos were raised to adulthood and crossed with wild type fish. F1 fish were raised and caudal 
fin was severed and genotyped as described below. Positive F1 fish were subjected to DNA 
sequencing. The F1 adult fish were intercrossed and the progeny were raised and genotyped as 
described below. To obtain the viable homozygous fish, progeny from the F1 intercrosses were 
raised in the 5PPT high [Ca2+] solution in the first month and then transferred into the fish 
system.  
 
Transient and stable knockout of igfbp5a and 5b genes using CRISPR/Cas9 
Two sgRNAs targeting igfbp5a exon 1 and 2 sgRNAs targeting igfbp5b exon 1 were 
designed using the online tool ZiFiT Targeter V4.2 (http://zifit.partners.org/ZiFiT). Their 
sequences are: igfbp5a-sgRNA-1, 5’-GGTGCGGAACGGGTGTCAGGTGG-3’ (sense strand, 
+114 - +136), igfbp5a-sgRNA-2, 5’-GTTCCGCACCGGAGGACACATGG-3’ (anti-sense 
strand, +123 - +101), igfbp5b-sgRNA-1, 5’-GGTGGGCTGTCAGCTAGTGAAGG-3’ (sense 
strand, +114 - +136), igfbp5b-sgRNA-2, 5’-GTGCGAGCCGTGCGATCAGAAGG-3’ (sense 
strand, +66 - +88). These sgRNAs were synthesized by in vitro transcription following a 
published method (Shao et al., 2014). sgRNAs (30 ng/μl) were mixed with Cas9 protein (700 
ng/μl) or mRNA (250 ng/μl) and co-injected into Tg(igfbp5a:GFP) or wild type embryos at the 
1-cell stage. The injected embryos were raised in E3 solution until 72 hpf and transferred to 
either the regular or low [Ca2+] solution. NaR cells were quantified at 120 hpf as previously 
reported (Liu et al., 2017a). To generate the igfbp5b mutant line, F0 fish were screened using 
T7E1 assays with the following primers, igfbp5b-gt-F, 5’-AACCCCAACCTGTGTTTTCA-3’, 
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igfbp5b-gt-R, 5’-GATACAAACCACCGCACCCA-3’. igfbp5b homozygous mutants were 
obtained following the cross strategy described above. 
 
Genotyping 
 To isolate genomic DNA, pooled embryos or individual adult caudal fin were incubated 
in 50 μl NaOH (50 mM) at 95 °C for 10 min and neutralized by adding 5 μl 1M Tris-HCl (pH 
8.0). T7E1 assay and heteroduplex motility assay (HMA) were carried out as reported (Zhu et 
al., 2014). For T7E1 assays, PCR was performed using following primers: igfbp5a-TAL-nF, 5’-
GAACGCTGTTCGCTTGAT-3’, igfbp5a-TAL-nR, 5’-CGCAGTCCTCGTCCACAT-3’. For 
HMA assays, PCR was performed using following primers: igfbp5a-HRMA1-F, 5’-
GTGGCATTTGTATGGGGACT-3’, igfbp5a-HRMA2-R: 5’-AGGTCAAGCAGCATCCGCA-
3’.  
Individual genotyping was carried out as previously reported (Dai et al., 2014a). Briefly, 
after immunostaining or in situ hybridization analysis, each embryo/larva was washed with 
1xPBST twice and methanol 3 times. They were air-dried overnight. Then, each embryo/larva 
was digested in 100 μl SZL buffer (50mM KCl, 2.5mM MgCl2, 10mM Tris-HCl pH 8.3, 0.45% 
NP-40, 0.45% Tween-20, 0.01% Gelatine) containing 100 μg/ml proteinase K for 1h at 60°C. 
The reaction was stopped by 15 min heat treatment (95°C). After spinning at 10,000 rpm for 1 
min, the supernatant was used as template for PCR followed by HMA assay as reported (Zhu et 
al., 2014). 
 
Zebrafish larva survival experiments 
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 For survival experiments, embryos/larvae of different genotypes were raised in E3 
solution to 72 or 120 hpf. They were then transferred to the low [Ca2+] solution. Dead larvae 
were collected daily and genotyped individually. 
 
Morphology analysis 
Body length is defined as the curvilinear distance from the head to the end of caudal tail. 
Somite number and head-trunk angles were measured manually (Kamei et al., 2011; Liu et al., 
2014). To visualize the bone morphology, calcein and Alizarin red staining were performed 
following a published protocol (Du et al., 2001). For calcein staining, juvenile fish were 
immersed in the calcein staining solution for 10 min. Then, they were washed 3 times in E3 
solution to remove residual calcein. Images were captured with a stereomicroscope (Leica 
MZ16F, Leica, Wetzlar, Germany) equipped with a QImaging QICAM camera (QImaging, 
Surrey, BC, Canada). 
 
qPCR, whole-mount in situ hybridization, and immunostaining 
Total RNA was isolated using TRIzol reagent (Invitrogen). RNA samples were treated 
with DNase I to remove DNA. One microgram of RNA was reverse transcribed to single-strand 
cDNA using M-MLV (Promega, Madison, WI) and oligo(dT)18 primer. RT-PCR was performed 
using Taq DNA polymerase (New England Biolabs). qPCR was carried out using SYBR Green 
(Bio-Rad, Hercules, CA) on a StepONE PLUS real-time thermocycler (Applied Biosystems, 
Foster City, CA). Primers for qPCR used in this study are shown below. igfbp5a: 5'- 
GCTGCACGCTCTGCTTTAC-3' and 5'-AATGGAACCTTGGCCTGAG-3'; igfbp5b: 5′-
GGGAGTGTGTACGAACGAGAA-3′ and 5′-TCCTGTCACAGTTAGGCAGGTA-3′; trpv5/6: 
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5'- GGACCCTACGTCATTGTGATAC-3' and 5'- GGTACTGCGGAAGTGCTAAG-3'; β-actin: 
5'-GATCTGGCATCACACCTTCTAC-3' and 5'-CCTGGATGGCCACATACAT-3'.  
Whole-mount in situ hybridization and immunostaining were performed as previously 
reported (Dai et al., 2014a). For double staining of in situ hybridization and immunostaining, 
mCherry or igfbp2b mRNA were detected using digoxigenin (DIG)-labeled antisense riboprobes 
(Zou et al., 2009). The mCherry signal was detected using anti-DIG-POD antibody (Roche), 
followed by Alexa 488 Tyramide Signal Amplification (Invitrogen). The igfbp2b signal was 
detected using anti-DIG-AP antibody (Roche), followed by NBT/BCIP staining. After in situ 
hybridization analysis, the stained larvae were washed in 1xPBST and incubated with pAkt or 
GFP antibody overnight at 4 °C. Next, they were stained with a Cy3 conjugated Goat anti-Rabbit 
IgG antibody (Jackson ImmunoResearch, West Grove, PA). Fluorescent images were acquired 
using a Nikon Eclipse E600 Fluorescence Microscope with PMCapture Pro 6 software. 
 
Plasmid and BAC constructs 
The construction of the Igfbp5a expression plasmid has been reported (Dai et al., 2014a). 
This plasmid was used as a template to generate Igfbp5a nuclear localization signal (NLS) and 
ligand binding domain (LBD) mutants. For the NLS mutant, the 236KGRK239 motif in Igfbp5a C-
domain was changed to LDGQ, the corresponding sequence of zebrafish Igfbp1a (Maures and 
Duan, 2002) by site-directed mutagenesis (Supplemental Table 1). For the LBD mutant, the 
sequence 86KPLLL92 in Igfbp5a was mutated to NQQQQ (Zhong et al., 2011). Next, human 
IGFBP5 G223R and IGFBP5 W242*, two cancer-associated IGFBP5 mutations (Ding et al., 
2016), were generated by site-direct mutagenesis (Supplemental Table 1). The resulting 
Igfbp5a/IGFBP5 DNAs were cloned into the pIRES2-mCherry using the EcoR1 and BamH1 
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sites. The pIRES2-mCherry plasmid was engineered by replacing the DsRed-Express2 cassette 
in the pIRES2-DsRed-Express2 plasmid with mCherry using the BstX1 and Not1 sites. The 
Igfbp5a/IGFBP5-IRES2-mCherry-KanR cassette DNAs were amplified by PCR using primers 
listed in Supplemental Table 1. They were inserted into the igfbp5a BAC construct (Liu et al., 
2017a) to replace the igfbp5a sequence from the start codon to the end of the first exon through 
homologous recombination. The resulting BAC DNA was validated by DNA sequencing using 
primers shown in Supplemental Table 1. The validated BAC(igfbp5a:Igfbp5a/IGFBP5-mCherry) 
DNA constructs were injected into igfbp5a-/-;Tg(igfbp5a:GFP) embryos at the 1-cell stage. The 
embryos were raised in the E3 solution until 72 hpf and then subjected to the low [Ca2+] 
challenge test by transferring into low [Ca2+] solution. Cells co-expressing mCherry and GFP 
were defined as igfbp5a/IGFBP5-expressing NaR cells. They were scored using the scoring 
system shown in Fig. 5B. A similar cloning strategy was used to generate BAC(igfbp5a:myr-Akt-
mCherry) plasmids. All these constructs were confirmed by DNA sequencing at the University 
of Michigan DNA Sequencing Core Facility. 
 
Cell culture, transfection, and flow cytometry analysis 
Human colorectal carcinoma (LoVo) cells were purchased from ATCC (Manassas, VA), 
and cultured in DMEM/F-12 supplemented with 10% FBS, penicillin, and streptomycin in a 
humidified-air atmosphere incubator containing 5% CO2 at 37°C. LoVo cells were seeded in 6-
well plates (Falcon, Corning, NY), and transfected with 2 µg pSuperBP5 or pSuper and 2 µg 
pCMV-BP545 or pCMV plasmids using Lipofectamine 2000 (Invitrogen). 24 hours post 
transfection, the cells were washed and incubated with fresh serum-free medium for 8 hours. 400 
ng/ml IGF2 was then added. Cells were collected after 3 days of IGF2 treatment. Cell cycle 
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analysis was carried out using an Attune Acoustic Focusing Cytometer (Applied Biosystems, 
Life Technologies, Carlsbad, CA) as previously described (Liu et al., 2017a). Briefly, a two-
parameter dot-plot of forward scatter (FSC) versus side scatter (SSC) was constructed along with 
a two-parameter dot-plot of FL2 (PI) area versus FSC area. In addition, a single-parameter FL2 
(PI) area histogram was constructed to illustrate relative DNA content in each cell cycle phase. 
 
Statistical analysis 
Values are shown as mean ± standard error of the mean (SEM). Statistical significance 
among experimental groups was determined using unpaired two-tailed t test, one-way ANOVA 
followed by Tukey’s multiple comparison test, Logrank test, or Chi-square test. Statistical 




Figure 2.1 Generation of igfbp5a mutant fish 
(A) Schematic diagram of the igfbp5a gene and the TALEN targeting sites. Exons are shown as 
boxes and introns as lines. Open and filled boxes represent untranslated and protein coding 
regions, respectively. The TALEN targeting sites are underlined. The spacer sequence is 
indicated in grey letters. (B) DNA sequence of the indicated zebrafish mutants. Open box 




Figure 2.2 Deletion of Igfbp5a leads to premature death 
(A) Structure of wild type Igfbp5a (WT), Igfbp5aΔ4, and Igfbp5aΔ11. SP, N, L, and C indicate 
the signal peptide, N-, Linker-, and C-domain of Igfbp5a. a.a. indicates amino acids and * 
indicates a stop codon. The underlined amino acids were introduced by a frameshift. (B-C) F2 
progeny of igfbp5a Δ4+/- intercrosses (left panel) and igfbp5a Δ11+/- (right panel) intercrosses 
were raised in E3 solution until 3 or 5 days post fertilization (dpf) and transferred into either fish 
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system water (B) or 5PPT high [Ca2+] solution (C). The fish were sampled randomly and 
genotyped at the indicated stages. The genotype distributions are shown. ****, P<0.0001 by chi-





Figure 2.3 The igfbp5a-/- mutant fish develop and grow normally in Ca2+ rich solutions 
(A) Progeny of igfbp5a+/- intercrosses were raised in E3 solution until 5 dpf and transferred into 
high [Ca2+] 5PPT solution. The vertebrate columns of 12 dpf larvae were visualized by calcein 
staining and quantified. Data shown are means ± SEM. n = 18~19 fish/group. No statistical 
significance was found among the groups using one-way ANOVA followed by Tukey’s multiple 
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comparison test. (B, C, and D) Embryos of the indicated genotypes were raised in E3 solution. 
Their body length (B) and somite number (C) was measured at 24 hpf and head-trunk angle (D) 
measured at 72 hpf. Data shown are means ± SEM. n = 12~73 fish/group. No statistical 
significance was found using one-way ANOVA followed by Tukey’s multiple comparison test. 
(E) Progeny of igfbp5a+/- intercrosses were sampled at the indicated stages. After NaR cells were 
visualized by in situ hybridization using a trpv5/6 cRNA probe and quantified, the fish were 
genotyped individually. Data shown are means ± SEM. n = 6~14 fish/group. No statistical 






Figure 2.4 igfbp5a mRNA levels in mutant fish 
(A) Heteroduplex mobility assay (HMA) results are shown. Upper and lower arrowheads 
indicate the wild-type and mutant homoduplex, respectively. Asterisk indicates the heteroduplex. 
RNA from 48 hpf embryos of indicated genotype was reversed transcribed to cDNA and used as 
template. (B) The expression of igfbp5a mRNA in 48 hpf embryos of the indicated genotypes 
were analyzed by qPCR and normalized by β-actin mRNA levels. Values are means ± SEM of 3 
independent experiments, each containing RNA isolated from a pool of 10-15 embryos. No 





Figure 2.5 Deletion of Igfbp5a does not alter igfbp5b expression 
(A) In situ hybridization analysis of igfbp5b in wild-type and igfbp5a-/- mutant larvae at the 
indicated stages. Arrows, arrowheads, and asterisk indicate signals in the neural tissues, 
pharyngeal arches, and pectoral fin, respectively. Scale bar = 0.1 mm. The frequency of larvae 
with the indicated expression patterns is shown in the bottom right corner in each panel. (B) No 
igfbp5b expression is detected in the yolk sac region in either wild-type or igfbp5a-/- mutant 
larvae. Arrowheads point to signals in the pharyngeal arches. Scale bar=0.1mm. (C) The 
expression of igfbp5b in fish of the indicated genotypes and stages was analyzed by qPCR and 
normalized by the β-actin levels. Values are means ± SEM of 3 independent experiments, each 
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containing RNA isolated from a pool of 20 embryos. No statistical difference was found by one-
way ANOVA followed by Tukey’s multiple comparison test. (D) Wild-type and igfbp5a-/- 
mutant embryos were raised in E3 solution to 72 hpf and transferred to the solutions with the 
indicated Ca2+ concentrations. After 48 hours, they were analyzed by qPCR analysis. The 
igfbp5b mRNA levels were normalized to β-actin mRNA levels. Values are means ± SEM of 3 
independent experiments, each containing RNA isolated from a pool of 20 larvae. No statistical 




Figure 2.6 Deletion of Igfbp5a increases mortality and impairs adaptive NaR cell proliferation 
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(A) Progeny of igfbp5a+/- intercrosses were raised in E3 solution until 5 dpf and transferred into 
low [Ca2+] solution. Dead larvae were collected daily and genotyped. The survival curve is 
shown and the numbers of fish are indicated. P<0.0001 by Logrank test. (B and C) Fish of the 
indicated genotypes were raised in solutions containing the indicated Ca2+ concentration to 11 
dpf and stained by Alizarin red. Representative images are shown in (B) and the average number 
of calcified vertebral columns shown in (C). n = 19~29 fish/group, ***, P<0.001. ****, 
P<0.0001, unpaired two-tailed t test. Scale bar = 0.5 mm. (D) Embryos of the indicated 
genotypes were raised in E3 solution till 72 hpf and transferred to solutions containing the 
indicated Ca2+ concentration. The expression of trpv5/6 mRNA was measured by qPCR and 
normalized to the NaR cell number at the corresponding time point and treatment. Values are 
means ± SEM of 3 independent experiments, each containing RNA isolated from a pool of 20 
larvae of the indicated stages. Different letters indicated statistically significant differences (P < 
0.05, one-way ANOVA followed by Tukey’s multiple comparison test). (E) Progeny of 
igfbp5a+/- intercrosses were raised in E3 solution to 72 hpf and transferred to solutions containing 
the indicated Ca2+ concentration. The fish were sampled at 120 hpf. NaR cells were visualized by 
in situ hybridization using the trpv5/6 cRNA probe and quantified. Each larva was genotyped 
afterwards. Data shown are mean ± SEM, n = 13~40 fish/group. Different letters indicated 
statistically significant differences (P < 0.05, one-way ANOVA followed by Tukey’s multiple 
comparison test). (F) Tg(igfbp5a:GFP) of the indicated genotypes were raised in E3 solution till 
72 hpf and transferred to low [Ca2+] solution. The number of GFP-labeled NaR cells was 
quantified at 72, 96, 104, and 120 hpf. Data shown are mean ± SEM, n = 7~36 fish/group. 
Different letters indicate significant differences (P < 0.05, one-way ANOVA followed by 
Tukey’s multiple comparison test). 
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Figure 2.7 igfbp5a Δ4 mutant fish are prone to dying under low Ca2+ stress 
Progeny of igfbp5aΔ4+/- intercrosses were raised in E3 solution until 5 dpf and transferred into 
the low [Ca2+] solution. Dead larvae were collected daily and genotyped. The survival curve is 
shown and the total numbers of fish for each genotype are indicated. The igfbp5aΔ4-/- group was 





Figure 2.8 CRISPR/Cas9-mediated transient deletion of Igfbp5a impairs adaptive NaR cell 
proliferation 
(A) The igfbp5a-targeting sgRNA-1 or -2 were co-injected with Cas9 protein into 
Tg(igfbp5a:GFP) embryos at the 1-cell stage. The injected embryos were raised until 5 dpf in E3 
solution and subjected to a T7E1 endonuclease assay. Cleaved bands were observed in sgRNA-1 
and sgRNA-2 injected larvae but not the uninjected larvae. Heterozygous igfbp5a+/- larvae were 
used as a positive control. (B) The injected embryos described in (A) were raised in E3 solution 
until 72hpf and transferred to solutions with the indicated Ca2+ concentrations. After 48 hours, 
GFP-expressing NaR cells were quantified in each fish. Values are means ± SEM. n= 15~41 fish 
per group. Different letters indicate significant differences among groups (P < 0.05). One-way 




Figure 2.9 Expression of IGF and insulin ligand and receptor genes in NaR cells 
(A) Tg(igfbp5a:GFP) embryos were raised in E3 solution to 72 hpf and transferred to solutions 
with the indicated Ca2+ concentrations. After 18 hours, NaR cells were sorted by FACS and 
mRNA levels of the indicated genes were measured. Values are mean ± SEM, n= 4 independent 
experiments, each containing RNA isolated from FACS-sorted GFP-expressing NaR cells from a 
pool of more than two hundred embryos. (B) Tg(igfbp5a:GFP) larvae (72hpf) were transferred to 
solutions with the indicated Ca2+ concentrations. After 48 hours, they were analyzed by GFP 
immunostaining (left panel) and in situ hybridization for igf2b mRNA (middle panels). Merged 
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Figure 2.10 Deletion of Igfbp5a but not its paralog Igfbp5b impairs low [Ca2+] stress-induced 
Akt-Tor signaling in NaR cells 
(A-D). Fish of the indicated genotypes raised in the E3 solution were transferred to solutions 
containing the indicated Ca2+ concentration at 72 hpf. After 24 hours, they were stained for 
phosphorylated Akt (A and B) or phosphorylated S6 (C and D). Representative images are 
shown in (A and C). The numbers of cells positive for pAkt or pS6 in each fish were quantified 
and the quantitative results are shown in (B and D). Values are means ± SEM, n = 6~12 
fish/group. Different letters indicate significant differences between groups (P < 0.05, one-way 
ANOVA followed by Tukey’s multiple comparison test). (E) Fish of the indicated genotypes 
were raised in E3 solution to 72 hpf and transferred to solutions containing the indicated [Ca2+] 
with or without U0126 (10 μM) or PD98059 (10 μM). After 8 hours, they were stained for 
phosphorylated Erk. The pErk signal was scored following a previously published scoring 
system (Dai et al., 2014a). Total numbers of fish are shown above the bar. (F) Deletion of 
Igfbp5b has no effect on Akt signaling. Larvae of the indicated genotypes were raised in E3 
solution to 72 hpf and transferred to solutions containing the indicated Ca2+ concentration. After 
8 hours, they were stained for phosphorylated Akt. The number of cells positive for pAkt was 
quantified. Values are means ± SEM, n = 13~18 fish/group. Different letters indicate significant 





Figure 2.11 Deletion of Igfbp5a has no effect on phosphorylated Erk signaling 
Wild-type and igfbp5a mutant fish were raised in E3 solution to 72 hpf and transferred to embryo 
solutions containing the indicated [Ca2+] with or without PD98059 (10 μM) or U0126 (10 μM). 
After 8 hours, they were stained for pErk. Representative views are shown. The quantified data 




Figure 2.12 Re-introduction of Igfbp5a or constitutively active Akt in NaR cells restores the 
adaptive proliferation 
(A) Structure of zebrafish Igfbp5a and its mutants. SP, N, L, and C domains are indicated. 
Mutated residues are shown. (B and C) The NaR division scoring system. Zebrafish igfbp5a-
/-;Tg(igfbp5a:GFP) embryos injected with the igfbp5a-IRES-mCherry BAC constructs 
containing the indicated genes were raised in E3 solution until 72 hpf and transferred to low 
[Ca2+] solutions. Igfbp5a expressing NaR cells are labeled by both GFP and mCherry. The NaR 
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division scoring system is shown in (B). During the 48 hour treatment period, NaR cells that 
divide 0, 1, or 2 times are scored as -, +, and ++. Scale bar = 0.05 mm. The quantified data is 
shown in (C). Chi-square test was used for statistical analysis. **, and ***, P< 0.01 and 0.001, 
n.s. not statistically significant, total numbers of cells are shown above the bar. (D) The larvae 
described in (B and C) were collected after 24 hours in low [Ca2+] solution and stained for 
phosphorylated Akt and mCherry in situ hybridization. Scale bar = 0.02 mm. (E) The experiment 
procedure was the same as in (B and C) except myr-Akt-mCherry BAC DNA was injected into 
igfbp5a-/-;Tg(igfbp5a:GFP) embryos. Chi-square test was used for statistical analysis. ****, P< 








Figure 2.13 IGFBP5 but not two cancer-associated IGFBP5 mutants promotes the mitotic 
response of human epithelial cells to IGF stimulation 
(A) Human LoVo epithelial cells were transfected with the indicated siRNA construct with or 
without pCMV-BP545. After 24 hours, they were treated with 400 ng/ml human IGF2 for 96 
hours and analyzed by flow cytometry. The percentage of S-phase cells is shown. Values shown 
are mean ± S.E.M., n = 3. Groups labeled with different letters are significantly different from 
each other (P<0.05, one-way ANOVA followed by Tukey’s multiple comparison test). (B) 
Structure of human IGFBP5 and its two cancer-associated mutants. SP, N, L, and C domains are 
indicated. Mutated residues are shown. * indicates stop codon. (C) Zebrafish igfbp5a-
/-;Tg(igfbp5a:GFP) embryos injected with the indicated human IGFBP5 were raised in E3 
solution until 72 hpf and transferred to low [Ca2+] solution. 48 hours later, GFP and mCherry 
double positive cells were quantified using the score system shown in Fig. 5B. Chi-square test 
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was used for statistical analysis. **, ***, and **** indicate P< 0.01, 0.001, and 0.001, n.s. not 




Table 2-1 Primers for cloning and sequencing of Igfbp5a, IGFBP5, and their mutants 



















IGFBP5 G223R IGFBP5-G223R-F GTGACCGCAAAAGATTCTACAAG 
IGFBP5-G223R-R CTTGTAGAATCTTTTGCGGTCAC 
IGFBP5 W242* IGFBP5-W242stop-F GGCATCTGCTGATGCGTGGACAAG 
IGFBP5-W242stop-R CTTGTCCACGCATCAGCAGATGCC 














Epithelial homeostasis and regeneration require a pool of quiescent cells. How the 
quiescent cells are established and maintained is poorly understood. Here we report that Trpv6, a 
cation channel responsible for epithelial Ca2+ absorption, functions as a key regulator of cellular 
quiescence. Genetic deletion and pharmacological blockade of Trpv6 promoted zebrafish 
epithelial cells to exit from quiescence and re-enter the cell cycle. Reintroducing Trpv6, but not 
its channel dead mutant, restored the quiescent state. Ca2+ imaging showed that Trpv6 is 
constitutively open in vivo. Mechanistically, Trpv6-mediated Ca2+ influx maintained the 
quiescent state by suppressing insulin-like growth factor (IGF)-mediated Akt-Tor and Erk 
signaling. In zebrafish epithelia and human colon carcinoma cells, Trpv6/TRPV6 elevated 
intracellular Ca2+ levels and activated PP2A, which down-regulated IGF signaling and promoted 
the quiescent state. Our findings suggest that Trpv6 mediates constitutive Ca2+ influx into 
epithelial cells to continuously suppress growth factor signaling and maintain the quiescent state.  
                                                 
 
2 This chapter is published Elife. 2019 Sep 17;8, with authors listed as: Yi Xin, Allison 
Malick, Meiqin Hu, Chengdong Liu, Heya Batah, Haoxing Xu, and Cunming Duan. 
Chapter 3 Cell-autonomous Regulation of Epithelial Cell Quiescence by Calcium Channel 
Trpv6 2 
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3.2 Introduction  
Quiescence is a non-proliferative cellular state found in many cell types in the body. 
While non-proliferative, these cells retain the ability to re-enter the cell cycle in response to 
appropriate cell-intrinsic and extrinsic signals (Matson and Cook, 2017; Sun and Buttitta, 2015; 
Yao, 2014). Quiescence protects long-lived cells, such as adult stem cells against the 
accumulation of genomic aberrations and stress. Maintaining a pool of quiescent cells is critical 
for tissue repair, wound healing, and regeneration (Cheung and Rando, 2013). This is 
particularly important for epithelia which are rapidly and continuously renewed throughout life. 
The intestinal epithelial cells, for example, are renewed every 4 to 5 days (van der Flier and 
Clevers, 2009). By synchronizing cultured mammalian cells in G0 via serum starvation followed 
with serum re-stimulation, Yao et al. (2008) showed that the Rb proteins (pRb, p107, and p130) 
and their interactions with E2F proteins are critical in regulating the proliferation-quiescence 
decision (Yao et al., 2008). Acting downstream, a bifurcation mechanism controlled by CDK2 
activity and p21 regulating the proliferation-quiescence decision has also been demonstrated in 
cultured mammalian cells (Spencer et al., 2013). While important insights have been learnt from 
in vitro studies, how the quiescent cell pools are established during development and maintained 
in vivo is not well understood. The exceptionally high turnover rate implies that cell type-
specific mechanism(s) must exist.  
The transient receptor potential cation channel subfamily V member 6 (TRPV6) is 
expressed in mammalian intestinal epithelial cells (Hoenderop et al., 2005). TRPV6 is a 
conserved calcium channel that constitutes the first and rate-limiting step in the transcellular 
Ca2+ transport pathway (Hoenderop et al., 2005; Peng et al., 1999; Peng et al., 2000; Wissenbach 
et al., 2001). In zebrafish, trpv6 is specifically expressed in a population of epithelial cells 
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known as ionocytes or NaR cells (Dai et al., 2014a; Pan et al., 2005). NaR cells take up Ca2+ 
from the surrounding habitats into the body to maintain body Ca2+ homeostasis (Liao et al., 
2009; Yan and Hwang, 2019b). NaR cells are polarized cells that functionally and molecularly 
similar to human intestinal epithelial cells. While located in the gill filaments and the intestine in 
the adult stages, these cells are distributed in the yolk sac skin during the embryonic and larval 
stages, making these easily accessible for experimental observation and perturbations (Dai et al., 
2014a; Pan et al., 2005). When zebrafish are grown in homeostatic normal [Ca2+] conditions, 
NaR cells are maintained in a quiescent state and the Akt-Tor activity is regulated at low levels. 
Low [Ca2+] stress increases Akt-Tor activity in these cells and promotes their re-entry into the 
cell cycle (Dai et al., 2014; Liu et al., 2017). This is similar to the proposed role of TOR 
signaling in adult stem cells (Chen et al., 2002; Kim and Guan, 2019; Meng et al., 2018a), 
suggesting an evolutionarily conserved mechanism(s) at work. More recent studies suggest that 
insulin-like growth factor binding protein 5a (Igfbp5a), a secreted protein that binds IGF with 
high-affinity, plays a critical role in activating Akt-Tor signaling in these cells via the IGF1 
receptor under calcium deficient states (Liu et al., 2018a). The mechanism controlling the 
quiescent state under normal [Ca2+] condition is currently unknown. In a previous study, we 
found that zebrafish mus mutant larvae, a loss-of-function Trpv6 mutant fish line obtained from 
an ENU mutagenesis screen (Vanoevelen et al., 2011), had many proliferating NaR cells and 
elevated Akt-Tor signaling, suggesting Trpv6 may play a negative role in regulating NaR cell 
proliferation (Dai et al., 2014a). How does Trpv6 act to inhibit Akt-Tor signaling and whether it 
involves in cell quiescence regulation are unknown. Because TRPV6/Trpv6 is the primary Ca2+ 
channel responsible for epithelial Ca2+ uptake and since Ca2+ is a major second messenger 
involved in cell proliferation and differentiation in many cell types (Clapham, 2007; Hoenderop 
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et al., 2005), we hypothesized that Trpv6 regulates the quiescent state by conducting Ca2+ influx 
into epithelial cells and suppressing IGF1 receptor mediated signaling. The objective of this 
study was to test this hypothesis and to elucidate the underlying mechanisms of Trpv6 action.  
3.3 Results  
3.3.1 Trpv6 is crucial for epithelial Ca2+ uptake in zebrafish 
Three trpv6 mutant fish lines were generated using CRISPR/Cas9 (Figure 3.1A). All 
three Trpv6 mutant proteins lack the 6 transmembrane domains and the critical ion pore region 
and are predicted to be null mutations (Figure 3.1B). The trpv6Δ7 and trpv6Δ8 lines were made 
in the Tg(igfbp5a:GFP) fish background. Tg(igfbp5a:GFP) is a transgenic fish line expressing 
EGFP in the trpv6-expressing NaR cells (Liu et al., 2017a), allowing real-time analysis of NaR 
cell proliferation. The trpv6Δ8-2 line was in a non-transgenic fish background and used in Ca2+ 
imaging analysis described later. The gross morphology and body size of the mutant fish were 
similar to their siblings (Figure 3.2). All mutant fish died within 2 weeks (Figure 3.1C and D). 
Alizarin red staining indicated a marked reduction in the calcified bone mass in the trpv6-/- 
mutant fish (Figure 3.1E), indicating body calcium deficiency. Fura-2 Ca2+ imaging experiments 
in HEK293 cells transfected with zebrafish Trpv6 and human TRPV6 were performed. The 
Trpv6-mediated [Ca2+]i change was similar to that of TRPV6 (Figure 3.1F). D542 in mammalian 
TRPV6 occupies a critical position in the ion pore region and mutation of this residue abolishes 
its Ca2+ permeability (McGoldrick et al., 2018; Sakipov et al., 2018). This residue is conserved in 
zebrafish Trpv6 at position 539 (Figure 3.3). We generated and tested Trpv6D539A mutant. The 
[Ca2+]i levels in Trpv6D539A mutant transfected cells were low and did not respond to changes 
in extracellular [Ca2+] (Figure 3.1F). The maximal Ca2+ influx rate was reduced to a negligible 
level in Trpv6D539A transfected cells (Figure 3.1G). Whole-cell patch clamp experiments 
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confirmed that the Trpv6 mediated Ca2+ current and this activity was abolished in the 
Trpv6D539A mutant (Figure 3.1H). These findings support the notion that Trpv6 plays an 
indispensable role in epithelial Ca2+ uptake and maintaining body Ca2+ balance and provided 
critical reagents for subsequent experiments.  
3.1.2 Trpv6 regulates the quiescence-proliferation decision in epithelial cells 
To determine the possible role of Trpv6 in NaR cells, double-blind tests were performed 
(Figure 3.4A). In agreement with previous studies (Dai et al., 2014; Liu et al., 2017), NaR cells 
in the wild-type and heterozygous siblings were distributed in the yolk sac region as single cells 
in a salt-and-pepper pattern (Figure 3.4B). NaR cells in the trpv6Δ8 mutant larvae were often 
observed in clusters of newly divided cells (Figure 3.4B). These proliferating NaR cells had 
enlarged apical opening (Figure 3.5). The NaR cell proliferation rate was significantly elevated 
in the mutant fish in all stages examined (Figure 3.4C). At 5 dpf, the trpv6Δ8 mutant fish had 3-
time more NaR cells (Figure 3.4C). Essentially same data were obtained with the trpv6Δ7 fish 
(Figure 3.4D). GdCl3, a Trpv6 inhibitor, was used to further test the role of Trpv6. GdCl3 
treatment increased NaR cell proliferation in the wild-type and heterozygous fish, while it did 
not further increase NaR cell proliferation in the mutant fish (Figure 3.4E and Figure 3.6). 
Ruthenium red, another Trpv6 inhibitor, had similar effects (Figure 3.6). Next, Trpv6 and 
Trpv6D539A were randomly expressed in NaR cells in trpv6Δ8-/-; Tg(igfbp5a:GFP) fish using a 
Tol2 transposon BAC-mediated genetic mosaic assay (Liu et al., 2018a). Reintroduction of 
Trpv6 reversed the quiescence to proliferation transition (Figure 3.4F) and reduced the apical 
opening site to the control levels (Figure 3.5). Trpv6D539A, however, had no such effect (Figure 
3.4F). These data showed that Trpv6 functions as a major barrier in the quiescence to 
proliferation transition and this action requires its Ca2+ permeability.  
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3.3.3 Trpv6 controls the quiescence-proliferation decision via regulating IGF signaling  
Previous studies showed that pre-exiting NaR cells in wild-type fish re-enter the cell 
cycle in response to low [Ca2+] treatment (Dai et al., 2014a; Liu et al., 2017a). To determine 
whether this effect is related to Trpv6, 3 dpf trpv6Δ7-/-;Tg(igfbp5a:GFP) larvae and siblings 
were subjected to low [Ca2+] challenge test. Low [Ca2+] treatment resulted in a 3-fold increase in 
proliferating NaR cells in the wild-type and heterozygous fish (Figure 3.7A). This value was 
comparable to that of trpv6Δ7-/- larvae kept in normal [Ca2+] media (Figure 3.7A). Low [Ca2+] 
treatment did not further increase NaR cell number in the mutant larvae (Figure 3.7A). Low 
[Ca2+] treatment also significantly increased trpv6 mRNA level in wild-type fish and 
heterozygous fish, an adaptive response in Ca2+ homeostasis reported previously (Liu et al., 
2017a). This increase, however, was abolished in trpv6-/- mutant (Figure 3.8A), likely due to 
non-sense mRNA decay of mutant trpv6 mRNA.  
Low [Ca2+] stress induces NaR cell proliferation and this has been attributed to the 
activation of IGF1 receptor-mediated PI3 kinase-Akt-Tor signaling (Dai et al., 2014a; Liu et al., 
2017a; Liu et al., 2018a). Gene expression analysis results showed that the igfr1a and igfr1b 
mRNA levels were comparable between trpv6Δ7-/- larvae and siblings (Figure 3.8B and C). 
Immunostaining results showed significant increases in the number of phosphorylated Akt-
positive NaR cells in trpv6Δ7-/- and trpv6Δ8-/- larvae kept in the normal [Ca2+] embryo medium 
(Figure 3.7B and Figure 3.9A). The levels of phospho-Akt in the siblings were minimal. Re-
expression of Trpv6 in mutant fish inhibited Akt phosphorylation in NaR cells (Figure 3.7D), 
indicating that Trp6 is both required and sufficient in suppressing Akt signaling. Tor signaling 
activity was also significantly elevated in the trpv6Δ7-/- and trpv6Δ8-/- mutant larvae (Figure 3.7C 
and Figure 3.9B). Blocking Trpv6 channel activity using GdCl3 and Ruthenium red increased 
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phospho-Akt levels and NaR cell proliferation in the wild-type fish (Figure 3.10). Mitogen-
activated kinase (MAPK) pathway is another major signaling pathway downstream of the IGF1 
receptor (Duan et al., 2010). Immunostaining results pErk signaling activity was significantly 
increased in trpv6-/- mutant larvae (Figure 3.7E and Figure 3.11). These data show that loss of 
Trpv6 expression or activity results in elevated IGF signaling in NaR cells.  
If Trvp6 regulates the quiescence-proliferation decision by suppressing the IGF1 
receptor-mediated signaling, then blockade of IGF1 receptor and key downstream signaling 
molecules should inhibit the quiescent to proliferation transition. Indeed, treatment of trpv6-/- 
mutant fish with BMS-754807, an IGF1 receptor inhibitor, abolished the quiescence to 
proliferation transition in mutant larvae (Figure 3.7F). However, IGF1 receptor inhibition did not 
show any significant effect on NaR cell proliferation in wild-type and heterozygous siblings 
(Figure 3.7F). Treatment of trpv6-/- mutant fish with PI3 kinase inhibitor Wortmannin, Tor 
inhibitor Rapamycin, and Mek inhibitor U0126 had similar effects (Figure 3.7G-I).  
3.3.4 Trpv6 constitutively conducts Ca2+ into epithelial cells and regulates the [Ca2+]i levels 
in vivo 
To investigate Trvp6-mediated Ca2+ influx in NaR cells in vivo, we generated the 
Tg(igfbp5a:GCaMP7a) fish, a stable reporter fish line expressing GCaMP7a in NaR cells 
(Figure 3.12). After validating the effectiveness of GCaMP7a in reporting intracellular Ca2+ 
levels ([Ca2+]i) (Figure 3.13), trpv6Δ8-2+/- ;Tg(igfbp5a:GCaMP7a)+/- fish were crossed with 
trpv6Δ8-2+/- fish and their offspring were screened at 3 dpf and subsequently genotyped 
individually. While GCaMP7a-positive cells were observed in ~50% of the siblings as expected, 
none of the trpv6Δ8-2-/- mutant larvae had any GCaMP7a-positive cells (Figure 3.14A). Addition 
of the Ca2+ ionophore ionomycin restored GCaMP7a signal in the mutant fish to a level 
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comparable to their siblings (Figure 3.14B and C), thus ruling out the possibility that GCaMP7a 
expression is altered in the mutant fish. Next, Trpv6 was randomly expressed in NaR cells in the 
trpv6 Δ8-2-/-; Tg(igfbp5a:GCaMP7a) fish using the genetic mosaic assay. Reinduction of Trpv6 
significantly increased GCaMP7a signal levels (Figure 3.14D). Ionomycin treatment did not 
result in further increase (Figure 3.14D). These genetic and in vivo imaging data argue strongly 
that Trpv6 is not only critical in conducting Ca2+ into NaR cells, but also in maintaining the high 
[Ca2+]i levels in these cells. We next used Trpv6 inhibitors to block Trpv6 activity in 
Tg(igfbp5a:GCaMP7a) fish. Within 8 min after the GdCl3 treatment, the [Ca2+]i levels became 
significantly lower and the reduction became more pronounced in 12 and 16 min (Figure 3.14E 
and G). When GdCl3 was washed out, the [Ca2+]i levels gradually increased and returned to 
normal levels after 12 min (Figure 3.14F and G). Similar results were obtained with Ruthenium 
red (Figures 3.15). Addition of the IGF1 receptor inhibitor BMS-754807 did not change the 
[Ca2+]i levels in NaR cells (Figures 3.16). Therefore, Trpv6 constitutively conducts Ca2+ into 
epithelial cells and continuously maintains high [Ca2+]i levels in vivo.  
3.3.5 Trpv6 inhibits IGF signaling and epithelial cell proliferation by regulating [Ca2+]i and 
PP2A is a downstream effector  
The observation that [Ca2+]i in NaR cells are continuously maintained at high levels was 
surprising and intriguing. To determine whether the observed high [Ca2+]i levels have any 
functional significance, Tg(igfbp5a:GFP) larvae were treated with the intracellular Ca2+ chelator 
BAPTA-AM. BAPTA-AM treatment resulted in a significant increase in NaR cell proliferation 
(Figure 3.14H) and in phospho-Akt signaling levels (Figure 3.14I). These data indicate that the 
high [Ca2+]i levels are critical in maintaining the quiescent state. To identify the downstream 
effector(s) of [Ca2+]i, a collection of small molecule inhibitors with known protein targets were 
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screened using Tg(igfbp5a:GFP) larvae. Okadaic acid and Calyculin, two inhibitors of the 
conserved protein phosphatase 2A (PP2A), were among the strongest hits. Treatment of 
Tg(igfbp5a:GFP) larvae with either drug significantly increased NaR cell proliferation (Figure 
3.16A and B). This effect is specific because the drug treatment had no such effect in PP2A 
deficient zebrafish (Figure 3.18). Importantly, the Okadaic acid and Calyculin treatment-induced 
NaR cell proliferation was abolished by the IGF1 receptor inhibitor BMS-754807, PI3K inhibitor 
Wortmannin, Tor inhibitor Rapamycin, and Mek inhibitor U0126 (Figure 3.17A-C). Okadaic 
acid or Calyculin treatment also resulted in significant increases in the phosphorylated-Akt levels 
in an IGF1 receptor-dependent manner (Figure 3.17D). However, Okadaic acid or Calyculin 
treatment did not change the [Ca2+]i levels (Figure 3.19), indicating that PP2A acts downstream 
of the [Ca2+]i.  
PP2A are a family of conserved protein phosphatases that dephosphorylate Akt and many 
other proteins (Perrotti and Neviani, 2013; Seshacharyulu et al., 2013). PP2A holoenzymes are 
heterotrimers. The core enzyme is made by a catalytic C subunit (Cα and Cβ isoform), a scaffold 
A subunit (Aα and Aβ), and many regulatory B subunits (Virshup and Shenolikar, 2009). The 
combination of these subunits results in a very large number of different holoenzyme complexes. 
Our database search suggests that the zebrafish genome contains 3 C subunit genes (ppp2ca, cb, 
and cc). We used CRISPR/Cas9 to transiently knockdown the ppp2c genes because stable 
knockout is likely embryonic lethal. The effectiveness of the targeting guide RNAs was validated 
(Figure 3.18). Transient knockdown of ppp2cs resulted in significant increases in the number of 
proliferating NaR cells (Figure 3.17E) and in phospho-Akt levels (Figure 3.17F), suggesting that 
PP2A mediates the action of Trpv6-mediated Ca2+ influx in zebrafish epithelia.  
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To determine whether this signaling mechanism is functional in human cells, TRPV6 
knockdown experiments were performed in human LoVo colon carcinoma cells using validated 
siRNA (Lallet-Daher et al., 2009). These cells were synchronized by serum starvation followed 
by serum re-stimulation. Knockdown of TRPV6 resulted in a significant increase in LoVo cell 
proliferation (Figure 3.20A and Figure 3.21). Treatment of LoVo cells with Ruthenium red, 
GdCl3, BAPTA-AM, and Okadaic acid all significantly increased cell proliferation (Figure 3.20B 
and Figure 3.22).  MTT assay results showed little changes in cell viability in GdCl3, BAPTA-
AM, and Okadaic acid treated cells. Ruthenium red treatment resulted in a modest but 
statistically significance decrease in cell viability (Figure 3.23). Finally, LoVo cells were 
transfected with PP2A-CαL199P and PP2A-CαH118N, two dominant-negative forms of catalytic 
subunit Cα of PP2A (Katsiari et al., 2005). Expression of PP2A-CαL199P and PP2A-CαH118N both 
significantly increased LoVo cell proliferation (Figures 3.20C and 3.24). 
3.4 Discussion  
In this study, we uncover a previously unrecognized role of Trpv6 and delineates a 
Trpv6-mediated and evolutionarily conserved Ca2+ signaling pathway controlling cell 
quiescence. We showed that genetic deletion of Trpv6 not only impaired Ca2+ uptake and 
reduced body Ca2+ content, but also promoted epithelial cells to exit quiescence and proliferate. 
Likewise, pharmacological inhibition of Trpv6 increased epithelial cell quiescence-proliferation 
transition. While low [Ca2+] treatment increased epithelial cell proliferation in the siblings, it had 
no such effect in trpv6-/- larvae, supporting the notion that Trpv6 functions as a major regulator 
of the quiescent state. Our genetic mosaic analysis results showed that the quiescent state is 
regulated by Trpv6 in a cell autonomous manner. Reintroduction of Trpv6 in the trpv6-/- mutant 
fish was sufficient to restore the [Ca2+]i levels, suppress IGF signaling, and reverse the cells back 
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to the quiescent state. The Trpv6D539A mutant had no such activity, suggesting that this action of 
Trpv6 requires its Ca2+ conductance activity. 
The impaired Ca2+ uptake, reduced body Ca2+ content, and premature death observed in  
trpv6Δ7 and trpv6Δ8 mutant fish are in good agreement with a previous study by Vanoevelen et 
al. (2011) using the mus mutant fish, but differ considerable from findings made in the mouse 
model. Bianco et al. reported that Trpv6 knockout mice were viable but had reduced intestinal 
Ca2+ uptake, increased urinary Ca2+ excretion, decreased bone mineral density, and decreased 
growth and fertility (Bianco et al., 2007). Another Trpv6-/- mutant mouse line reported by Chen 
et al., however, had normal blood Ca2+ concentration and normal bone formation, but with an 
increased number of osteoclasts (Chen et al., 2014). A third Trpv6-/- mutant mouse model 
showed reduced fertility in male only (Weissgerber et al., 2012). The reason(s) of these 
discrepancies among these mouse studies is not fully understood, but factors such as dietary Ca2+ 
contents may have been critical (Van der Eerden et al., 2012). Zebrafish embryos continuously 
lose Ca2+ and other ions into the surrounding hypo-osmotic environments and must constantly 
take up Ca2+  from the habitat to survive (Liu et al., 2018a). This may also contribute to the 
premature phenotypes found in the zebrafish mutants. Another factor to take into consideration is 
genetic redundancy. In mammals, there is another closely related TRPV sub-family member, 
TRPV5. TRPV5 plays similar roles in the transcellular Ca2+ transport pathway, although it is 
mainly expressed in the kidney (Hoenderop et al., 2005). It has been shown that TRPV5 
expression in the intestine is elevated in Trpv6 mutant mice (Woudenberg-Vrenken et al., 2012). 
In comparison, zebrafish genome has a single trpv6 gene and lacks this genetic redundancy 
(Vanoevelen et al., 2011).  
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An important finding made in this study is that TRPV6 mediates constitutive Ca2+ 
influx into epithelial cells in vivo. The notion that TRPV6 is the primary epithelial Ca2+ channel 
is supported by in vitro findings made in mammalian cells over-expressing TRPV6 (Fecher-Trost 
et al., 2017) and by measuring endogenous TRPV6-mediated Ca2+ influx in cultured Jurkat T 
cells and rat cauda epidermal principle cells (Gao da et al., 2016; Kever et al., 2019). Fura-2 
Ca2+ imaging studies in cultured mammalian cells transfected with TRPV6 indicated that this 
channel may be constitutively open (Vennekens et al., 2000). Although another study reported 
that patch-clamp recording of mammalian cells transfected with TRPV6 failed to detect 
spontaneous channel activity (Bodding and Flockerzi, 2004), a recent study has provided 
structural and functional evidence that TRPV6 is constitutively active (McGoldrick et al., 
2018). Other studies have reported that TRPV6 activity is activated by a reduction in [Ca2+]i 
concentration, and inactivated by higher [Ca2+]i in mammalian cells (Nilius et al., 2000; Yue et 
al., 2001). How TRPV6/Trpv6 channel activity is regulated in vivo is less clear. In this study, 
we generated a reporter fish line using the high-performance genetic calcium reporter 
GCaMP7a to measure intracellular Ca2+ activity in vivo. GCaMPs has been used for imaging 
intracellular Ca2+ activity in zebrafish neurons (Muto and Kawakami, 2013). This approach has 
alleviated the concern associated with Fura-2 and cell culture systems. Our in vivo Ca2+ 
imaging results showed that the Trpv6 channel is constitutively open in NaR cells in vivo. This 
conclusion is supported by the facts that genetic deletion of trpv6 reduced the [Ca2+]i to 
undetectable levels and re-expression of Trpv6 restored the [Ca2+]i levels in NaR cells. Addition 
of ionomycin did not result in further increase, indicating the endogenous [Ca2+]i levels are high 
in these cells. More direct evidence came from the [Ca2+]i dynamics analysis results. Within 
minutes after the addition of Trpv6 blockers GdCl3 or Ruthenium red, the levels of [Ca2+]i were 
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significantly reduced. When these drugs were washed out, the [Ca2+]i signal levels returned to 
normal levels. It was thought that Ca2+ transporting epithelial cells, being continuously 
challenged by Ca2+ traffic from the apical side, maintain low levels of [Ca2+]i using the cytosolic 
Ca2+ binding protein (Hoenderop et al., 2005). The in vivo imaging findings made in this study 
challenge this conventional view. We postulate that maintaining high [Ca2+]i levels in these Ca2+ 
transporting cells is likely beneficial to the organism because it keeps these cells in differentiated 
state and functioning as Ca2+ transporting units. This idea is supported by the fact that treatment 
of zebrafish with the intracellular Ca2+ chelator BAPTA-AM promoted quiescent epithelial cells 
to proliferate.  
Mechanistically, Trpv6 regulates the quiescent state by mediating constitutive Ca2+ influx 
to continuously down-regulating IGF1 receptor-mediated Akt-Tor and Erk signaling. This is 
supported by the findings that 1) genetic deletion of Trpv6 or pharmacological inhibition of 
Trpv6-mediated Ca2+ uptake increased Akt-Tor and pErk signaling activity in an IGF1 receptor-
dependent manner; 2) re-expression of Trpv6 in the mutant cells suppressed Akt signaling; and 
3) inhibition of the IGF1 receptor, PI3 kinase, Tor, and Mek activity abolished or inhibited NaR 
cell proliferation in trpv6-/- mutant fish.  This conclusion is consistent with previous reports that 
up-regulating of IGF signaling promotes NaR cells to exit the quiescence and re-enter the cell 
cycle (Liu et al., 2017a; Liu et al., 2018a). NaR cells are one of the five types of ionocytes 
originated from a population of epidermal stem cells, which are specified by the expression of 
p63 (ΔNp63), a direct target of BMP signaling (Bakkers et al., 2002; Janicke et al., 2007; Lee 
and Kimelman, 2002). These epidermal stem cells further develop into Foxi3a/b-activated 
ionocyte progenitor cells and keratinocyte progenitor cells with low Foxi3a/b expression (Hsiao 
et al., 2007). Krüppel-like factor 4 (Klf4) plays an important role in maintaining the ionocyte 
 91 
progenitor cell pool by stimulating epidermal cell stem proliferation (Chen et al., 2019). In 
addition, several hormones, including isotocin, cortisol and stanniocalcin 1, have been implicated 
in the regulation of the ionocyte progenitor cell pool (Chou et al., 2011; Chou et al., 2015; Yan 
and Hwang, 2019b). Fox3a/3b form a positive regulatory loop and this loop is critical in 
specifying ionocyte progenitors to give rise to the 5 types of ionocytes (Chang et al., 2009; Hsiao 
et al., 2007; Yan and Hwang, 2019b). A hallmark of NaR cells is the expression of Trpv6 (Liu et 
al., 2017a; Pan et al., 2005). The role of Trpv6 and IGF signaling in NaR cell quiescence 
regulation unraveled in this study differs from the mechanisms acting in epidermal stem cells and 
ionocyte progenitor cells, and provides novel insights into the regulation of NaR cell 
development and function. 
Our chemical biology screens and genetic studies identified PP2A as a key effector 
downstream of TRPV6/Trvp6. Inhibition of PP2A by two distinct inhibitors led to elevated Akt 
signaling and increased epithelial cell proliferation. Importantly, an IGF1 receptor inhibitor 
abolished these changes. Likewise, CRISPR/Cas9-mediated transient knockdown of PP2A 
catalytic subunits increased epithelial cell proliferation and Akt signaling. PP2A can activate Akt 
and Erk signaling at multiple sites in the IGF signaling pathway (O'Connor, 2003). Numerous 
biochemical studies showing that PP2A can dephosphorylate Akt (Perrotti and Neviani, 2013; 
Seshacharyulu et al., 2013). In several human cancer cell lines, PP2A regulates Shc 
phosphorylation state and up-regulates ERK signaling activity in the IGF1-induced signaling 
pathway (Yumoto et al., 2006). Our in vivo findings, together with the in vitro findings indicate 
that a [Ca2+]i-regulated PP2A isoform(s) likely acts downstream of TRPV6/Trpv6 and regulates 
the quiescent state in epithelial cells. This is in good agreement with a recent study showing that 
compromising PP2A activity delays cell cycle exit in Drosophila (Sun and Buttitta, 2015). The 
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TRPV6-[Ca2+]i-PP2A signaling axis appears to be conserved in human colon carcinoma cells 
because siRNA-mediated knockdown or inhibition of TRPV6 increased LoVo cell proliferation. 
Likewise, chelating intracellular Ca2+, genetic and pharmacological inhibition of PP2A activity 
resulted in elevated cell proliferation of LoVo cells. The B regulatory subunits control substrate 
specificity and intracellular distribution of the PP2A holoenzymes and are encoded by a large set 
of genes classified into four families, i.e., B, B′, B″, and B″′ (Virshup and Shenolikar, 2009). 
Recent studies suggest that PR72/130 and PR70, 2 members of the B" family, possess 2 
conserved EF hand motifs (termed EF1 and EF2) and increasing [Ca2+]i increased the 
holoenzyme assembly and phosphatase activity (Kurimchak et al., 2013; Magenta et al., 2008). 
Another mechanism involves the action of [Ca2+]i-dependent m-calpain: m-calpain degrades 
PR72 and PR130 into a 45 kDa fragment (Janssens et al., 2009). This fragment, termed as PR45, 
is resistant to further degradation and exhibits enhanced PP2A activity. These two mechanisms 
may be related because the calpain-mediated proteolytic activation of PP2A depends on the EF 
hand integrity (Janssens et al., 2009). Future studies are needed to determine whether these 
mechanisms mediate TRPV6/Trpv6 action in epithelial cells. 
Our findings linking the Trpv6-meiated Ca2+ uptake to the cellular quiescence regulation 
have important biomedical implications. Approximately 90% of human cancers arise in 
epithelial tissues and over-proliferation is one of the cancer hallmarks (Hanahan and 
Weinberg, 2011). The IGF signaling pathway is one of the most frequently mutated signaling 
pathways in epithelial tissue-derived cancers, including colon and prostate cancers (Massoner 
et al., 2010). The IGF2 gene and IRS2 gene are frequently gained in colon cancer (Cancer 
Genome Atlas, 2012) and have been proposed as a colorectal cancer "driver" oncogenes (Day et 
al., 2013). TRPV6 gene is frequently up regulated in prostate, colon, and other cancer tissues 
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(Lehen'kyi et al., 2012; Prevarskaya et al., 2018). At present, it is unclear whether the elevated 
TRPV6 expression promotes tumor growth or it is an adaptive response (Lehen'kyi et al., 
2012; Prevarskaya et al., 2018). Knockdown or overexpression of TRPV6 in cultured cancer 
cells showed mixed effects in increasing/decreasing proliferation and/or apoptosis (Chow et al., 
2007; Lehen'Kyi et al., 2007; Lehen'kyi et al., 2012; Raphael et al., 2014; Skrzypski et al., 
2016a). Future studies are needed to clarify the role of TRPV6-[Ca2+]i-PP2A in prostate and 
colon cancer initiation and progression and its relationship to IGF signaling.  
 
3.5 Materials and methods 
 
Chemicals and reagents  
 All chemical reagents were purchased from Fisher Scientific (Pittsburgh, PA, USA) 
unless stated otherwise. Restriction enzymes were bought from New England Bio Labs (Beverly, 
MA, USA).  
 
Zebrafish husbandry 
Fish were raised following standard zebrafish husbandry guideline (Westerfield, 2000a). 
Embryos were obtained by natural cross and staged following Kimmel at al. (Kimmel et al., 
1995b). E3 embryo rearing solution (containing 0.33 mM [Ca2+]) was prepared as reported 
(Westerfield, 2000a). Two additional embryo rearing solutions containing 0.2 mM [Ca2+] (i.e., 
normal [Ca2+] solution) or 0.001 mM [Ca2+] (i.e., low [Ca2+] solution) were made following 
previously reported formula (Dai et al., 2014a). To inhibit pigmentation, 0.003% (w/v) N-
phenylthiourea (PTU) was added in some experiments. All experiments were conducted in 
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accordance with the guidelines approved by the University of Michigan Institutional Committee 
on the Use and Care of Animals. 
 
Generation of trpv6-/- fish lines using CRISPR/Cas9  
The sgRNA targeting trpv6 (5’-GGGCTCGTTGATGAGCTCCG-3’) was designed using 
CHOPCHOP (http://chopchop.cbu.uib.no/). The sgRNA (30 ng/μl) was mixed with capped with 
Cas9 protein (700 ng/μl) and co-injected into Tg(igfbp5a:GFP) or wild-type embryos at the 1-
cell stage as described (Xin and Duan, 2018). After confirming indels by PCR followed by 
hetero-duplex assay using a subset of F0 embryos, the remaining F0 embryos were raised to 
adulthood and crossed with Tg(igfbp5a:GFP) or wild-type fish. F1 fish were raised to the 
adulthood and genotyped. After confirming indels by DNA sequencing, the heterozygous F1 fish 
were intercrossed to generate F2 fish.  
 
Transient knockdown of ppp2cs  
Three sgRNAs targeting ppp2cs were designed using CHOPCHOP 
(http://chopchop.cbu.uib.no/). Their sequences are: ppp2ca-sgRNA: 5’-
GTTCCATAAGATCGTGAAAC-3’; ppp2cb-sgRNA: 5’-GAGCGTTCTCACTTGGTTCT-3’; 
ppp2ca2-sgRNA: 5’-GACGAAGGAGTCGAATGTGC-3’. sgRNAs (30 ng/μl) were mixed with 
Cas9 protein (700 ng/μl) and co-injected into Tg(igfbp5a:GFP) or wild type embryos at the 1-cell 
stage as reported (Xin and Duan, 2018). A subset of injected embryos were pooled, DNA 
isolated, and analyzed by PCR followed by hetero-duplex assays as reported (Liu et al., 2018a). 




To isolate genomic DNA, pooled embryos or individual adult caudal fin were incubated 
in 50 μl NaOH (50 mM) at 95 °C for 10 min and neutralized by adding 5 μl 1 M Tris-HCl (pH 
8.0). PCR was performed using the following primers: trpv6-gt-f, 5’-
TGACATTGTGTGTGTTTGTTGC-3’; trpv6-gt-r, 5’-GTGAAGGGCTGTTAAACCTGTC-3’; 
trpv6-HMA-f, 5’- GCAGCGGTGGCTTTAATGAAT-3’; trpv6-HMA-r, 5’- 
AAACCTGTCAATCAGAGCACAC-3’; ppp2ca-gt-f, 5’- TCACCATCAGTGCATGTCAATA-
3’; ppp2ca-gt-r, 5’- CTCGATCCACATAGTCTCCCAT-3’; ppp2cb-gt-f, 5’- 
TGGATGATAAAGCGTTTACGAA-3’; ppp2cb-gt-r, 5’- ACGTTACACATTGCTTTCATGC-




Body length, defined as the curvilinear distance from the head to the end of caudal tail, 
was measured. Alizarin red staining was performed following a published protocol (Du et al., 
2001). Images were captured with a stereomicroscope (Leica MZ16F, Leica, Wetzlar, Germany) 
equipped with a QImaging QICAM camera (QImaging, Surrey, BC, Canada). 
 
Whole-mount in situ hybridization, and immunostaining  
For whole mount immunostaining or in situ hybridization analysis, zebrafish larvae were 
fixed in 4% paraformaldehyde, permeabilized in methanol, and analyzed as described previously 
(Dai et al., 2014a). For double color in situ hybridization and immunostaining, mCherry mRNA 
signal was detected using anti-DIG-POD antibody (Roche), followed by Alexa 488 Tyramide 
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Signal Amplification (Invitrogen). After in situ hybridization, the stained larvae were washed in 
1X PBST and incubated with phosphorylated Akt antibody overnight at 4℃ and then stained 
with a Cy3-conjugated goat anti-rabbit immunoglobulin G antibody (Jackson ImmunoResearch). 
Fluorescent images were acquired using a Nikon Eclipse E600 Fluorescence Microscope with 
PMCapture Pro 6 software.  
 
Plasmid and BAC constructs 
The ORF of zebrafish Trpv6 were amplified by PCR and cloned into pEGFPN1 using the 
following primers: BglII-zftrpv6-F, 5’-atatAGATCTcgccaccATGCCACCCGCCATATC-3’; no 
stop-zftrpv6-ca-SalI-R, 5’- TACCGTCGACcaGAGAAACTTGAAATTggggcaatc-3’; 
Trpv6D539A was engineered by site-directed mutagenesis using the following primers: 
zTrpv6_D539A_f, 5’-GGTCAGATTGCCTTGCCAGTGGA-3’;  zTrpv6_D539A_r, 5’- 
TCCACTGGCAAGGCAATCTGACC-3’.  Human TRPV6 ORF was sub-cloned into pEGFPN1 
using the following primers: 5’-atatCTCGAGcgccaccATGGGTTTGTCACTG-3’; 5’- 
TACCGTCGACcaGATCTGATATTCC-3’. EGFP sequence in those vectors was replaced by 
mCherry sequence from pmCherry-C1 vector using the following primers: AgeI-mCherry-F, 5’- 
caACCGGTCGCCACCATGGTGAGCAAGGGC-3’; mCherry-NotI-stop-r, 5’- 
TCGCGGCCGCCTACTTGTACAGCTCGTCC-3’. Wild-type zebrafish Trpv6 and 
Trpv6D539A tagged with mCherry were then inserted into the igfbp5aBAC construct to replace 
the igfbp5a coding sequence from the start codon to the end of the first exon through 




CCATATCTGGTGAA-3’ and igfbp5a_frt-kan-rev, 5′-
GTTTACTTTTGTCCCATATAAAACAAATACTACAAGTCAATAAAACATACCCGCGTG
TAGGCTGGAGCTGCTTC-3′. The resulted BAC DNA was validated by sequencing. The 
validated BAC DNA and Tol2 mRNA were mixed and injected into 1-cell stage trpv6-/-; 
Tg(igfbp5a:GFP) embryos. The embryos were raised and analyzed. Cells co-expressing mCherry 
and GFP were identified and scored using a reported scoring system (Liu et al., 2018a).  
PP2AcL199P and PP2AcH118N were kind gifts from Dr. George Tsokos, Harvard Medical School. 
They were subloned into pIRES-mCherry vector using the following primers: EcoRI-PP2A-f: 5’-
ccgGAATTCATGGACGAGAAGGTGTTCAC-3’, BamHI-PP2A-r: 5’-
cgcGGATCCTTACAGGAAGTAGTCTGGGG-3’ and used in cell transfection.  
 
Generation of the Tg(igfbp5a:GCaMP7a) fish line 
GCaMP7a DNA was cloned into pEGFPN1 to replace the EGFP sequence using the 
following primers: BamHI-HA-F, 5’- cgcggatccATGGCATACCCCTACGACG-3’; GCaMP7a-
stop-NotI-R, 5’- atttgcggccgcTTACTTAGCGGTCATCATC-3’. BAC (igfbp5a:GCaMP7a) 
construct was generated following a published protocol (Liu et al., 2017a). The following 
primers were used to amplify the GCaMP7a cassette sequence: igfbp5a_GCaMP7a_fw, 5′- 
GTTTTGCCATTTCAAAGCTGGTGAAATAGGTGTTCTACAGTAGGACGATGGCATACC
CCTACGACGTGCCCGAC -3′ and igfbp5a_frt-kan-rev. The resulted BAC (igfbp5a:GCaMP7a) 
was validated by PCR using the following primers: igfbp5a-5UTR-fw, 5’-
GAACGCTGTTCGCTTGAT-3’ and GCaMP7a-stop-NotI-R, 5’- 
ATTTGCGGCCGCTTACTTAGCGGTCATCATC -3’. The BAC (igfbp5a:GCaMP7a) DNA 
and Tol2 mRNA were mixed and injected into zebrafish embryos at 1-cell stage. The F0 embryos 
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were screened at 72 hpf by checking GCaMP7a responses to high or low [Ca2+] solutions. 
GCaMP7a-positive F0 embryos were raised and crossed with wild-type fish to obtain F1 
individuals. F2 fish were generated by crossing F1 fish.  
 
Live GCaMP7a imaging  
Zebrafish larvae were anesthetized using normal [Ca2+] embryo solution supplemented 
with 0.168 mg/ml tricaine. They were mounted in 0.3% low-melting agarose gel and immersed 
in 1 ml normal [Ca2+] solution. A Leica TCS SP8 confocal microscope equipped with the HC 




Zebrafish larvae raised in E3 embryo rearing solution were transferred to normal or low [Ca2+] 
embryo solution from at 3 dpf. Two days later, caudal fin was clipped for genotyping. The larvae 
were pooled and RNA was isolated. Reverse transcription reaction was performed using M-MLV 
(Invitrogen) oligo(dT)18 oligos primer. qPCR was carried out using SYBR Green (Bio-Rad). 
Primers for qPCR are: trpv6-qPCR-F: 5’- GGACCCTACGTCATTGTGATAC-3’, trpv6-qPCR-
R: 5’- GGTACTGCGGAAGTGCTAAG-3’, igf1ra-qPCR-F: 5’- 
CGTACCTCAATGCCAACAAG-3’,  igf1ra-qPCR-R: 5’- TAGGGCTGTTCGGCTAATGT-3’, 
igf1rb-qPCR-F: 5’- AAACTTGGGACCAGGGAACT-3’, igf1rb-qPCR-R: 5’- 
ATCTTCTCCCGCTCCACTTC-3’. 18s-qPCR-F: 5’- AATCGCATTTGCCATCACCG-3’, 18s-
qPCR-R: 5’- TCACCACCCTCTCAACCTCA-3’.  
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Cell culture  
Human embryonal kidney cells (HEK293) and human LoVo conlon cancer cells were 
obtained from ATCC. HEK293 cells were cultured in DMEM or DMEM/F12 supplemented with 
10% FBS, penicillin and streptomycin in a humidified-air atmosphere incubator containing 5% 
CO2. 
 
Fura-2 imaging and electrophysiology recording 
HEK293 cells were plated onto 24 mm cover glass coated with L-polylysine and 
transfected with 0.3 µg of plasmid DNA using Lipofectamine 2000. Twenty-four hours after the 
transfection, the cover glass was mounted on an imaging chamber and washed with calcium-free 
Krebs-Ringer HEPES (KRH) solution (118 mM NaCl, 4.8 mM KCl, 1 mM MgCl2, 5 mM D-
glucose, and 10 mM HEPES, pH=7.4). Fura-2 loading was performed following a published 
method (Kovacs et al., 2012). Successfully transfected cells were chosen by mCherry expression. 
Their cytosolic Ca2+ levels were recorded by an EasyRatio Pro system (PTI) at two different 
wavelengths (340 nm and 380 nm). The Fura-2 ratio (F340 /F380) was used to determine 
changes in intracellular [Ca2+]i. At least 50 cells were measured in each slide. Patch clamp 
recordings were performed at room temperature (Weissgerber et al., 2012). The internal pipette 
solution contained (in mM): Aspartate-Cs 145, NaCl 8, MgCl2 2, HEPES 10, EGTA 10, Mg-
ATP 2, pH 7.2. Normal external solution contained (in mM): NaCl 135, KCl 6, MgCl2 1.2, 
HEPES 10, Glucose 12, pH 7.4, supplemented with 10 mM CaCl2 or 30 mM BaCl2. For 
measuring Ca2+ currents, cells were perfused with normal external solution at first and then 
switched to solutions as indicated. DVF solutions contains (in mM): NaCl 150, EDTA 10, 
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HEPES 10, pH 7.4. Solutions with different concentration of Ca2+ contains (in mM): NaCl 150, 
HEPES 10, Glucose 12, pH 7.4, supplemented with 0 to 10 mM CaCl2 as indicated. 
 
Flowcytometry analysis and MTT assay 
Human LoVo cells were washed 3 times with serum-free medium (SFM) and starved in 
SFM for 12h. The cells were then stimulated with 2% FBS medium with or without inhibitors. 
Forty-eight hours later, cell cycle analysis was performed using Attune Acoustic Focusing 
cytometer (Applied Biosystems, Life Technologies) after propidium iodide staining (Liu et al., 
2018a). For siRNA transfection, 100 pmol siRNA and 1.5 µl Lipofectamine RNAiMAX 
(Invitrogen) was used in each well in 24-well tissue culture plates. For plasmid transfection, 2 µg 
plasmid and 2 µl Lipofectamine 3000 (Invitrogen) were used in in each well in 24-well tissue 
culture plates. Six hrs post transfection, cells were grown in complete media containing 10% 
FBS. There were washed 3 times with SFM and synchronized by incubation in SFM for 12h. The 
synchronized cells were stimulated with 2% FBS-containing medium for 48 hrs and subjected to 
cell cycle analysis or MTT assay. For MTT assay, 5mg/ml MTT (Invitrogen) stock solution was 
diluted in 2% FBS-containing medium and cells were stained for 4hr at 37 ℃ before dissolving 
using DMSO. Absorbance at 540nm was read by microplate reader (Tecan).  
 
Statistical analysis 
Values are shown as Mean ± standard error of the mean (SEM). Statistical significance 
among experimental groups was determined using one-way ANOVA followed by Tukey’s 
multiple comparison test or student t-test. Chi-square test was used to analyze the association 
between two categorical variables. Statistical significances were accepted at P < 0.05 or greater.  
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Figure 3.1 Genetic deletion of the conserved epithelial calcium channel Trpv6 results in calcium 
deficiency and premature death  
(A) Schematic diagram showing trpv6 gene (WT) and various mutant sequences. Filled boxes 
indicate trpv6 ORF and open boxes indicate UTRs. Introns are shown as lines. The gRNA 
targeting site is indicated by blue color and PAM motif is underlined. Deleted and inserted 
nucleotides are indicated by dash lines and red letters, respectively. (B) Schematic diagram of 
Trpv6 (WT) and its mutants. Putative function domains are indicated. The grey box indicates 
altered sequence caused by frame shifts. (C-D) Survival curves of trpv6Δ8-/-; Tg(igfbp5a:GFP) 
(C) and trpv6Δ7-/-; Tg (igfbp5a:GFP) fish (D) and siblings. The numbers of total fish are 
indicated. (E) Representative images of Alizarin red stained wild-type and trpv6Δ8-/-; 
Tg(igfbp5a:GFP) fish at 7 day post fertilization (dpf). (F) Fura-2 Ca2+ imaging analysis of 
HEK293 cells transfected with the indicated plasmids. n > 50 cells from 3 independent 
experiments. (G) The maximal influx rate. n = 3 independent experiments. (H) Currents evoked 
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by a RAMP voltage from -120mV to +120 mV in HEK293 cells transfected with the indicated 
plasmids. In this and all subsequent figures, unless specified otherwise data shown are Mean ± 
SEM. Different letters indicate significant difference at P < 0.05, one-way ANOVA followed by 





Figure 3.2 Morphology of trpv6 mutant fish 
(A-B) Gross morphology (A) and body size (B) of trpv6Δ8-/-; Tg(igfbp5a:GFP) fish and siblings. 




Figure 3.3 Sequence alignment in the pore region of zebrafish Trpv6, human TRPV5, and human 
TRPV6 
Transmembrane domain 5 and 6 are indicated in yellow and orange letters. The ion pore region 
is indicated by black letters and the critical Asp residue (D) is labeled in red.  
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Figure 3.4 Trpv6 regulates epithelial cell quiescence-proliferation decision  
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(A) Diagram of the experimental design. (B) Representative images. In this and all subsequent 
larval images, lateral views of the yolk-sac region are shown with dorsal up and anterior to the 
left. (C-D) Mean NaR cell number/fish of the indicated genotypes. n = 6-9. (E) Progenies of 
trpv6 Δ8+/-; Tg (igfbp5a:GFP) intercross were raised to 3 dpf and treated with 100 µM GdCl3 
from 3 to 5 dpf. NaR cells in each fish were quantified following individual genotyping. n = 13-
22. (F) Progenies of trpv6Δ8+/-;Tg(igfbp5a:GFP) intercross were injected with the indicated 
BAC-mCherry DNA at one-cell stage. At 5 dpf, the Trpv6-expressing NaR cells in each fish 
were scored following a published scoring system (Liu et al., 2018a). Representative images are 
shown in the left and quantified results in the right panel. ****, P <0.0001 by Chi-Square test, 





Figure 3.5 Genetic deletion of Trpv6 increases epithelial cell apical opening  
(A-B) Progenies of a trpv6Δ8+/-;Tg (igfbp5a:GFP) intercross were injected with or without the 
BAC (igfbp5a:Trpv6-mCherry) DNA. At 3dpf, larvae were photographed followed by individual 
genotyping. Representative images are shown in (A). The apical opening of NaR cells were 
quantified and shown in (B). Data are Mean ± SEM, n = 8-42. Different letters indicate 






Figure 3.6 Inhibition of Trpv6 increases epithelial cell proliferation 
(A-B) Tg(igfbp5a:GFP) fish were treated with Ruthenium Red (2 µM) or GdCl3 (100 µM) from 
3 to 5 dpf. Representative images are shown in (A). NaR cell numbers were quantified and 





Figure 3.7 Trpv6 prevents the quiescence to proliferation transition via regulating IGF1 receptor-
mediated IGF signaling 
(A) Progenies of trpv6Δ7+/-; Tg(igfbp5a:GFP) intercrosses were grown in embryo solutions with 
the indicated Ca2+ concentration from 3 dpf to 5 dpf. NaR cells in each fish were quantified 
followed by individual genotyping. n = 5-17 fish. (B-C) Embryos of the indicated genotypes 
were raised to 3 dpf and treated with 0.3 µM BMS-754807 or DMSO. At 4 dpf, the treated fish 
were subjected to immunostaining using an anti-phospho-Akt antibody (B) or an anti-phospho-
S6 antibody (C). Representative images are shown in (figure supplement 2A and 2B). n = 5-41. 
(D) Progenies of a trpv6Δ8+/-; Tg (igfbp5a:GFP) intercross were injected with the indicated 
BAC-mCherry DNA at one-cell stage. At 4 dpf, the larvae were subjected to phospho-Akt and 
mCherry double staining. (E) Embryos of the indicated genotypes were raised to 3 dpf and 
treated with 30 µM U0126 or DMSO. At 4 dpf, the treated fish were subjected to 
immunostaining using an anti-phospho-Erk antibody. pErk signals were scaled as shown in (Dai 
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et al., 2014a). n=4-24.  (F-I) Progenies of trpv6Δ8+/-; Tg(igfbp5a:GFP) or trpv6Δ7+/-; 
Tg(igfbp5a:GFP) intercrosses were raised to 3 dpf and treated with BMS-754807 (0. 3 µM), 
Wortmannin (0. 06 µM), Rapamycin (1 µM), U0126 (10 µM) or DMSO from 3 to 5 dpf. NaR 






Figure 3.8 trpv6, igf1ra, igf1rb expression in trpv6-/- 
(A-C) trpv6Δ7+/-; Tg(igfbp5a:GFP) intercrosses were raised in normal or low [Ca2+] solutions 
from 3-5 dpf. Caudal fin was clipped for genotyping and 4-6 fish from the same genotype group 
were pooled for RNA extraction and RT-qPCR. Gene expression level was normalized to 18s. 





Figure 3.9 Akt-Tor pathway activation in trpv6-/- 
(A-B) trpv6Δ8+/-; Tg(igfbp5a:GFP) intercrosses were treated with 0.3 µM BMS-754807 or 
DMSO. At 4 dpf, the treated fish were subjected to immunostaining using an anti-phospho-Akt 





Figure 3.10 Inhibition of Trpv6 increases Akt signaling.  
(A-B) Wild type fish were treated with Ruthenium Red (30 µM) or GdCl3 (100 µM) from 3 to 4 
dpf and analyzed by immunostaining using an anti-phospho-Akt antibody. Representative 
images are shown in (A) and quantified results shown in (B). **, **** indicate P < 0.01 and 





Figure 3.11 pErk level was elevated in in trpv6Δ7-/- 
(A) trpv6Δ7+/-; Tg(igfbp5a:GFP) intercrosses were treated with 30 µM U0126 or DMSO from 3-
4 dpf and then stained for phosphorylated-Erk signals. pErk signals were scaled as shown in (Dai 





Figure 3.12 Schematic diagram showing the BAC(igfbp5a:GCaMP7a) construct 
Filled boxes indicate igfbp5a ORF and open boxes indicate its UTRs. The iTol2 cassette and 
GCaMP7a reporter cassette were introduced into DKEYP-56B7 by homologous recombination. 





Figure 3.13 Validation of Tg(igfbp5a:GCaMP7a) fish 
(A-B) Embryos injected with BAC(igfbp5a:GCaMP7a) DNA were raised in E3 embryo solution 
and imaged at 3 dpf before and after the addition of the indicated chemicals (Ionomycin: 5 µM, 
CaCl2: 10 mM, EGTA: 10 mM). 
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Figure 3.14 Trpv6 is constitutively open and mediates Ca2+ influx and maintain high [Ca2+]i in 
epithelial cells in vivo 
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(A) trpv6Δ8-2+/-;Tg (igfbp5a:GCaMP7a)+/- was crossed with trpv6Δ8-2+/-. The progenies were 
imaged at 3 dpf followed by individual genotyping. Percentage of GCaMP7a-positive fish is 
shown. *, P < 0.05 by Chi-Square test, n = 21/21. 6 fish in trpv6-/- group contain GCaMP7a gene 
indicated by genotyping results. (B-C) Fish described in (A) were imaged before and after the 
addition of 7.5 µM Ionomycin + 10 mM CaCl2. Representative images are shown in (B) and the 
quantified results are shown in (C). n = 5-7. (D) Progenies from a trpv6Δ8-2+/-;Tg 
(igfbp5a:GCaMP7a)+/- and trpv6Δ8-2+/- intercross were injected with BAC (igfbp5a:Trpv6-
mCherry) DNA at 1-cell stage. They were raised to 3 dpf. GCaMP7a signal intensity in Trpv6-
mCherry-expressing cells and non-expressing NaR cells were quantified before and after the 
addition of 7.5 µM Ionomycin+10 mM CaCl2. n = 4. (E-G) Time-lapse images of 3 dpf Tg 
(igfbp5a:GCaMP7a) larvae after the addition of 100 µM GdCl3 (E) or following drug removal 
(F). Changes in GCaMP7a and mCherry signal intensity ratio were quantified and shown in (G). 
n = 5. * and **** indicate P < 0.05 and < 0.0001 by Two-way ANOVA followed by Dunnett's 
multiple comparisons test. (H) Wild-type larvae were treated with BAPTA-AM (100 µM) from 3 
dpf to 5 dpf.  NaR cells were labeled by in situ hybridization using a trpv6 riboprobe and 
quantified. (I) Larvae described in (H) were stained for phosphorylated Akt after 24 hour 
treatment. Mean ± SEM. ****, P<0.0001, unpaired t-test. n = 15-19. 
 119 
 
Figure 3.15 Inhibition of Trpv6 decreases [Ca2+]i in NaR cells 
(A-C) Time-lapse images of 3 dpf larvae were taken after the addition (A) and removal (B) of 
100 µM Ruthenium red (RR) at the indicated time points. Fluorescence change of GCaMP7a 
(green) and mCherry (red) were quantified and shown in (C). Mean ± SEM, n = 8. **,***, and 




Figure 3.16 Inhibition of IGF1 receptor does not change [Ca2+]i in NaR cells 
Time-lapse images of 3 dpf Tg (igfbp5a:GCaMP7a) larvae at the indicated time points after 
adding 0.3 µM BMS-754807. Changes in GCaMP7a (green) and mCherry (red) signal intensity 
were quantified. Representative images are shown in (A) and quantified results are shown in (B). 
Mean ± SEM, n = 3. No significance was found by two-way ANOVA followed by Dunnett's 




Figure 3.17 PP2A is a downstream effector of Trpv6 
(A-B) Tg(igfbp5a:GFP) embryos were treated with 1 µM Okadaic acid (OA) or 0.1 µM 
Calyculin A in the presence or absence of 0.3 µM BMS-754807 from 3 dpf. NaR cells were 
quantified at 4 and 5 dpf. Data shown are n = 10-38. (C) Tg(igfbp5a:GFP) embryos were treated 
with 1 µM Okadaic acid (OA) in the presence or absence of Wortmannin (0. 06 µM), 
Rapamycin (1 µM), U0126 (10 µM) or DMSO from 3 to 5 dpf. NaR cells were quantified at 4 
and 5 dpf. Data shown are n = 16-19. (D) Wild-type larvae were treated with 1 µM Okadaic acid 
or 0.1 µM Calyculin in the presence or absence of 0.3 µM BMS-754807 from 3 dpf to 4 dpf. 
They were analyzed by immunostaining for phospho-Akt. n = 9-16. (E) Tg(igfbp5a:GFP) 
embryos were injected with gRNAs targeting three ppp2c genes and Cas9 protein at one-cell 
stage. They were raised to 5 dpf. NaR cell division was quantified following a published scoring 
system (Liu et al., 2018a). n = 24-28. ****, P< 0.0001 by Chi-Square test. (F) The embryos 
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treated as in (E) were raised to 4 dpf and analyzed by immunostaining for phospho-Akt signal. n 






Figure 3.18 Transient knockdown of pp2a catalytic subunit genes 
(A) Schematic diagram and guide RNA targeting sites. The target sites are labeled by blue letters 
and the PAM motif is underlined. (B) Embryos injected with gRNAs and Cas9 protein were 
raised to 1 dpf. Each of them was lysed and analyzed by PCR followed by hetero-duplex motility 
assay. (C) Embryos injected with gRNAs and Cas9 protein were raised to 3 dpf and treated with 
Calyculin or vehicle. Values are Mean ± SEM, n = 7-15.  
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Figure 3.19 Inhibition of PP2A does not change [Ca2+]i in NaR cells 
Time-lapse images of 3 dpf Tg (igfbp5a:GCaMP7a) larvae at the indicated time points after 
adding 1 µM Okadaic acid (OA) (A, B) or 0.1 µM Calyculin (C, D). Changes in GCaMP7a 
(green) and mCherry (red) signal intensity were quantified. Representative images are shown in 
(A, C) and quantified results are shown in (B, D). Mean ± SEM, n = 3. No significance was 




Figure 3.20 Knockdown and inhibition of TRPV6 and PP2A increases human colon carcinoma 
cell proliferation 
(A) LoVo cells transfected with scrambled siRNA or TRPV6 targeting siRNA were 
synchronized by serum starvation followed with serum re-stimulation. Cells were analyzed by 
flow cytometry analysis after propidium iodide staining. Percentage of S-phase cells are 
calculated and shown. Mean ± SEM, n = 3. **, P<0.01 by unpaired t-test. (B) LoVo cells were 
synchronized by serum starvation. They were re-stimulated with 2% FBS medium containing 
Ruthenium Red (RR, 100 µM), GdCl3 (100 µM), BAPTA-AM (100 µM), Okadaic acid (OA, 20 
nM) or DMSO for 48 hours and analyzed by flow cytometry analysis after propidium iodide 
staining. Percentage of S-phase cells are shown. Mean ± SEM, n = 3. One-way ANOVA 
followed by Tukey’s multiple comparison test was used to analyze data in B and C. ****, ***, 
** indicates P<0.0001, P<0.001, P<0.01 respectively. (C) LoVo cells transfected with the 
indicated DN-PP2A constructs were synchronized by serum starvation followed with serum re-
stimulation. Cells were analyzed by flow cytometry analysis after propidium iodide staining. 




Figure 3.21 Cell cycle analysis results of TRPV6 knockdown 
The PI fluorescence intensity is given in arbitrary units (a.u.) on the X-axis, and the Y-axis 
indicates cell counts normalized to percent of the max as measured by flow cytometry. 







Figure 3.22 Cell cycle analysis results of pharmacological inhibiting TRPV6-Ca2+-PP2A 
pathway 
The PI fluorescence intensity is given in arbitrary units (a.u.) on the X-axis, and the Y-axis 
indicates cell counts normalized to percent of the max as measured by flow cytometry. 
Pharmacological inhibition of TRPV6, PP2A or chelating intracellular Ca2+ using BAPTA-AM 





Figure 3.23 LoVo cell viability 
LoVo cells were synchronized by serum starvation. They were re-stimulated with 2% FBS 
medium containing Ruthenium Red (RR, 100 µM), GdCl3 (100 µM), BAPTA-AM (100 µM), 
Okadaic acid (OA, 20 nM) or DMSO for 48 hours and analyzed by MTT assays. Mean ± SEM, 






Figure 3.24 Cell cycle analysis results of overexpression dominant-negative PP2A 
The PI fluorescence intensity is given in arbitrary units (a.u.) on the X-axis, and the Y-axis 
indicates cell counts normalized to percent of the max as measured by flow cytometry. 
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4.1 Abstract 
Epithelial tissues face constant environmental challenges and frequently re-activate a 
pool of quiescent cells to maintain tissue homeostasis. The molecular mechanisms governing the 
quiescence-proliferation balance is poorly defined. Using a zebrafish model, here we report that 
Ca2+/calmodulin-dependent kinase kinase (CaMKK) plays a critical role in promoting the 
quiescence-proliferation transition in a group of Ca2+-transporting epithelial cells (NaR cells). 
NaR cells are maintained in the quiescent state by Trpv6-mediated constitutive Ca2+ influx. 
Lowering the intracellular Ca2+ ([Ca2+]i) levels by genetic deletion of Trpv6, pharmacological 
inhibition of Trpv6, competitive blockade of Trpv6-mediated Ca2+ influx, or removing Ca2+ from 
the embryo rearing solution all resulted in elevated Akt and Tor activity and NaR cell 
quiescence-proliferation transition. This action was abolished by inhibition of IGF1 receptor. 
Chemical biology screens and CRISPR/Cas9 knockdown experiments identified CaMKK as a 
key link between [Ca2+]i and IGF-Akt-Tor signaling. Depletion of the ER Ca2+ store by 
inhibiting sarco/endoplasmic reticulum Ca²⁺-ATPase abolished NaR cell reactivation and Akt 
signaling. These results suggest that ER Ca2+ release in response to the reduction of [Ca2+]i is 
important in activating CaMKK and IGF signaling and this in turn promoting quiescent cells to 
re-enter the cell cycle. Importantly, this [Ca2+]i-CaMKK-Akt signaling mechanism is conserved 
in human colon carcinoma cells.  
Chapter 4 CaMKK Promotes Epithelial Cell Quiescence-Proliferation Transition by 
Increasing IGF1 Receptor-PI3K-Akt Activity 
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4.2 Introduction 
Epithelial tissues provide the protective layer against the external environment and play 
critical role in nutrient absorption, gas exchange, and water-ion balance. As such, epithelia 
tissues have a very high turnaround rate. Its tissue homeostasis is maintained by re-activating a 
pool of quiescent cells. The molecular mechanisms governing the quiescence-proliferation 
transition is poorly defined. Recently, a group of quiescent epithelial cells in zebrafish absorptive 
epithelia, known as Na+-K+-ATPase-rich (NaR) cells have been shown to be reactivated in 
respond to low environmental Ca2+ stress (Dai et al., 2014a). This has been attributed to the 
activation of the insulin-like growth factor receptor 1 (IGF1R)-mediated phosphoinositide-3-
kinases (PI3K)-Akt and target of rapamycin (Tor) signaling  (Dai et al., 2014a). These findings 
made with fish NaR cells resemble previous studies made in the mouse adult hematopoietic stem 
cells (HSCs) and the fly neural stem cells (Chell and Brand, 2010; Lee et al., 2007; Paik et al., 
2009; Siegemund et al., 2015; Wang et al., 2018a), suggesting that the activity of IGF-PI3K-Akt-
Tor is critical in cellular quiescence reactivation in multiple cell types across a wide range of 
species.  
In addition to the IGF-PI3K-Akt-Tor signaling, Ca2+ signaling has been shown to regulate 
cellular quiescence in intestinal stem cells (ISCs) (Deng et al., 2015), pluripotency of mouse 
embryonic stem cells (mESCs) (MacDougall et al., 2019),  and mesenchymal stem cell (Lee et 
al., 2018). In fact, Ca2+ is a universal signaling in the cell and it influences many cellular 
processes (Clapham, 2007). The Ca2+ signaling toolkits can be hijacked by cancer cells for 
unrestrained cell cycle progression (Varghese et al., 2019). In a recent study, we have shown that 
Trpv6-mediated Ca2+ influx establishes the quiescent state of NaR cells by maintaining high 
intracellular Ca2+ concentrations ([Ca2+]i) (Xin et al., 2019). Genetic deletion and 
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pharmacological inhibition of Trpv6 resulted in reduced [Ca2+]i levels and this in turn leads to 
increased IGF signaling and promotes NaR quiescence-proliferation transition. The molecular 
mechanisms linking the reduction of intracellular Ca2+ ([Ca2+]i) levels to the activation of IGF 
signaling, however, is unclear. 
In the present study, we investigated the role of Ca2+ signaling in NaR cell recativation 
and its cross-talk with the IGF-PI3K-Akt-Tor signaling pathway. We found that lowering the 
intracellular Ca2+ ([Ca2+]i) levels by genetic deletion of Trpv6, pharmacological inhibition of 
Trpv6-mediated Ca2+ influx, or removing Ca2+ from the embryo rearing solution all increased 
IGF signaling and led to NaR cell quiescence-proliferation transition. We further showed that 
CaMKK functions as a link between changes in [Ca2+]i to IGF-Akt-Tor signaling activation.  
4.3 Results 
4.3.1 Reducing [Ca2+]i stimulates quiescence exit of NaR cells 
Treatment of Tg(igfbp5a: GCaMP7a) zebrafish larvae with the Trpv6 channel inhibitor 
lanthanum chloride (Kovacs et al., 2011) resulted in decreased intracellular Ca2+ level in NaR 
cells, while mCherry fluorescence in these cells remained largely unchanged (Figure 4.1A and 
B). TRPV6 channel permeability is estimated to be about 100 times more selective for Ca2+ than 
for Na+ (Voets et al., 2004). Increasing environmental Na+ concentration from 0.5 mM to 100 
mM significantly reduced intracellular Ca2+ level (Figure 4.1D and E). (NMDG)Cl of the same 
concentration had no such effect, suggesting osmolarity or Cl- concentration change does not 
affect Ca2+ influx in NaR cells. When Ca2+ influx is restricted through reducing environmental 
Ca2+ (Normal [Ca2+]e = 0.2 mM, Low [Ca2+]e = 0.001 mM), intracellular Ca2+ level in the NaR 
cells decreases dramatically as well (Figure 4.1G and H). All those treatments reduced [Ca2+]i 
and promoted the reactivation of NaR cells (Figure 4.1C, F, and I). 
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4.3.2 Depletion of endoplasmic reticulum Ca2+ abolished NaR cell reactivation   
Ca2+ serves as a versatile and universal second messenger controlling a wide range of 
biological processes. Tight control of intracellular Ca2+ concentrations in different compartments 
is crucial for precisely decoding the Ca2+ signals for specific cellular function (Bootman, 2012). 
To determine whether intracellular Ca2+ stores such as ER plays any role, we imaged [Ca2+]i for 
a long period. As described before, GCaMP7a fluorescence in NaR cells decreases greatly once 
extracellular Ca2+ is removed, however, after 30 min incubation in low [Ca2+]e, GCaMP7a 
fluorescence gradually came back, indicating the replenishment of intracellular Ca2+ across time 
(Figure 4.2A). Addition of intracellular Ca2+ chelator BAPTA-AM in the low Ca2+ solution 
significantly decreased low Ca2+ -induced NaR cell reactivation (Figure 4.2B). These results 
indicate that when [Ca2+]i decreased, ER released Ca2+ into the cytosol. Chelating extracellular 
Ca2+ using EGTA (2 mM) also induced NaR cell reactivation (Figure 4.2C). The endoplasmic 
reticulum (ER) is the major intracellular Ca2+ reservoir. However, when we measured [Ca2+]ER 
using a genetically-encoded ER Ca2+ indicator ER-LAR-GECO1 (Wu et al., 2014), no major 
change in [Ca2+]ER was observed during low [Ca2+]e incubation (Figure 4.2D). But when an 
inhibitor targeting sarco/endoplasmic reticulum Ca2+-ATPase, thapsigargin (TG) was added into 
low Ca2+ solution, [Ca2+]ER decreased dramatically as Ca2+ uptake by ER is blocked (Figure 
4.2D), suggesting ER-LAR-GECO1 fluorescence can report a major change of [Ca2+]ER level. 
Depletion of ER Ca2+ store using TG or another SERCA inhibitor cyclopiazonic (CPA) strongly 
attenuated the low [Ca2+]i -mediated reactivation of NaR cells (Figure 4.2E and F).  
4.3.3 CaMKK activity is required for low [Ca2+]i-mediated NaR cell reactivation 
We next tried to identify the molecular link between reduced [Ca2+]i to the reactivation of 
NaR cells through screening chemicals targeting Ca2+-sensitive molecules.  Among the hits that 
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inhibited low [Ca2+]i -induced reactivation of NaR cells, CaMKK inhibitor STO-609 had the 
strongest inhibitory effects (Figure 4.3A). Loss of Trpv6 in trpv6-/- mutant fish induces 
quiescence exit in NaR cells as reported (Figure 4.3B) and reactivation of NaR cells in the 
mutant fish can be fully suppressed by CaMKK inhibition. Restricting Ca2+ influx through Trpv6 
by addition of high [Na+]e also resulted in increased NaR cell reactivation and that can be 
blocked by CaMKK inhibitor as well (Figure 4.3C). Knockdown of camkks through 
CRISPR/Cas9 also resulted dramatically decreased the low [Ca2+]i -mediated NaR cell 
reactivation in F0 larvae (Figure 4.3D). Additionally, CaM inhibitor W-7 and calmidazolium 
chloride also resulted in reduced NaR cell reactivation (Figure 4.3E).  
4.3.4 CaMKK possibly regulates epithelial cell reactivation through phosphorylating Akt 
Akt has been known as a low affinity downstream target of CaMKK and can be directly 
phosphorylated by CaMKK at Thr308 site (Yano et al., 1998). Follow-up studies have shown 
CaMKK-dependent Akt activation in mouse muscle cells, HEK293 cells, LNCaP cells, human 
gastric adenocarcinoma cells, and malignant ovarian tissue (Chen et al., 2002; Gocher et al., 
2017; Ma et al., 2016; Schmitt et al., 2012; Wang et al., 2015b). Recent studies suggest both 
CaMKKα and CaMKKβ are involved in Akt phosphorylation (Gocher et al., 2017; Witczak et 
al., 2007). Therefore, we propose CaMKK promotes NaR cells reactivation through 
phosphorylating Akt. Akt phosphorylation had been known to be specifically elevated in NaR 
cells upon low Ca2+ acclimation or in the trpv6-/- mutants (Dai et al., 2014a; Xin et al., 2019). As 
anticipated, other ways to reduce [Ca2+]i resulted in elevated Akt phosphorylation as well (Figure 
4.4A and B). And maintaining ER-Ca2+ store is also critical for Akt phosphorylation as both 
SERCA inhibitors TG and CPA strongly suppressed low [Ca2+]i-activated Akt phosphorylation 
(Figure 4.4C and D).  
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To further investigate which isoform of Akt is the key player mediating the reactivation 
of NaR cell, selective Akt isoform inhibitors and pan Akt inhibitor Triciribine were tested. 
Selective Akt1 inhibitor A-674563 significantly diminished low Ca2+-mediated reactivation of 
NaR cells while selective inhibitor for Akt2 CCT128930 does not had any effects (Figure 4.4E 
and F), indicating Akt1 is probably a more critical player for low [Ca2+]i -triggered activation of 
IGF signaling pathway. Phosphorylation of both Ser 473 site and Thr 308 site are required for 
maximal activation of the kinase (Alessi et al., 1996). STO-609 could inhibited phosphorylation 
at both residues in the low [Ca2+]i -reactivated NaR cells. Such effects are also evolutionarily 
conserved from fish to humans as low [Ca2+]i -amplified Akt phosphorylation in cultured human 
colon carcinoma cells (Caco2) can also inhibited by CaMKK inhibitor STO-609 (Figure 4.5).  
4.4 Discussion 
In this study, we uncover an intriguing pathway that regulates epithelial cell quiescence 
to proliferation transition (Figure 4.6). Using multiple methods reducing Ca2+ influx through 
Trpv6, we showed that reduction in [Ca2+]i level promotes quiescent NaR cells to reenter the cell 
cycle and proliferate. We observed a replenishment of [Ca2+]i after long-term incubation under 
low Ca2+ medium, probably coming from Ca2+ release from the ER Ca2+ store. Chelation of 
intracellular Ca2+ with BAPTA-AM partially blocked this NaR reactivation. It is thus proposed 
that local Ca2+ microdomains are underlying the quiescence exit of NaR cells under low [Ca2+]i.  
In further support of this hypothesis, depletion of ER Ca2+ store using SERCA inhibitors 
completely abolished low [Ca2+]i -triggered NaR cell reactivation.  
Ca2+ microdomains have long been recognized as critical regulators for Ca2+ signaling 
(Berridge, 2006). The [Ca2+]i a cell under resting conditions is around 100 nM, while ER [Ca2+] 
([Ca2+]ER) is maintained around 100 µM. Release of ER Ca2+ via a the 1,4,5-triphosphate 
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receptor (IP3R) or ryanodine receptor (RyR) can result in a sharp increase in [Ca2+]i locally, 
creating Ca2+ microdomains without changing much of global [Ca2+]i level (Bagur and 
Hajnoczky, 2017).  Ca2+ microdomains can regulate specific cellular processes in different 
regions of the cell, given that the actions of local Ca2+ signals may be restricted to effectors (such 
as channels, transporters and binding proteins) located within sub-micron distances from the 
Ca2+ source (Carafoli and Krebs, 2016). ER-mitochondria membrane contacts or ER-plasma 
membrane contacts during store-operated calcium entry (SOCE) are two major interfaces for 
Ca2+ microdomains (Bagur and Hajnoczky, 2017). In this case, SOCE is less likely to be 
involved as ER Ca2+ store depletion induced by SERCA inhibitors inhibited NaR cell 
reactivation rather than triggered this process. Further studies are required to further determine 
whether local Ca2+ microdomains at ER-mitochondria membrane contacts are critical for the 
quiescence to proliferation transition of NaR cells. 
Next, chemical biology screen revealed that CaMKK is potentially mediating the 
quiescence exit of NaR cells. Utilizing both pharmacological and genetic approaches, we 
validated that CaMKK activity is required for reactivating NaR cells. CaM is a ubiquitously 
expressed, highly -conserved protein with each globular end containing a pair of helix-loop-helix 
EF-hand Ca2+-binding motifs connected by a flexible α helix (Chin and Means, 2000). Each EF 
motif allows calmodulin to sense intracellular Ca2+ levels by binding one Ca2+ ion. Binding of 
Ca2+ produces a conformational change in CaM, exposing hydrophobic residues that promote 
interactions of the Ca2+/CaM complex to numerous target proteins, thereby regulating their 
functions (Davis et al., 1989). Ca2+/CaM-dependent kinases include Ca2+/CaM -dependent kinase 
kinase (CaMKK) as well as its downstream targets CaMKI and the predominantly nuclear 
CaMKIV (Wayman et al., 2011). CaMKK comprises 1 (α) and 2 (β) isoforms in mammals and 3 
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isoforms (camkk1a, camkk1b and camkk2) in zebrafish. They are encoded by different genes and 
expressed in cells as monomer, containing a catalytic, autoinhibitory, and CaM-binding domain 
(Swulius and Waxham, 2008). Like all other CaM-dependent kinases, CaMKK is held in an 
inactive state by its autoinhibitory domain, which interacts with the catalytic domain to prevent 
kinase activity. Binding of Ca2+/CaM relieves this inhibition by displacing the autoinhibitory 
domain and exposing the catalytic site. This leads to the activation of CaMKK and the 
subsequent phosphorylation of its downstream substrates (Tokumitsu and Soderling, 1996). 
Ca2+/CaM binding is absolutely required for the relief of CaMKK1 autoinhibition, which results 
in its activation. However, CaMKK2 also exhibits significant activity even in the absence of 
Ca2+/CaM binding (Tokumitsu et al., 2001). The Ca2+/CaM sensitivity of CaMKK2 is uniquely 
dependent on phosphorylation of Ser129, Ser133 and Ser137 located within a regulatory 
sequence N-terminal to the catalytic domain (Green et al., 2011). Phosphorylation of Ser137 by 
proline-directed kinases (Pro-K) primes CaMKK2 for subsequent phosphorylation on Ser133 and 
Ser129 by glycogen synthase kinase 3 (GSK3). Without phosphorylation at these sites, CaMKK2 
exhibits increased autonomous activity in the absence of Ca2+/CaM. Additionally, once bound to 
Ca2+/CaM, CaMKK2 undergoes autophosphorylation at Thr85, which generates Ca2+-
independent autonomous activity by maintaining CaMKK2 in the activated state after removal of 
the Ca2+ stimulus (Scott et al., 2015).  
Ca2+ has long been known to drive proliferation in many cell types through direct 
activation of CaM and CaM-dependent kinases including CaMKK upon Ca2+ influx (Berchtold 
and Villalobo, 2014; Gocher et al., 2017; Kahl and Means, 2003; Olianas et al., 2018). Increasing 
evidence have shown CaMKKs are involved in cellular quiescence to proliferation regulation. 
CaMKK2 has been shown to be an important regulator of anabolic pathways downstream of the 
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androgen receptor in prostate cancer cells (Massie et al., 2011). Pharmacological inhibition of 
CaMKK2 improves survival and accelerates hematopoietic stem and progenitor cell recovery 
following hematopoietic radiation injury (Racioppi et al., 2017). 
Another interesting finding in this paper is that Ca2+ mainly controls NaR cell quiescence 
exit through Akt1. As AKT controls a plethora of cellular processes, pan-AKT inhibitors could 
affect the functions of normal cells and may result in severe side effects, which is probably one 
of the reasons that AKT inhibitors have been less successful than expected in the clinical trials 
(Molife et al., 2014; Yap et al., 2011). AKT comprises three isoforms (AKT1, AKT2, and 
AKT3), and the different isoforms are believed to mediate critical non-redundant or even 
opposing functions in cancer (Wang et al., 2018b). The opposing functions of AKT1 and AKT2 
in cell migration and invasion were also demonstrated in vivo in mouse models (Chin and Toker, 
2010; Irie et al., 2005; Liu et al., 2006). Moreover, specific AKT isoforms have been 
demonstrated to be drivers in particular cancers. For example, in PTEN-deficient prostate cancer, 
AKT2 is required for cancer cell survival and maintenance while AKT1 is dispensable (Chin and 
Toker, 2010). Therefore, precise inhibition of specific AKT isoforms in particular cancers at 
specific stages provides a way to overcome the disadvantages of pan-AKT inhibition in terms of 
toxicity.  
Overall, this study reveals a previously uncovered role of active CaMKK under a globally 
low intracellular Ca2+ condition. The initial reduction in [Ca2+]i might trigger Ca2+ release from 




4.5 Methods and Materials 
 
Ethics statement 
All experiments were conducted in accordance with the guidelines approved by the 
University of Michigan Institutional Committee on the Use and Care of Animals. 
 
Zebrafish husbandry 
Fish were raised according to the standard zebrafish husbandry guidelines (Westerfield, 
2000a). Embryos were obtained by natural cross and staged following Kimmel at al. (Kimmel et 
al., 1995b). Artificial freshwater with different Ca2+ and other ion concentrations was prepared 
using double deionized water generated by Milli-Q Academic System (Millipore) as reported 
(Dai., et al 2014). In some experiments, 0.003% (w/v) N-phenylthiourea (PTU) was added to 
prevent pigmentation.   
 
Plasmid construction 
ER-LAR-GECO1 cassette was amplified from CMV-ER-LAR-GECO1 and integrated 
into Kanamycin resistance gene carrying plasmid using the following primers: BglII-ER-F, 5’-
gaagatctATGCTGCTGCCCGTCCCCCT-3’; ER-stop-NotI-R, 5’-
atttgcggccgcTTACAGCTCGTCCTTCTTCG-3’; ER-LAR-GECO1-Kana cassette was then 
amplified and integrated into igfbp5aBAC as reported (Liu., et al, 2017) using the following 
primers: igfbp5a-ER-LAR-f, 5’-
GTTTTGCCATTTCAAAGCTGGTGAAATAGGTGTTCTACAGTAGGACGATGCTGCTGC






Tg (igfbp5a:GCaMP7a) was injected with BAC (igfbp5a:mCherry) and raised in E3 
embryo solution till 3 dpf. Fish were anesthetized and then mounted in 1% low-melting curve 
agarose gel and later agarose gels on yolk sac regions were removed. Leica SP8 equipped HC PL 
APO 93X/1.30 GLYC were used for imaging. LAS X and Image J were used for image analysis. 
 
Transient knockout of CaMKKs 
Three sgRNAs targeting camkks were designed using CHOPCHOP 
(http://chopchop.cbu.uib.no/). Their sequences are: camkk1a-sgRNA1: 5’-
GGACACTCGTTTGGATTCGA-3’; camkk1a-sgRNA2: 5’-GCCAGACAGGTGTGGCCTCT-
3’; camkk1b-sgRNA1: 5’-GGTCCTGTACCCGTTTGGTG-3’; camkk1b-sgRNA2: 5’-
GCAGCTGGATCTCTCCTGCA-3’; camkk2-sgRNA1: 5’-GTTTGTAGAGCCGTGATGG-3’; 
camkk2-sgRNA2: 5’-GCAGGTCCTGGAAGTAGAAG-3’; 40 pg sgRNAs and 400 pg Cas9 
mRNA were co-injected into Tg(igfbp5a:GFP) at the 1-cell stage as reported (Xin and Duan, 
2018). A subset of injected embryos was pooled, DNA isolated, and analyzed by PCR followed 
by hetero-duplex assay as reported (Liu et al., 2018). After confirming the indels, the remaining 
injected embryos were used for experiments.   
 
Whole mount in situ hybridization and immunostaining 
 144 
Zebrafish larvae were fixed in 4% paraformaldehyde, permeabilized in methanol, and 
subjected to immunostaining or in situ hybridization as reported before (Dai., et al 2014). 
 
Cell culture and western blot 
Cell culture and flowcytometry analysis. Human colorectal adenocarcinoma (Caco2) cells 
were cultured in DMEM supplemented with 10% FBS, penicillin, and streptomycin in a 
humidified air atmosphere incubator containing 5% CO2 at 37℃. Culture media was prepared 
by adding CaCl2 to DMEM without Ca2+ at the desired concentration. After washing three times 
with these media, Caco2 cells were incubated in low Ca2+ SFM containing DMSO or STO-609 
for 24 hours before IGF2 treatment. Cells were harvest for western blot analysis 10 min after 
treatment with 200ng/ml IGF2. 
 
Statistical analysis 
Values are shown as Mean ± standard error of the mean (SEM). Statistical significance 
among experimental groups was determined using one-way ANOVA followed by Tukey’s 




Figure 4.1 Reducing [Ca2+]i stimulates NaR cell reactivation 
 (A, B, D, E, G, H) Tg (igfbp5a:GCaMP7a) was injected with BAC(igfbp5a:mCherry) and raised 
in E3 till 3 dpf. GCaMP7a and mCherry co-expressing NaR cells were exposed to normal [Ca2+] 
solution and then switched to different medium as labelled. GCaMP7a intensity at normal [Ca2+] 
condition and 3 minutes post medium change was shown in and quantified (mean ± SEM) in E. 
One-way ANOVA followed by Tukey’s multiple comparison test was used for statistical 
analysis, ***P < 0.001, ****P < 0.0001, fish n > 3, cell n > 20. (C, F, I) For measuring NaR cell 
reactivation under the same condition, Tg (igfbp5a:GFP) was subjected to treatment indicated 
from 3-5 dpf and NaR cells were quantified at 5 dpf. Data shown are mean ± SEM, one-way 
ANOVA followed by Tukey’s multiple comparison test was used for statistical analysis, ****P 




Figure 4.2 ER Ca2+ plays a role in NaR cell reactivation 
(A) Time course of NaR cell [Ca2+]I after low Ca2+ stress.  BAC (igfbp5a:GCaMP7a) and BAC 
(igfbp5a:mCherry) constructs were co-injected into 1-cell stage wild-type embryos. The 
fluorescent intensity change in NaR cells co-expressing GCaMP7a and mCherry were imaged 
and quantified after transferring to to low Ca2+ solution. Representative images were shown in 
the left panel and quantified results in the right panel. Data shown are mean ± SEM, unpaired t-
test, **P < 0.01, n = 42 in 10 fish. (B) BAPTA-AM treatment.  wild-type fish were treated with 
DMSO or 100 µM BAPTA-AM from 3 dpf to 5 dpf and analyzed by in situ hybridization using 
trpv6 probe. NaR cell number in each fish was quantified and shown as mean ± SEM. **P < 
0.01,  unpaired t-test,  n=21-22. (C) EGTA treatment. Tg(igfbp5a:GFP) fish were treated with 
normal Ca2+ solution  with or without 2 mM EGTA between 3-5 dpf.  NaR cell number in each 
fish was quantified and shown (mean ± SEM). ****P < 0.0001, unpaired t-test, fish n= 11-11. 
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(D) Thapsigargin treatment reduces [Ca2+]ER. BAC(igfbp5a:ER-LAR-GECO1) was injected into 
Tg(igfbp5a:GFP) embryos at 1-cell stage. At 3 dpf, fish were treated with normal or low Ca2+ 
with/without 0.5 µM Thapsigargin. Maximal projection of z-stack images of ER-LAR-GECO1 
and GFP fluorescence at 30 min post treatment are shown in the left panel and quantified results 
in the right panel. Data shown are mean ± SEM, **P < 0.01, one-way ANOVA followed by 
Tukey’s multiple comparison test, n=3-8. (E) Thapsigargin treatment increases NaR cell 
reactivation. Tg(igfbp5a:GFP) fish were transferred to the low Ca2+ solution containing DMSO, 
0.25 µM Thapsigargin or 5 µM CPA at 3 dp. Two days later, NaR cell number in each fish was 
quantified. Datd shown are mean ± SEM. ****P < 0.0001, one-way ANOVA, n= 10-13. (F) 
Thapsigargin inhibits Gd3+-induced NaR cell activation. Tg(igfbp5a:GFP) fish were treated with 
indicated chemicals (100 mM GdCl3, 0.5 µM Thapsigargin) from 3 to 4 dpf.  NaR cell number 





Figure 4.3 CaMKK activity is required for NaR cell reactivation. 
(A) STO-609 treatment abolishes elevated NaR cell reactivation in trpv6-/- fish. Progenies of 
trpv6Δ7+/-; Tg(igfbp5a:GFP) intercrosses were raised in normal Ca2+ solutions.  10 µM STO-609 
was added at 3 dpf. After NaR cell number in each larva was quantified at 5 dpf, fish were 
genotyped. Data shown are mean ± SEM. ****P < 0.0001, One-way ANOVA followed by 
Tukey’s multiple comparison test. n= 12-41. (B) STO-609 treatment inhibits low Ca2+ stress-
induced NaR cell reactivation. Tg(igfbp5a:GFP) fish were transferred to the low Ca2+ solutions 
containing DMSO or STO-609 at 3 dpf. Fish were imaged at 4 dpf and 5 dpf. NaR cell number 
in each fish was quantified and shown as mean ± SEM. ****P < 0.0001,  2-way ANOVA 
followed by multiple comparison to the DMSO group, n = 17-20. (C) STO-609 treatment 
inhibits NaCl-induced NaR cell activation. Tg(igfbp5a:GFP) fish were raised in normal Ca2+ 
solution. 100 mM NaCl and/or 10 µM STO-609) were added at 3 dpf. NaR cell number in each 
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fish was quantified at 5 dpf and shown as mean ± SEM.  ****P < 0.0001, one-way ANOVA 
followed by Tukey’s multiple comparison test,  n= 22-24. (D) Knockdown of camkk genes 
inhibits NaR cell reactivation. Tg(igfbp5a:GFP) fish were injected with guide RNAs targeting 
zebrafish camkks and Cas9 mRNAs at one-cell stage. The injected embryos were raised. At 3 
dpf, they were subjected to the low Ca2+ stress test. NaR cell number in each fish was quantified 
at 5 dpf. Representative images are shown in the left panel and qautified data in the right.  Data 
shown are mean ± SEM. ****P < 0.0001, one-way ANOVA followed by Tukey’s multiple 
comparison test, n= 42-66. (E) Inhibition of calmodulin inhibits NaR cell reactivation NaR cell 
reactivation. Tg(igfbp5a:GFP) fish were transferred to the low Ca2+ solutions containing DMSO,  
5 µM calmidazolium chloride, or 50 µM W-7 from 3-5 dpf.  NaR cell number in each fish was 
quantified at 5 dpf  and shown as  mean ± SEM. ****P < 0.0001, One-way ANOVA followed by 





Figure 4.4 Akt1 signaling is required in NaR cell reactivation  
 (A-D) Wild-type larvae were treated with indicated conditions from 3 dpf to 4 dpf. The larvae 
were fixed and analyzed by immunostaining using antibody against phosphor-Akt (S473). pAkt 
473-positive cells were quantified and shown as mean ± SEM . *P < 0.05, ***P < 0.001, ****P 
< 0.0001, One-way ANOVA followed by Tukey’s multiple comparison test, n= 11-32.  
(E) Wild-type larvae were treated with low Ca2+ with Akt inhibitors at indicated concentrations 
from 3 dpf to 5 dpf and then subjected for in situ hybridization using trpv6 probe for NaR cell 
number quantification. NaR cell number were categorized according to scales reported before 
(Dai., et al, 2014). (F) WT larvae were treated from 3-4 dpf with low Ca2+ conditions with 
DMSO or Akt inhibitors at indicated concentrations and then subjected to pAkt-473 
immunostaining. pAkt-473-positive cells were quantified (mean ± SEM). One-way ANOVA 
followed by Tukey’s multiple comparison test or unpaired t-test was used for statistical analysis, 
*P < 0.05, ****P < 0.0001, n= 9-36.  
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Figure 4.5 STO-609 treatment abolished low Ca2+-mediated AKT signaling activation in 
zebrafish and in human colon carcinoma cells 
(A-B) Wild-type zebrafish larvae were transferred to the low Ca2+ containing the indicated 
concentrations of STO-609 or DMSO from 3 dpf to 4 dpf.  They were fixed and analyzed by 
immunostaining using an antibody against phosphor-Akt (S473) (A) or phospho-pAkt (Thr308).  
pAk-positive cells were quantified and shown as mean ± SEM, *P < 0.05, ****P < 0.0001, One-
way ANOVA ANOVA, n= 11-28. (C-D) Caco2 cells were treated with low Ca2+ serum-free 
medium containing DMSO or STO-609 for 24 hours before adding 200 ng/ml IGF-1. 10 min 
after the IGF-1 treatment, cells were harvest and subjected to western blot analysis using 
antibodies against phospho-Akt (Ser473) and phospho-pAkt (Thr308). A representative result is 
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shown in (A) and quantified results in (B). *P < 0.05, ***P < 0.001, ****P < 0.0001, one-way 






Figure 4.6. Schematic diagram of the proposed model.  
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Table 4-1 Key Resources Table 
Reagent type 



































Catalog no.: C1530 
chemical compound, 
drug 









Selleck Chemicals  
Catalog no.: S2670 
chemical compound, 
drug CCT128930 
Selleck Chemicals  




hydrate  Sigma-Aldrich 
Catalog no.:  B1427 
chemical compound, 
drug W-7 Calbiochem Catalog no.: 681629 
chemical compound, 
drug Calmidazolium chloride 
Tocris Bioscience 
Catalog no.: 2561 
chemical compound, 
drug Gadolinium(III) chloride 
Sigma-Aldrich 
Catalog no.: 439770 
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antibody 
Phospho-Akt (Ser473) Cell Signaling Technology Catalog no.: 4060 
antibody 
Phospho-Akt (Thr308) Cell Signaling 
Technology 















Previous studies have shown that the IGF/PI3-kinase/Akt/Tor pathway is required for the 
NaR cell reactivation under low [Ca2+] stress (Dai et al., 2014a). How this activation of IGF 
signaling under low [Ca2+] stress is regulated was not clear. In Chapter 2, I presented results 
showing that genetic deletion of igfbp5a blunted the low [Ca2+] stress-induced IGF signaling and 
NaR cell proliferation. Likewise, knockdown of IGFBP5 in human colon carcinoma cells also 
resulted in reduced IGF-stimulated cell proliferation, suggesting this is an evolutionarily 
conserved mechanism. These results reveal a conserved mechanism by which a locally expressed 
Igfbp activates IGF signaling and promoting cell quiescence-proliferation transition under Ca2+-
deficient states. 
Trpv6 is the epithelial Ca2+ channel with high selectivity for Ca2+. Through constructing a 
NaR cell-specific Ca2+ reporter fish, I showed in Chapter 3 that Trpv6 mediates constitutive Ca2+ 
influx and maintains the high [Ca2+]i in NaR cells. Pharmacological inhibition of Trpv6 activity 
or genetic knockout of Trpv6 resulted in reduced intracellular Ca2+ level and reduced IGF 
signaling in NaR cells and NaR cell reactivation. Blockage of IGF1 receptor or PI3 kinase or Tor 
activity retained NaR cells in quiescent state in trpv6-/-, suggesting Ca2+ influx-mediated by 
Trpv6 suppressed IGF signaling pathway. Using a chemical biology screen, I unraveled a novel 
player in IGF signaling-mediated regulation of NaR cellular quiescence, protein phosphatase 2A 
(PP2A). Genetic knockdown or pharmacological inhibition of PP2A elevates Akt 
Chapter 5 Conclusions and Future Directions 
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phosphorylation and NaR cell proliferation under normal Ca2+ conditions, indicating PP2A 
actions downstream of Ca2+ and upstream of Akt phosphorylation.  
Ca2+/calmodulin-dependent kinase kinase (CaMKK) is a calcium-dependent kinase and 
typically gets activated upon Ca2+ influx and increased intracellular Ca2+ concentration 
(Brzozowski and Skelding, 2019). Through chemical biology screening and later validated using 
CRISPR/Cas9-mediated knockdown of zebrafish camkk genes, I found CaMKK activity is 
required for low [Ca2+]i-triggered NaR cell quiescence exit decision. I propose that Ca2+ release 
from ER Ca2+ store can form local Ca2+ microdomains and activate CaMKK. In line with this 
hypothesis, depletion of ER Ca2+ store by blocking Ca2+ uptake into ER abolished Akt signaling 
activation as well as NaR cell quiescence exit under low [Ca2+]i. Taken together, these findings 
reveal a novel role of CaMKK in regulating IGF/PI3K/AKT/TOR pathway upon reduction of 
[Ca2+]i. 
 
5.2 Future directions 
5.2.1 Explore whether Igfbp5a activity is regulated by low [Ca2+] stress 
IGFBP5/Igfbp5a has been shown to inhibit and/or potentiate IGF actions in mammalian 
and zebrafish cells (Dai et al., 2010; Liu et al., 2018a; Ren et al., 2008; Zheng et al., 1998a). 
How the same protein exerts these opposing biological effects is not completely understood, and 
the importance of IGFBP5 proteinases has been suggested (Allard and Duan, 2018; Clemmons, 
2018; Conover and Oxvig, 2017; Zheng et al., 1998b). In vitro studies suggested that pregnancy-
associated plasma protein-A (PAPP-A) is tethered to the cell-surface and it cleaves IGFBP4, 
IGFBP5, and to a lesser degree IGFBP2, while PAPP-A2 is secreted and mainly cleaves IGFBP3 
and IGFBP5 (Gyrup and Oxvig, 2007; Oxvig, 2015). Recently, a hypocalcaemic hormone 
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stanniocalcin (STC) was identified as a powerful inhibitor of PAPP-A proteolytic activity in 
mice (Jepsen et al., 2015). Stanniocalcin was initially discovered in corpuscles of Stannius in 
teleost fish (Wagner et al., 1986) and later identified in mammalians as well (Wagner et al., 
1995). In zebrafish, stanniocalcin level was known to be regulated by environmental Ca2+ (Chou 
et al., 2015; Tseng et al., 2009). In a pilot experiment, I found zebrafish stc1 gene expression was 
positively associated with environmental Ca2+ level and is downregulated in trpv6-/- knockout 
(Figure 5.1). It will be interesting to further test if Igfbp5a is cleaved by PAPP-A in zebrafish 
and whether this process is modulated by Ca2+ through stanniocalcin. 
5.2.2 Determine whether PP2A or CaMKK activity is altered by Ca2+ 
Chemical biology screen unravels two novel regulators involved in Ca2+-regulated 
IGF/PI3K/AKT/TOR pathway, PP2A and CaMKK. The specific PP2A is unclear at present. 
PP2A has 3 distinct families of regulatory subunits.  One family of the regulatory subunits (B’’) 
are known to contain EF motifs and are potentially Ca2+-dependent. In a preliminary experiment, 
I found that knockdown of the two B’’ regulatory subunits of PP2A did not induce NaR cell 
proliferation (Figure 5.2). Other genes encoding B’’ regulatory subunits need to be tested in the 
future. Additionally, Ca2+ may regulate PP2A through other mechanisms. For example, PP2A 
activity has been reported to be under the regulation of other Ca2+-dependent molecules such as 
the Ca2+-dependent protease m-calpain (Janssens et al., 2009). It will also be critical to 
determine whether PP2A or CaMKK enzyme activity is altered by [Ca2+]i. Antibody targeting 
phosphorylated-PP2A are available but has not been tested in zebrafish (De Palma et al., 2019; 
Liu et al., 2008). An alternative way is to sort out GFP labelled-NaR cells through FACS and 
then assay PP2A or CaMKK activity using commercially available kit (Wallace et al., 2012; 
Yurimoto et al., 2012).  
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5.2.3 Determine whether local Ca2+ microdomains are involved  
Based on the CaMKK inhibitor STO-609 results and the fact that intracellular Ca2+ 
chelator BAPTA-AM decreased low Ca2+-mediated NaR cell proliferation. I postulate that Ca2+ 
release from ER is the underlying source for Ca2+ microdomains under low [Ca2+]i. Consistent 
with the proposed model, I found ER Ca2+ depletion abolished low Ca2+ stress-triggered Akt 
signaling elevation and NaR cell reactivation. However, preliminary analysis using the ER-
targeting Ca2+ reporter (ER-LAR-GECO1) did not show a significant reduction of ER Ca2+ level 
in NaR cells under low Ca2+ stress.  [Ca2+]ER is around 100 μM in the resting state and in the low 
micromolar range in the depletion state (Suzuki et al., 2014), 5000 to 10000-fold than that of the 
the cytosol.. LAR-GECO1 is a low affinity Ca2+ indicator (Kd = 24 µM) (Wu et al., 2014). A 
subtle change that is enough to induce a steep increase Ca2+ in the cytosol locally may not be 
captured by this Ca2+ indicator. Recently, bioluminescence low-affinity ER Ca2+ indicator with 
disassociation constant around 100 µM (Hossain et al., 2018) or CEPIA family reporters with 
even lower affinity towards Ca2+ (Kd = 500-700 µM) (Suzuki et al., 2014) has been reported and 
could be used to visualize the ER Ca2+ change in our system. These tools can be used in the 
future.  We can also analyze the cytosolic Ca2+ signals in the GCaMP7a reporter fish line under 
higher resolution to detect any aberrant microdomain Ca2+ signals in NaR cells. In combination 
with GFP-tagged IP3R (Thillaiappan et al., 2017) and organelle-specific marker, one can also 
determine whether the observed local Ca2+ microdomain is mediated by IP3R at the specific 
interorganellar surfaces. Deciphering this subcellular localization will shed new light on our 
understanding about how AKT signaling is regulated at endomembranes (Jethwa et al., 2015; 




Figure 5.1 stc1 expression is downregulated in low [Ca2+]e and trpv6-/- 
(A) Wild-type embryos were acclimated in varying Ca2+ solutions from 0-72 hpf. 10-20 embryos 
were pooled for RNA extraction and RT-qPCR. stc1 gene expression was normalized to beta-
actin. Mean ± SEM, n=3. One-way ANOVA followed by Turkey’s multiple comparison test was 
used for statistical analysis and different letter indicates P < 0.5. (B) Caudal fin of trpv6+/- 
intercrossed progeny were clipped at 7 dpf for genotyping. 6-10 embryos of the same genotype 
group were pooled together for RNA extraction and RT-qPCR. stc1 gene expression was 
normalized to beta-actin. Mean ± SEM, n=4. Unpaired t-test was used for statistical analysis and 






Figure 5.2 Knockdown of ppp2r3a and ppp2r3c doesn’t induce NaR cell proliferation  
(A) Schematic diagram of guide RNA targeting sites of ppp2r3a and ppp2r3c. Target sites are 
outlined by the red box. Red characters indicate the guide RNA targeting site sequence and blue 
characters indicate the PAM sequence. (B) Tg(igfbp5a:GFP) is injected with guide RNAs 
targeting ppp2r3a and ppp2r3c mixed with Cas9 mRNA at 1-cell stage. NaR cells were imaged 
and quantified at 3 dpf and 5 dpf. Unpaired  t-tests suggest slight decrease rather than increase of 
NaR cell number at both 3 dpf and 5 dpf. 
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